RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: hepatocellular carcinoma
Accession: DOID:684
browse the term
Definition: A liver carcinoma that has_material_basis_in undifferentiated hepatocytes and located_in the liver. (DO)
Synonyms: exact_synonym: Childhood Hepatocellular Carcinoma; HCC; Hepatocellular Cancer; Hepatocellular Carcinoma, Childhood Type, Somatic; LCC; adult liver cancer; adult liver cancers; hepatocellular cancers; hepatocellular carcinomas; hepatoma; hepatomas; liver cell carcinoma; liver cell carcinomas
narrow_synonym: HEPATOBLASTOMA; HEPATOBLASTOMA CAUSED BY SOMATIC MUTATION; hepatitis B virus induced hepatocellular carcinoma; hepatitis C virus induced hepatocellular carcinoma; hepatitis virus-related hepatocellular carcinoma
primary_id: MESH:D006528
alt_id: OMIM:114550
xref: EFO:0000182 ; EFO:0000189 ; EFO:0008503 ; EFO:0008504 ; EFO:0008505 ; ICD-O:M8170/3; NCI:C129298 ; NCI:C24029 ; NCI:C3099 ; NCI:C38756 ; NCI:C60416 ; ORDO:88673
For additional species annotation, visit the
Alliance of Genome Resources .
G
A2M
alpha-2-macroglobulin
ISO
CTD Direct Evidence: marker/mechanism mRNA,protein:increased expression:liver:
CTD RGD
PMID:15509519
RGD:1358261
NCBI chr 5:62,406,928...62,483,690
Ensembl chr 5:62,440,810...62,483,678
G
AADAT
aminoadipate aminotransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr14:19,768,816...19,792,254
Ensembl chr14:19,768,776...19,792,256
G
ABCA1
ATP binding cassette subfamily A member 1
severity
ISO
mRNA:decreased expression:liver (human)
RGD
PMID:16941710 PMID:30580964
RGD:1598532 RGD:24922199
NCBI chr 1:246,144,277...246,278,492
Ensembl chr 1:246,144,277...246,278,492
G
ABCB1
ATP-binding cassette, sub-family B (MDR/TAP), member 1
susceptibility
ISO
DNA:polymorphism: : c.1465C > T(human) DNA:polymorphism: :c.3751G>A(human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17510421 PMID:23488625 PMID:24175826 PMID:25625052
RGD:11041138 RGD:14700904 RGD:14700905
NCBI chr 9:93,049,955...93,146,469
G
ABCB4
ATP binding cassette subfamily B member 4
ISO
CTD Direct Evidence: marker/mechanism OMIM:114550
CTD MouseDO
PMID:22022477
NCBI chr 9:93,171,371...93,262,124
G
ABCC3
ATP binding cassette subfamily C member 3
ISO
mRNA:increased expression:liver
RGD
PMID:25842354
RGD:11535155
NCBI chr12:26,920,764...26,978,389
Ensembl chr12:26,920,821...26,978,363
G
ABCE1
ATP binding cassette subfamily E member 1
ISO
mRNA:increased expression:liver (human)
RGD
PMID:21932399
RGD:11041873
NCBI chr 8:83,302,055...83,353,208
Ensembl chr 8:83,299,322...83,353,109
G
ABL1
ABL proto-oncogene 1, non-receptor tyrosine kinase
ISO
RGD
PMID:32171747
RGD:126907997
NCBI chr 1:270,761,641...270,906,708
Ensembl chr 1:270,761,668...270,906,708
G
ACACA
acetyl-CoA carboxylase alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147110
NCBI chr12:38,580,916...38,875,067
Ensembl chr12:38,581,457...38,824,712
G
ACE
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1
susceptibility
ISO
CTD Direct Evidence: therapeutic DNA:insertion/deletion:intron 16:
CTD RGD
PMID:16328049 PMID:25208933
RGD:11343535
NCBI chr12:15,394,487...15,414,609
Ensembl chr12:15,394,487...15,414,703
G
ACER3
alkaline ceramidase 3
disease_progression
ISO
RGD
PMID:30097213
RGD:35673325
NCBI chr 9:10,985,078...11,167,386
Ensembl chr 9:10,967,857...11,162,502
G
ACLY
ATP citrate lyase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147110
NCBI chr12:20,796,678...20,841,301
Ensembl chr12:20,796,749...20,841,298
G
ACO2
aconitase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 5:7,014,383...7,071,023
Ensembl chr 5:7,008,719...7,071,025
G
ACOX1
acyl-CoA oxidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12771043 PMID:15565109
NCBI chr12:5,450,913...5,479,550
Ensembl chr12:5,439,361...5,479,546
G
ACSL4
acyl-CoA synthetase long chain family member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144
NCBI chr X:89,760,863...89,838,103
Ensembl chr X:89,760,866...89,806,274
G
ACTB
actin beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144 PMID:21472284
NCBI chr 3:4,084,275...4,090,383
Ensembl chr 3:4,082,216...4,090,356
G
ADAMTS1
ADAM metallopeptidase with thrombospondin type 1 motif 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19514085
NCBI chr13:190,277,175...190,285,957
Ensembl chr13:190,276,430...190,286,214
G
ADAMTS13
ADAM metallopeptidase with thrombospondin type 1 motif 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:273,022,014...273,066,916
Ensembl chr 1:273,024,009...273,056,039
G
ADD1
adducin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144
NCBI chr 8:1,627,146...1,710,653
Ensembl chr 8:1,627,062...1,710,650
G
ADGRG7
adhesion G protein-coupled receptor G7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr13:158,334,535...158,402,752
Ensembl chr13:158,338,849...158,408,525
G
ADH4
alcohol dehydrogenase 4 (class II), pi polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:121,225,485...121,259,262 NCBI chr X:98,582,002...98,583,002
Ensembl chr 8:121,225,656...121,261,746
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
susceptibility
ISO
DNA:SNP:intron:+276T>G (rs1501299) (human)
RGD
PMID:23740135
RGD:14401720
NCBI chr13:124,633,906...124,646,237
Ensembl chr13:124,633,685...124,646,646
G
ADRA1A
adrenoceptor alpha 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr14:10,623,391...10,733,378
Ensembl chr14:10,626,293...10,733,068
G
ADRA2B
adrenoceptor alpha 2B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 3:45,760,966...45,762,306
Ensembl chr 3:45,760,541...45,764,175
G
AFP
alpha fetoprotein
severity treatment disease_progression
ISO
protein:increased expression:serum (human) CTD Direct Evidence: marker/mechanism associated with hepatitis B
RGD CTD
PMID:9029167 PMID:15276417 PMID:22147961 PMID:22392353 PMID:24012840 PMID:25968302 PMID:25999787 PMID:28284560 PMID:28611981 PMID:32961231 More...
RGD:125097525 RGD:126790579 RGD:126790583 RGD:14401581 RGD:152177911
NCBI chr 8:69,677,690...69,698,864
Ensembl chr 8:69,677,690...69,698,864
G
AICDA
activation induced cytidine deaminase
ISO
RGD
PMID:18997814
RGD:127285629
NCBI chr 5:62,777,236...62,787,342
Ensembl chr 5:62,777,352...62,787,369
G
AK3
adenylate kinase 3
ISO
protein:decreased expression:liver
RGD
PMID:17203974
RGD:13842477
NCBI chr 1:217,236,561...217,263,144
Ensembl chr 1:217,236,482...217,261,367
G
AKR1A1
aldo-keto reductase family 1 member A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32805337
NCBI chr 6:165,811,245...165,825,168
Ensembl chr 6:165,811,247...165,824,896
G
AKR1B1
aldo-keto reductase family 1 member B
ISO
protein:increased expression:liver (human) protein:increased expression:liver (rat)
RGD
PMID:19422879 PMID:21683810
RGD:5509919 RGD:8548685
NCBI chr18:14,593,516...14,752,316
Ensembl chr18:14,684,036...14,752,310
G
AKT1
AKT serine/threonine kinase 1
treatment
ISO
ClinVar Annotator: match by term: Hepatocellular cancer
RGD ClinVar
PMID:17611497 PMID:18256540 PMID:18392055 PMID:18504432 PMID:18611285 PMID:18954143 PMID:19418217 PMID:19487299 PMID:19853286 PMID:20233444 PMID:20453058 PMID:21464312 PMID:21512767 PMID:21793738 PMID:22538770 PMID:22610119 PMID:22722201 PMID:22722839 PMID:22980975 PMID:23237847 PMID:23348505 PMID:23700467 PMID:23728071 PMID:23934607 PMID:24190505 PMID:24657128 PMID:25157968 PMID:25741868 PMID:25999787 PMID:26619011 PMID:28492532 PMID:31801250 More...
RGD:151893509 RGD:152177911
G
AKT2
AKT serine/threonine kinase 2
ISO
protein:increased phosphorylation:liver cancer cell (rat) protein:increased phosphorylation:liver (mouse)
RGD
PMID:19309364 PMID:28100771
RGD:127285675 RGD:2313299
NCBI chr 6:48,555,785...48,620,472
Ensembl chr 6:48,555,795...48,587,919
G
ALB
albumin
susceptibility
ISO
associated with hepatitis C;protein:decreased expression:serum protein:decreased expression:serum (human)
RGD
PMID:22392353 PMID:23892757 PMID:29040987
RGD:11035269 RGD:125097525 RGD:14694841
NCBI chr 8:69,643,427...69,663,152
Ensembl chr 8:69,531,487...69,721,696
G
ALDH2
aldehyde dehydrogenase 2 family member
no_association severity susceptibility
ISO
DNA:missense mutation:exon 12: (human) mRNA, protein:decreased expression:liver (human) associated with hepatitis B;DNA;missense mutation, haplotype:cds: (rs671) (human) DNA:missense mutation:cds: (rs671) (human) protein:decreased expression: liver (human) associated with alcohol use disorder;DNA:missense mutation:cds: (human) associated with alcoholic liver cirrhosis;DNA:missense mutation:cds:p.E487K (human) associated with hepatitis C:DNA:SNP:exon 12 (human) DNA:missense mutation:cds, exon 12:p.E487K (human)
RGD
PMID:1916152 PMID:10737710 PMID:12940444 PMID:18439068 PMID:25778454 PMID:26150517 PMID:26827895 PMID:28027570 PMID:29765251 More...
RGD:11054822 RGD:14696699 RGD:14696778 RGD:14696779 RGD:14700899 RGD:15036809 RGD:15042857 RGD:15042859 RGD:15042862
NCBI chr14:39,902,317...39,933,113
Ensembl chr14:39,896,565...39,933,124
G
ALDH7A1
aldehyde dehydrogenase 7 family member A1
severity
ISO
mRNA:altered expression:liver tumor (human)
RGD
PMID:30901224
RGD:152995286
NCBI chr 2:129,663,226...129,709,728
Ensembl chr 2:129,662,969...129,709,705
G
ALDOC
aldolase, fructose-bisphosphate C
ISO
mRNA:increased expression:liver
RGD
PMID:3830170
RGD:2301136
NCBI chr12:44,823,376...44,827,273
Ensembl chr12:44,822,780...44,827,597
G
ALX4
ALX homeobox 4
ameliorates
ISO
mRNA, protein:decreased expression:liver
RGD
PMID:28081728 PMID:31132711
RGD:153323329 RGD:153323330
NCBI chr 2:18,070,726...18,085,685
Ensembl chr 2:18,037,401...18,085,683
G
ANGPTL6
angiopoietin like 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:68,947,067...68,958,820
Ensembl chr 2:68,947,071...68,958,766
G
ANK3
ankyrin 3
ISO
protein:decreased expression:liver
RGD
PMID:26652480
RGD:153344559
NCBI chr14:63,416,154...63,809,220
G
ANLN
anillin, actin binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr18:37,647,952...37,710,939
Ensembl chr18:37,647,961...37,708,575
G
ANTXR1
ANTXR cell adhesion molecule 1
treatment
ISO
RGD
PMID:20650339
RGD:9684932
NCBI chr 3:73,157,744...73,398,379
Ensembl chr 3:73,157,747...73,398,379
G
ANXA10
annexin A10
disease_progression
ISO
mRNA:decreased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr14:21,249,020...21,315,260
Ensembl chr14:21,248,531...21,315,190
G
ANXA2
annexin A2
ISO
mRNA, protein:increased expression:liver (human)
RGD
PMID:33675609
RGD:152999436
NCBI chr 1:111,588,721...111,635,064
Ensembl chr 1:111,588,306...111,635,059
G
ANXA4
annexin A4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 3:72,623,311...72,654,591
Ensembl chr 3:72,622,358...72,694,212
G
ANXA6
annexin A6
disease_progression
ISO
associated with tumor vascularization; protein:decreased expression:liver tumor (human)
RGD
PMID:30901224
RGD:152995286
NCBI chr16:71,857,229...71,913,723
Ensembl chr16:71,857,258...71,913,723
G
APC
APC regulator of WNT signaling pathway
ISO
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma
OMIM ClinVar
PMID:1316610 PMID:8381579 PMID:8381580 PMID:9536098 PMID:9824584 PMID:11247896 PMID:11466687 PMID:15311282 PMID:15459959 PMID:17293347 PMID:17489848 PMID:17576681 PMID:18199528 PMID:19793053 PMID:20223039 PMID:20685668 PMID:21859464 PMID:21901162 PMID:22135120 PMID:22425061 PMID:22431159 PMID:22447671 PMID:22703879 PMID:23159591 PMID:23460355 PMID:23484150 PMID:24033266 PMID:24448499 PMID:24573554 PMID:24599579 PMID:24728327 PMID:25186627 PMID:25479140 PMID:25590978 PMID:25637381 PMID:25741868 PMID:25925381 PMID:25980754 PMID:26207792 PMID:26447891 PMID:26467025 PMID:26530882 PMID:26580448 PMID:26690363 PMID:26845104 PMID:26900293 PMID:27028212 PMID:27081525 PMID:27150160 PMID:27600092 PMID:28127413 PMID:28135048 PMID:28135145 PMID:28195569 PMID:28492532 PMID:29641532 PMID:29684080 PMID:30267214 PMID:30374176 PMID:31428572 PMID:32390703 PMID:34426522 PMID:35189564 PMID:35264596 More...
NCBI chr 2:116,913,354...116,985,303
Ensembl chr 2:116,812,582...117,034,887
G
APCS
amyloid P component, serum
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144
NCBI chr 4:90,900,585...90,901,854
Ensembl chr 4:90,898,689...90,901,874
G
APEX1
apurinic/apyrimidinic endodeoxyribonuclease 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25109342 PMID:33841550
RGD:152998960
NCBI chr 7:78,451,845...78,454,938
Ensembl chr 7:78,451,851...78,454,938
G
APLN
apelin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr X:106,236,746...106,246,563
Ensembl chr X:106,236,749...106,246,377
G
APOA1
apolipoprotein A1
disease_progression
ISO
CTD Direct Evidence: marker/mechanism associated with hepatitis B; protein:decreased expression:plasma (human)
CTD RGD
PMID:21472284 PMID:23935864 PMID:31211449
RGD:153350082 RGD:25671438
NCBI chr 9:44,216,481...44,218,360
Ensembl chr 9:44,216,392...44,218,713
G
APOA2
apolipoprotein A2
ISO
associated with hepatitis B; mRNA:increased expression:liver
RGD
PMID:31211449
RGD:153350082
NCBI chr 4:89,237,514...89,239,126
Ensembl chr 4:89,237,511...89,240,319
G
APOA4
apolipoprotein A4
disease_progression
ISO
associated with hepatitis B;
RGD
PMID:31211449
RGD:153350082
NCBI chr 9:44,201,587...44,204,072
Ensembl chr 9:44,201,508...44,204,206
G
APOC2
apolipoprotein C2
ISO
associated with hepatitis B; mRNA:increased expression:liver
RGD
PMID:31211449
RGD:153350082
NCBI chr 6:51,404,219...51,406,302
G
APOC3
apolipoprotein C3
susceptibility disease_progression
ISO
associated with Chronic Hepatitis B;DNA:SNP: :rs2854116(human) associated with hepatitis B;
RGD
PMID:27547913 PMID:31211449
RGD:153344620 RGD:153350082
NCBI chr 9:44,211,171...44,213,538
Ensembl chr 9:44,211,194...44,213,533
G
APOC4
apolipoprotein C4
disease_progression
ISO
associated with hepatitis B;
RGD
PMID:31211449
RGD:153350082
NCBI chr 6:51,400,909...51,403,719
Ensembl chr 6:51,400,931...51,405,169
G
APOE
apolipoprotein E
ISO
protein:increased expression:liver, serum (mouse)
RGD
PMID:21644509
RGD:6903288
NCBI chr 6:51,373,113...51,375,333
Ensembl chr 6:51,372,292...51,375,330
G
APOF
apolipoprotein F
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 5:21,759,670...21,760,753
Ensembl chr 5:21,759,475...21,760,815
G
APRT
adenine phosphoribosyltransferase
ISO
protein:increased activity:hepatoma (rat)
RGD
PMID:6327016
RGD:5135035
NCBI chr 6:890,272...893,278
Ensembl chr 6:890,831...893,276
G
AR
androgen receptor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18639551
NCBI chr X:53,609,113...53,806,778
Ensembl chr X:53,609,176...53,800,677
G
ARG1
arginase 1
disease_progression
ISO
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human)
RGD
PMID:17210712 PMID:30901224
RGD:152995286 RGD:4140476
NCBI chr 1:32,006,035...32,028,983
Ensembl chr 1:32,006,046...32,028,988
G
ARHGAP11A
Rho GTPase activating protein 11A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:136,497,436...136,522,355
G
ARHGAP44
Rho GTPase activating protein 44
exacerbates
ISO
protein:decreased expression:liver (human)
RGD
PMID:31136984
RGD:401901276
NCBI chr12:57,049,900...57,206,706
Ensembl chr12:57,049,895...57,206,889
G
ARHGEF39
Rho guanine nucleotide exchange factor 39
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:236,383,684...236,387,705
Ensembl chr 1:236,383,925...236,387,667
G
ARID1A
AT-rich interaction domain 1A
treatment exacerbates
ISO
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:liver (human) mRNA, protein:decreased expression:liver (human) human gene in mouse model associated with non-alcoholic steatohepatitis
RGD CTD
PMID:22561517 PMID:22634756 PMID:22922871 PMID:25975202 PMID:26569409 PMID:26589513 PMID:29113912 PMID:29136504 More...
RGD:11344640 RGD:125097485 RGD:125097495 RGD:125097519 RGD:126790634
NCBI chr 6:84,049,729...84,124,302
Ensembl chr 6:84,049,087...84,123,349
G
ARID1B
AT-rich interaction domain 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22634756
NCBI chr 1:9,791,627...10,227,381
Ensembl chr 1:9,791,633...10,227,502
G
ARID2
AT-rich interaction domain 2
exacerbates disease_progression
ISO
CTD Direct Evidence: marker/mechanism associated with hepatitis B;protein:decreased expression:liver
RGD CTD
PMID:21822264 PMID:22634756 PMID:25701229 PMID:27351279 PMID:28498550 PMID:32071245 More...
RGD:150340708 RGD:150340711 RGD:150340712 RGD:150429631
NCBI chr 5:76,637,385...76,800,155
Ensembl chr 5:76,636,967...76,797,043
G
ARID3A
AT-rich interaction domain 3A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35179300
NCBI chr 2:77,428,618...77,464,916
Ensembl chr 2:77,431,087...77,464,628
G
ARRB2
arrestin beta 2
treatment
ISO
RGD
PMID:33841550
RGD:152998960
NCBI chr12:52,161,776...52,170,362
Ensembl chr12:52,161,778...52,170,342
G
ASF1B
anti-silencing function 1B histone chaperone
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:65,063,186...65,072,681
Ensembl chr 2:65,062,766...65,072,679
G
ASL
argininosuccinate lyase
disease_progression
ISO
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human)
RGD
PMID:30901224
RGD:152995286
NCBI chr 3:16,637,481...16,646,869
Ensembl chr 3:16,637,481...16,646,867
G
ASNS
asparagine synthetase (glutamine-hydrolyzing)
ISO
protein:increased activity:serum (rat)
RGD
PMID:10081
RGD:2316006
NCBI chr 9:77,318,341...77,336,290
Ensembl chr 9:77,318,213...77,343,035
G
ASPG
asparaginase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
G
ASPM
assembly factor for spindle microtubules
disease_progression
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:18676753 PMID:28284560
RGD:13439743
NCBI chr10:19,971,516...20,039,680
Ensembl chr10:19,975,192...20,039,623
G
ASS1
argininosuccinate synthase 1
disease_progression
ISO
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human)
RGD
PMID:12359751 PMID:30901224
RGD:152995286 RGD:4140479
NCBI chr 1:270,531,434...270,586,364
Ensembl chr 1:270,531,589...270,586,364
G
ATG101
autophagy related 101
disease_progression
ISO
RGD
PMID:35592424
RGD:153350091
NCBI chr 5:17,418,085...17,425,770
Ensembl chr 5:17,418,121...17,425,624
G
ATG7
autophagy related 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29191453
NCBI chr13:67,301,756...67,699,141
Ensembl chr13:67,417,938...67,707,654
G
ATM
ATM serine/threonine kinase
exacerbates
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (human)
CTD RGD
PMID:12866955 PMID:19919837
RGD:126781750
NCBI chr 9:36,620,656...36,759,555
Ensembl chr 9:36,620,658...36,759,552
G
ATP5PB
ATP synthase peripheral stalk-membrane subunit b
ISO
associated with hepatitis C
RGD
PMID:18932288
RGD:14696822
NCBI chr 4:108,896,063...108,907,626
Ensembl chr 4:108,896,057...108,907,805
G
ATP5PD
ATP synthase peripheral stalk subunit d
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr12:6,241,467...6,247,344
G
ATP7B
ATPase copper transporting beta
onset
ISO
RGD
PMID:8291609
RGD:15036817
NCBI chr11:15,892,549...15,942,070
Ensembl chr11:15,876,612...15,942,064
G
AURKA
aurora kinase A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr17:56,954,838...56,972,435
G
AURKB
aurora kinase B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr12:53,410,833...53,426,165
Ensembl chr12:53,410,177...53,423,225
G
AXIN1
axin 1
disease_progression
ISO
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma protein:decreased expression:liver (human) associated with Hepatitis B, Chronic,DNA:SNP, haplotype:exon:(rs1805105) T>C (human)
OMIM ClinVar RGD
PMID:10700176 PMID:25741868 PMID:25741905 PMID:26968103 PMID:28492532 PMID:31514071 PMID:37582359 More...
RGD:14402039 RGD:150530482
NCBI chr 3:41,344,908...41,393,999
Ensembl chr 3:41,337,071...41,393,997
G
AXIN2
axin 2
ISO
protein:increased expression:liver:
RGD
PMID:11809809
RGD:151356508
NCBI chr12:12,311,293...12,343,207
Ensembl chr12:12,311,298...12,343,200
G
AZGP1
alpha-2-glycoprotein 1, zinc-binding
disease_progression
ISO
mRNA:decreased expression:liver associated with hepatitis B;mRNA:decreased expression:liver
RGD
PMID:22625427 PMID:26902423 PMID:27993894
RGD:153350130 RGD:153350132 RGD:153350133
NCBI chr 3:7,867,521...7,874,857
G
AZIN1
antizyme inhibitor 1
disease_progression
ISO
RNA:increased editing:liver
RGD
PMID:23291631
RGD:14700705
NCBI chr 4:34,221,368...34,257,261
Ensembl chr 4:34,234,679...34,257,134
G
BANF1
BAF nuclear assembly factor 1
treatment
ISO
mRNA, protein:increased expression:liver (human) mRNA, protein:increased expression:liver (rat)
RGD
PMID:29059470
RGD:155791679
NCBI chr 2:6,333,451...6,335,326
Ensembl chr 2:6,333,453...6,334,839
G
BAX
BCL2 associated X, apoptosis regulator
treatment
ISO
RGD
PMID:33841550
RGD:152998960
NCBI chr 6:54,222,341...54,228,150
Ensembl chr 6:54,222,336...54,228,140
G
BCL2
BCL2 apoptosis regulator
treatment
ISO
mRNA:increased expression:liver (mouse)
RGD
PMID:28100771 PMID:33841550
RGD:127285675 RGD:152998960
NCBI chr 1:158,337,403...158,518,214
Ensembl chr 1:158,337,522...158,518,879
G
BCL2L1
BCL2 like 1
treatment
ISO
CTD Direct Evidence: marker/mechanism|therapeutic mRNA:increased expression:liver (mouse)
CTD RGD
PMID:10629087 PMID:11509945 PMID:28100771 PMID:33841550
RGD:127285675 RGD:152998960
NCBI chr17:35,366,139...35,415,798
Ensembl chr17:35,366,143...35,414,694
G
BCO2
beta-carotene oxygenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:39,864,136...39,916,491
Ensembl chr 9:39,872,645...39,917,263
G
BCORL1
BCL6 corepressor like 1
disease_progression
ISO
RGD
PMID:26879601 PMID:29679906
RGD:11556159 RGD:150340705
NCBI chr X:106,547,754...106,613,130
Ensembl chr X:106,549,139...106,612,894
G
BHMT
betaine--homocysteine S-methyltransferase
disease_progression
ISO
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human)
RGD
PMID:30901224
RGD:152995286
NCBI chr 2:87,911,093...87,935,252
Ensembl chr 2:87,910,603...87,935,252
G
BHMT2
betaine--homocysteine S-methyltransferase 2
severity
ISO
mRNA:altered expression:liver tumor (human)
RGD
PMID:30901224
RGD:152995286
NCBI chr 2:87,866,631...87,882,623
Ensembl chr 2:87,866,621...87,882,716
G
BID
BH3 interacting domain death agonist
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15289866
NCBI chr 5:69,849,007...69,874,647
Ensembl chr 5:69,849,002...69,875,853
G
BIRC3
baculoviral IAP repeat containing 3
exacerbates treatment ameliorates
ISO
associated with hepatitis B;mRNA, protein:increased expression:liver (human) human cell line in a mouse model
RGD
PMID:22682366 PMID:22820591 PMID:30210622 PMID:30368883 PMID:33310033
RGD:152998937 RGD:152998984 RGD:152998986 RGD:152998988 RGD:152999010
NCBI chr 9:33,003,570...33,020,252
Ensembl chr 9:33,003,276...33,020,242
G
BIRC5
baculoviral IAP repeat containing 5
disease_progression
ISO
CTD Direct Evidence: marker/mechanism|therapeutic mRNA:increased expression:liver (human)
CTD RGD
PMID:16086872 PMID:20514400 PMID:31964418
RGD:153344516
NCBI chr12:3,747,276...3,755,214
Ensembl chr12:3,747,279...3,755,215
G
BIRC7
baculoviral IAP repeat containing 7
exacerbates
ISO
mRNA:increased expression:liver (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr17:62,351,663...62,356,220
G
BLZF1
basic leucine zipper nuclear factor 1
disease_progression
ISO
RGD
PMID:26342799
RGD:14398326
NCBI chr 4:81,597,312...81,639,788
Ensembl chr 4:81,571,300...81,639,577
G
BMI1
BMI1 proto-oncogene, polycomb ring finger
treatment
ISO
RGD
PMID:26919246
RGD:14928318
NCBI chr10:52,586,089...52,596,154
Ensembl chr10:52,586,509...52,596,564
G
BMPER
BMP binding endothelial regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr18:39,417,830...39,664,010
Ensembl chr18:39,412,838...39,663,592
G
BRAF
B-Raf proto-oncogene, serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27222248
NCBI chr18:8,957,963...9,132,558
Ensembl chr18:8,957,991...9,132,553
G
BSG
basigin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36574092
NCBI chr 2:77,735,586...77,743,451
G
BTG2
BTG anti-proliferation factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18393292
NCBI chr 9:64,033,853...64,037,795
Ensembl chr 9:64,031,832...64,035,837
G
BUB1
BUB1 mitotic checkpoint serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 3:45,585,188...45,623,240
Ensembl chr 3:45,585,226...45,624,543
G
BUB1B
BUB1 mitotic checkpoint serine/threonine kinase B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:131,093,026...131,143,840
Ensembl chr 1:131,092,958...131,143,794
G
C3
complement C3
ISO
RGD
PMID:23245919
RGD:11040806
NCBI chr 2:72,431,470...72,471,622
Ensembl chr 2:72,431,212...72,472,228
G
C9
complement C9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144 PMID:28284560
NCBI chr16:24,521,318...24,575,939
Ensembl chr16:24,520,634...24,590,338
G
CA12
carbonic anhydrase 12
disease_progression ameliorates
ISO
mRNA:altered expression:liver
RGD
PMID:29900055 PMID:31934040 PMID:35362480
RGD:153352325 RGD:153352328 RGD:155226869
NCBI chr 1:108,649,277...108,710,658
Ensembl chr 1:108,649,271...108,710,651
G
CA2
carbonic anhydrase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 4:51,194,686...51,211,436
Ensembl chr 4:51,193,756...51,211,259
G
CA9
carbonic anhydrase 9
ISO
mRNA:altered expression:liver
RGD
PMID:29900055
RGD:155226869
NCBI chr 1:236,393,727...236,400,994
Ensembl chr 1:236,394,306...236,400,822
G
CAB39
calcium binding protein 39
disease_progression
ISO
RGD
PMID:28605041
RGD:14398832
NCBI chr15:131,492,575...131,584,963
Ensembl chr15:131,492,578...131,584,962
G
CAD
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
ISO
DNA:amplification:cds (rat) mRNA:increased expression:liver
RGD
PMID:2888462 PMID:2914957 PMID:7053379
RGD:10755426 RGD:2303530 RGD:5132587
NCBI chr 3:111,887,017...111,914,511
Ensembl chr 3:111,887,020...111,914,492
G
CADM1
cell adhesion molecule 1
ISO
DNA, mRNA, protein:hypermethylation, decreased expression:promoter:liver
RGD
PMID:17428255
RGD:2289095
NCBI chr 9:42,644,487...42,984,934
Ensembl chr 9:42,644,429...42,985,017
G
CADM2
cell adhesion molecule 2
disease_progression
ISO
mRNA, protein:decreased expression:liver
RGD
PMID:24240726
RGD:15092075
NCBI chr13:169,681,947...170,753,114
Ensembl chr13:169,688,958...170,014,005
G
CALR
calreticulin
exacerbates treatment
ISO
protein:increased expression:liver (human) human cells and recombinant gene in a mouse model
RGD
PMID:12096119 PMID:24997628 PMID:27055635
RGD:150521681 RGD:150521690 RGD:150521691
NCBI chr 2:66,098,263...66,102,074
Ensembl chr 2:66,098,229...66,102,132
G
CAMK2N1
calcium/calmodulin dependent protein kinase II inhibitor 1
ISO
RGD
PMID:23651211
RGD:18337283
NCBI chr 6:78,730,204...78,734,232
Ensembl chr 6:78,730,206...78,733,740
G
CAP2
cyclase associated actin cytoskeleton regulatory protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:13,211,110...13,350,966
Ensembl chr 7:13,211,574...13,350,961
G
CAPN3
calpain 3
ISO
mRNA:decreased expression:skeletal muscle
RGD
PMID:10806331
RGD:1600777
NCBI chr 1:128,960,117...129,013,508
Ensembl chr 1:128,960,118...129,013,546
G
CARM1
coactivator associated arginine methyltransferase 1
ISO
mRNA,protein:increased expression:liver:
RGD
PMID:23912631
RGD:9586718
NCBI chr 2:69,602,121...69,644,862
Ensembl chr 2:69,602,136...69,644,854
G
CASP3
caspase 3
treatment
ISO
RGD
PMID:29133031 PMID:33841550
RGD:13782296 RGD:152998960
NCBI chr15:45,744,320...45,753,252
Ensembl chr15:45,742,751...45,764,213
G
CASP8
caspase 8
treatment severity
ISO
associated with hepatitis B;DNA:insertion/deletion:promoter: (rs3834129) (human)
OMIM RGD
PMID:28643196 PMID:29133031
RGD:13782296 RGD:14695027
NCBI chr15:104,923,659...104,948,470
Ensembl chr15:104,923,953...104,948,468
G
CASP9
caspase 9
treatment
ISO
RGD
PMID:29133031
RGD:13782296
NCBI chr 6:74,707,597...74,730,033
Ensembl chr 6:74,706,516...74,730,007
G
CAT
catalase
disease_progression
ISO
associated with liver cirrhosis with Hepatitis C;DNA:SNP:promoter:-262T>C (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:21907168 PMID:33010264
RGD:27095879
NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452
G
CBFB
core-binding factor subunit beta
ISO
mRNA:decreased expression:liver
RGD
PMID:17094378
RGD:126775147
NCBI chr 6:27,684,320...27,750,856
Ensembl chr 6:27,684,030...27,750,852
G
CBL
Cbl proto-oncogene
disease_progression
ISO
RGD
PMID:26474280
RGD:11536137
NCBI chr 9:46,416,937...46,512,855
Ensembl chr 9:46,416,938...46,512,834
G
CBX2
chromobox 2
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr12:2,570,841...2,580,336
Ensembl chr12:2,570,851...2,580,337
G
CBX4
chromobox 4
disease_progression
ISO
protein:increased expression:cytoplasm:
RGD
PMID:23943028 PMID:24838576
RGD:9586738 RGD:9586739
NCBI chr12:2,520,913...2,527,245
Ensembl chr12:2,521,027...2,527,241
G
CBX7
chromobox 7
ISO
mRNA:decreased expression:liver
RGD
PMID:22041561
RGD:9587355
NCBI chr 5:9,070,312...9,090,467
Ensembl chr 5:9,070,353...9,087,634
G
CCBE1
collagen and calcium binding EGF domains 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:161,320,627...161,556,539
Ensembl chr 1:161,321,273...161,556,537
G
CCL1
C-C motif chemokine ligand 1
ISO
mRNA:increased expression:liver (mouse)
RGD
PMID:26569409
RGD:11344640
NCBI chr12:40,728,014...40,731,411
Ensembl chr12:40,728,014...40,731,411
G
CCL14
C-C motif chemokine ligand 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr12:39,611,887...39,616,050
Ensembl chr12:39,611,868...39,616,159
G
CCL2
chemokine (C-C motif) ligand 2
treatment
ISO
RNA:increased expression:liver
RGD
PMID:12679798 PMID:22402625 PMID:27980102
RGD:14995459 RGD:14995468 RGD:14995927
NCBI chr12:40,798,109...40,800,013
Ensembl chr12:40,798,109...40,800,026
G
CCL3L1
chemokine (C-C motif) ligand 3-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16284949
NCBI chr12:39,491,999...39,493,345
Ensembl chr12:39,491,914...39,493,774
G
CCL5
C-C motif chemokine ligand 5
susceptibility treatment
ISO
DNA:polymorphisms:promoter:-403G>A,-28C>G (human) associated with alcoholic liver cirrhosis;DNA:SNP:promoter:-403G>A(human)
RGD
PMID:21610221 PMID:22374185 PMID:28011329
RGD:14995306 RGD:14995333 RGD:14995338
NCBI chr12:39,652,731...39,659,121
Ensembl chr12:39,648,598...39,659,118
G
CCN1
cellular communication network factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17699798
NCBI chr 4:130,392,404...130,395,179
Ensembl chr 4:130,392,407...130,395,150
G
CCNA1
cyclin A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12029619
NCBI chr11:12,396,149...12,405,357
Ensembl chr11:12,396,301...12,405,350
G
CCNB1
cyclin B1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr16:47,338,239...47,348,385
Ensembl chr16:47,338,110...47,348,377
G
CCNB2
cyclin B2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:112,907,047...112,942,218
Ensembl chr 1:112,907,047...112,942,235
G
CCND1
cyclin D1
susceptibility
ISO
associated with Hepatitis B, Chronic;DNA:SNP:splice-site mutation:870G>A (human) mRNA:increased expression:liver (mouse) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12029619 PMID:19919837 PMID:22649188 PMID:25822088 PMID:25851350 PMID:26189965 PMID:28100771 More...
RGD:127285675 RGD:14401586
NCBI chr 2:3,621,242...3,633,380
Ensembl chr 2:3,621,246...3,633,296
G
CCND2
cyclin D2
disease_progression susceptibility severity
ISO
associated with hepatitis B associated with Chronic Hepatitis C;DNA:SNP: :rs1049606(human) DNA:hypermethylation:CpG site
RGD
PMID:22004425 PMID:31059558 PMID:33320844
RGD:151664743 RGD:151665109 RGD:151665169
NCBI chr 5:66,092,483...66,114,575
Ensembl chr 5:66,087,379...66,114,571
G
CCNE1
cyclin E1
ameliorates
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12029619 PMID:17196522 PMID:22634754 PMID:28100771 PMID:29551768
RGD:127285675 RGD:153297807 RGD:2289277
NCBI chr 6:39,919,541...39,933,224
Ensembl chr 6:39,919,624...39,933,363
G
CCNF
cyclin F
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 3:39,585,597...39,603,088
Ensembl chr 3:39,585,607...39,603,079
G
CCNG1
cyclin G1
severity treatment disease_progression
ISO
protein:decreased expression:liver (human) human cells in mouse model protein:increased expression:liver (human)
RGD
PMID:19584283 PMID:22835824 PMID:23804702 PMID:24034575 PMID:25431954 PMID:26345095 PMID:27982046 PMID:33543294 More...
RGD:151356922 RGD:151356932 RGD:151356933 RGD:151356967 RGD:151356970 RGD:151356981 RGD:151361198 RGD:151361200
NCBI chr16:60,349,255...60,356,737
Ensembl chr16:60,349,258...60,356,738
G
CCNG2
cyclin G2
ISO
RGD
PMID:27982046
RGD:151361200
NCBI chr 8:72,790,394...72,800,553
Ensembl chr 8:72,791,703...72,800,551
G
CCR1
C-C motif chemokine receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16284949
NCBI chr13:29,227,218...29,233,862
Ensembl chr13:29,227,222...29,233,960
G
CD163
CD163 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 5:63,300,200...63,334,497
Ensembl chr 5:63,300,231...63,334,498
G
CD274
CD274 molecule
disease_progression
ISO
CTD Direct Evidence: marker/mechanism associated with hepatitis B associated with hepatitis B
CTD RGD
PMID:21912640 PMID:22396772 PMID:30267213
RGD:40818240 RGD:41410800
NCBI chr 1:216,646,378...216,792,731
Ensembl chr 1:216,660,041...216,792,724
G
CD276
CD276 molecule
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16217749
NCBI chr 7:59,703,283...59,733,910
Ensembl chr 7:59,703,289...59,733,777
G
CD34
CD34 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:134,912,793...134,937,763
Ensembl chr 9:134,913,121...134,937,762
G
CD40LG
CD40 ligand
ISO
RGD
PMID:19016771
RGD:2313413
NCBI chr X:111,778,666...111,788,901
Ensembl chr X:111,778,493...111,789,709
G
CD5L
CD5 molecule like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 4:92,394,535...92,412,146
G
CD68
CD68 molecule
severity
ISO
protein:increased expression:liver (human)
RGD
PMID:28656201
RGD:40924686
NCBI chr12:52,874,754...52,877,256
Ensembl chr12:52,874,785...52,877,695
G
CDC20
cell division cycle 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:167,886,266...167,890,587
Ensembl chr 6:167,886,270...167,890,583
G
CDC25C
cell division cycle 25C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:140,289,156...140,323,696
Ensembl chr 2:140,289,115...140,324,425
G
CDC27
cell division cycle 27
ISO
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar
NCBI chr12:16,810,868...16,882,271
Ensembl chr12:16,810,910...16,882,269
G
CDC45
cell division cycle 45
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr14:51,133,111...51,158,604
Ensembl chr14:51,133,408...51,158,606
G
CDC6
cell division cycle 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr12:22,101,281...22,118,441
Ensembl chr12:22,101,282...22,118,593
G
CDCA2
cell division cycle associated 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr14:9,517,763...9,571,303
Ensembl chr14:9,518,201...9,566,588
G
CDCA3
cell division cycle associated 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 5:63,858,905...63,861,902
Ensembl chr 5:63,859,541...63,864,269
G
CDCA5
cell division cycle associated 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:7,103,648...7,112,772
Ensembl chr 2:7,103,673...7,113,202
G
CDCA8
cell division cycle associated 8
disease_progression
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver (human)
CTD RGD
PMID:28284560 PMID:35693827
RGD:153344586
NCBI chr 6:93,750,694...93,764,845
Ensembl chr 6:93,750,689...93,764,836
G
CDH1
cadherin 1
severity
ISO
DNA:hypermethylation protein:decreased expression:liver mRNA:increased expression:liver
RGD
PMID:17295234 PMID:18837082 PMID:24840851 PMID:30697077
RGD:14402045 RGD:14402046 RGD:14402047 RGD:2289638
NCBI chr 6:18,075,487...18,155,986
Ensembl chr 6:18,075,480...18,155,986
G
CDH13
cadherin 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18425332 PMID:18553387 PMID:28284560
NCBI chr 6:4,809,752...5,832,188
Ensembl chr 6:4,808,255...5,832,415
G
CDK1
cyclin dependent kinase 1
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (human)
CTD RGD
PMID:19136513 PMID:28284560
RGD:2316317
NCBI chr14:64,233,945...64,255,290
Ensembl chr14:64,233,987...64,372,197
G
CDK12
cyclin dependent kinase 12
exacerbates
ISO
mRNA, protein:increased expression:liver (human)
RGD
PMID:31519701
RGD:151361172
NCBI chr12:22,755,365...22,831,397
Ensembl chr12:22,775,226...22,831,333
G
CDK13
cyclin dependent kinase 13
onset
ISO
DNA:amplification: :
RGD
PMID:22912832
RGD:155641228
NCBI chr18:54,310,311...54,430,060
Ensembl chr18:54,310,324...54,430,786
G
CDK14
cyclin dependent kinase 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22922871
NCBI chr 9:70,678,012...71,310,253
Ensembl chr 9:70,499,873...71,310,250
G
CDK4
cyclin dependent kinase 4
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:26189965 PMID:33841550
RGD:152998960
NCBI chr 5:23,039,206...23,041,959
Ensembl chr 5:23,038,891...23,042,061
G
CDKN1A
cyclin dependent kinase inhibitor 1A
ISO
OMIM:114550
MouseDO
NCBI chr 7:32,354,776...32,363,771
Ensembl chr 7:32,359,455...32,363,761
G
CDKN1B
cyclin dependent kinase inhibitor 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20698225
NCBI chr 5:59,731,224...59,735,831
Ensembl chr 5:59,731,206...59,735,831
G
CDKN1C
cyclin dependent kinase inhibitor 1C
severity
ISO
protein:decreased expression:liver (human)
RGD
PMID:26606000
RGD:11354707
NCBI chr 2:2,019,391...2,022,092
Ensembl chr 2:2,019,830...2,021,853
G
CDKN2A
cyclin dependent kinase inhibitor 2A
severity
ISO
Protein:decreased expression:liver ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma | ClinVar Annotator: match by term: LIVER CELL CARCINOMA
RGD ClinVar
PMID:7780957 PMID:8521414 PMID:9185756 PMID:9324288 PMID:10491434 PMID:14508519 PMID:16234564 PMID:16317707 PMID:16896043 PMID:21462282 PMID:25157968 PMID:25741868 PMID:25780468 PMID:26225579 PMID:26467025 PMID:26619011 PMID:28492532 PMID:35001868 More...
RGD:1600816
NCBI chr 1:200,774,496...200,799,149
Ensembl chr 1:200,792,469...200,798,854
G
CDKN2B
cyclin dependent kinase inhibitor 2B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33010264
NCBI chr 1:200,666,250...200,770,880
Ensembl chr 1:200,761,004...200,766,056
G
CDKN2C
cyclin dependent kinase inhibitor 2C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:161,160,290...161,166,681
Ensembl chr 6:161,160,297...161,166,529
G
CDKN3
cyclin dependent kinase inhibitor 3
treatment severity
ISO
associated with alcoholism; protein:increased expression:liver mRNA:increased expression:liver CTD Direct Evidence: marker/mechanism protein:decreased expression:liver
RGD CTD
PMID:22390936 PMID:23292002 PMID:27314282 PMID:28284560
RGD:15090800 RGD:15090801 RGD:15090802
NCBI chr 1:183,792,606...183,809,178
Ensembl chr 1:183,792,688...183,809,174
G
CDT1
chromatin licensing and DNA replication factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:893,377...897,706
Ensembl chr 6:893,381...897,934
G
CEBPA
CCAAT enhancer binding protein alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16288022 PMID:21785164
NCBI chr 6:43,083,200...43,085,884
Ensembl chr 6:43,083,207...43,085,836
G
CEBPB
CCAAT enhancer binding protein beta
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver (human)
CTD RGD
PMID:14563831 PMID:30659195
RGD:40903042
NCBI chr17:51,722,633...51,723,673
Ensembl chr17:51,722,426...51,724,305
G
CEBPD
CCAAT enhancer binding protein delta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14563831
NCBI chr 4:79,872,863...79,874,481
Ensembl chr 4:79,872,939...79,874,477
G
CELSR3
cadherin EGF LAG seven-pass G-type receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr13:31,331,563...31,357,374
Ensembl chr13:31,331,574...31,357,469
G
CENPA
centromere protein A
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (human)
CTD RGD
PMID:21956590 PMID:28284560
RGD:36947377
NCBI chr 3:112,263,912...112,272,638
Ensembl chr 3:112,263,915...112,272,621
G
CENPE
centromere protein E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:117,888,968...117,965,325
Ensembl chr 8:117,888,970...117,965,252
G
CENPF
centromere protein F
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:128,948,386...129,012,241
Ensembl chr 9:128,948,498...129,012,218
G
CENPM
centromere protein M
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 5:6,677,607...6,690,322
Ensembl chr 5:6,677,717...6,690,308
G
CENPU
centromere protein U
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr15:45,818,562...45,851,461
Ensembl chr15:45,818,951...45,851,441
G
CENPW
centromere protein W
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:36,405,693...36,695,989
Ensembl chr 1:36,685,265...36,695,955
G
CEP131
centrosomal protein 131
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr12:1,537,900...1,556,931
Ensembl chr12:1,538,326...1,556,929
G
CEP164
centrosomal protein 164
susceptibility
ISO
associated with Chronic Hepatitis C;DNA:SNP: :rs573455 (human)
RGD
PMID:22004425
RGD:151665169
NCBI chr 9:44,670,857...44,752,477
Ensembl chr 9:44,670,874...44,752,469
G
CEP55
centrosomal protein 55
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr14:104,957,256...104,980,690
Ensembl chr14:104,957,311...104,980,689
G
CFP
complement factor properdin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr X:42,145,754...42,152,879
Ensembl chr X:42,143,697...42,152,868
G
CHAF1B
chromatin assembly factor 1 subunit B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr13:200,048,096...200,074,902
Ensembl chr13:200,048,149...200,072,556
G
CHD4
chromodomain helicase DNA binding protein 4
exacerbates
ISO
mRNA:increased expression:liver (human) protein:increased expression:liver (human)
RGD
PMID:26095183 PMID:28486105 PMID:32070428
RGD:11571740 RGD:153323299 RGD:153323308
NCBI chr 5:64,071,627...64,105,212
Ensembl chr 5:64,065,992...64,105,173
G
CHD5
chromodomain helicase DNA binding protein 5
ISO
mRNA:decreased expression:liver
RGD
PMID:26517514
RGD:11537550
NCBI chr 6:67,017,410...67,086,685
Ensembl chr 6:67,017,417...67,086,711
G
CKAP2L
cytoskeleton associated protein 2 like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 3:43,736,526...43,772,995
Ensembl chr 3:43,736,744...43,772,974
G
CKAP4
cytoskeleton associated protein 4
disease_progression
ISO
associated with tumor vascularization; mRNA,protein:increased expression:liver tumor (human)
RGD
PMID:30901224
RGD:152995286
NCBI chr 5:14,021,131...14,031,196
Ensembl chr 5:14,021,131...14,030,039
G
CLDN1
claudin 1
severity
ISO
protein:increased expression:liver (human) associated with liver cirrhosis;protein:increased expression:liver (human) protein:decreased expression:liver (human)
RGD
PMID:17270214 PMID:24696415 PMID:24815833
RGD:26884345 RGD:26884348 RGD:26884352
NCBI chr13:127,714,857...127,730,628
Ensembl chr13:127,712,777...127,730,657
G
CLEC1B
C-type lectin domain family 1 member B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 5:61,889,874...61,896,964
Ensembl chr 5:61,889,930...61,946,340
G
CLEC4G
C-type lectin domain family 4 member G
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:71,433,406...71,436,570
Ensembl chr 2:71,433,421...71,436,567
G
CLPTM1L
CLPTM1 like
susceptibility disease_progression
ISO
DNA:SNPs::rs401681(human) DNA:SNP: :rs401681(human)
RGD
PMID:25339005 PMID:29042796
RGD:150530496 RGD:150537100
NCBI chr16:79,237,000...79,248,503
Ensembl chr16:79,237,061...79,248,500
G
CLTRN
collectrin, amino acid transport regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr X:12,183,793...12,215,474
Ensembl chr X:12,183,796...12,224,964
G
CNDP1
carnosine dipeptidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:149,523,983...149,564,728
Ensembl chr 1:149,521,510...149,562,623
G
CNOT9
CCR4-NOT transcription complex subunit 9
ISO
ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar
PMID:26619011
NCBI chr15:120,590,354...120,622,203
Ensembl chr15:120,590,641...120,623,898
G
CNTNAP4
contactin associated protein family member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:11,316,534...11,589,628
Ensembl chr 6:11,317,848...11,589,300
G
COL15A1
collagen type XV alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:240,718,128...240,829,188
Ensembl chr 1:240,709,086...240,829,185
G
COL18A1
collagen type XVIII alpha 1 chain
severity
ISO
Protein:increased expression
RGD
PMID:15739185
RGD:1600906
NCBI chr13:207,907,835...207,984,082
Ensembl chr13:207,940,948...207,982,938
G
COLEC10
collectin subfamily member 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 4:19,692,990...20,143,740
Ensembl chr 4:19,692,830...19,744,135
G
COMT
catechol-O-methyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15341023
NCBI chr14:51,384,729...51,403,997
Ensembl chr14:51,385,738...51,403,998
G
COPS5
COP9 signalosome subunit 5
severity
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (human)
CTD RGD
PMID:20698225 PMID:26606000
RGD:11354707
NCBI chr 4:67,740,528...67,758,153
Ensembl chr 4:67,739,251...67,758,150
G
CP
ceruloplasmin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19229483
NCBI chr13:89,396,713...89,463,540
Ensembl chr13:89,396,708...89,463,476
G
CPEB3
cytoplasmic polyadenylation element binding protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr14:103,675,164...103,871,245
Ensembl chr14:103,675,175...103,871,227
G
CPS1
carbamoyl-phosphate synthase 1
disease_progression
ISO
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human)
RGD
PMID:30901224
RGD:152995286
NCBI chr15:113,210,038...113,339,086
Ensembl chr15:113,150,157...113,339,078
G
CRADD
CASP2 and RIPK1 domain containing adaptor with death domain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 5:89,257,603...89,480,414
Ensembl chr 5:89,267,944...89,479,712
G
CREBBP
CREB binding protein
ISO
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: LIVER CELL CARCINOMA
ClinVar
PMID:21390126 PMID:21680795 PMID:21796119 PMID:22832583 PMID:23334668 PMID:23685749 PMID:23778141 PMID:26087898 PMID:26619011 PMID:27257180 PMID:28492532 PMID:28970362 PMID:29551561 PMID:33560380 More...
NCBI chr 3:38,388,366...38,530,243
Ensembl chr 3:38,388,547...38,530,224
G
CRHBP
corticotropin releasing hormone binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:85,814,399...85,830,598
Ensembl chr 2:85,816,816...85,831,179
G
CRP
C-reactive protein, pentraxin-related
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144
NCBI chr 4:90,793,361...90,801,020
Ensembl chr 4:90,793,350...90,805,218
G
CSF1R
colony stimulating factor 1 receptor
severity exacerbates
ISO
DNA:hypomethylation:promoter (human) mRNA:increased expression:liver (human) protein:increased expression: liver (human) protein:increased expression:liver (human)
RGD
PMID:11412385 PMID:14969845 PMID:20551429 PMID:32724427 PMID:32760707
RGD:150524279 RGD:150524282 RGD:150524286 RGD:150524301 RGD:150524302
NCBI chr 2:151,102,138...151,130,311
Ensembl chr 2:151,102,147...151,147,633
G
CSF2
colony stimulating factor 2
treatment
ISO
RGD
PMID:12731087
RGD:10450243
NCBI chr 2:134,354,724...134,357,155
Ensembl chr 2:134,354,724...134,357,155
G
CSK
C-terminal Src kinase
ISO
protein:decreased expression:liver
RGD
PMID:9918913
RGD:5134372
NCBI chr 7:58,736,473...58,755,034
Ensembl chr 7:58,736,531...58,755,260
G
CSMD1
CUB and Sushi multiple domains 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr15:34,361,722...36,243,762
Ensembl chr15:34,363,758...35,023,152
G
CSPG4
chondroitin sulfate proteoglycan 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:57,949,182...57,988,602
Ensembl chr 7:57,949,455...57,988,335
G
CSRNP1
cysteine and serine rich nuclear protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr13:23,833,130...23,845,198
Ensembl chr13:23,833,134...23,845,204
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
susceptibility
ISO
DNA:SNPs: :rs231775,rs231725(human) protein:increased expression:CD4+ and CD8+ T cells:
RGD
PMID:23432218 PMID:28648905
RGD:14398741 RGD:14398742
NCBI chr15:107,283,081...107,288,041
Ensembl chr15:107,282,927...107,289,103
G
CTNNB1
catenin beta 1
exacerbates susceptibility severity
ISO
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma | ClinVar Annotator: match by term: LIVER CELL CARCINOMA DNA:missense mutations:exon 3:multiple (human) associated with Hepatitis B, Chronic,DNA:SNP, haplotype: :rs3864004 (human) DNA:Mutations:exon: associated with hepatitis B;DNA:SNPs: :rs3864004,rs11564475(human)
OMIM ClinVar RGD
PMID:9065402 PMID:9065403 PMID:9294210 PMID:9500465 PMID:9927029 PMID:10027390 PMID:10192393 PMID:10391090 PMID:10398436 PMID:10435629 PMID:10655994 PMID:10666372 PMID:11351304 PMID:11930117 PMID:11950921 PMID:12124804 PMID:15133491 PMID:19101982 PMID:19234609 PMID:21903672 PMID:23033978 PMID:23265383 PMID:24614104 PMID:24728327 PMID:24788118 PMID:25157968 PMID:25326635 PMID:25326669 PMID:25741868 PMID:26350204 PMID:26502894 PMID:26619011 PMID:26822237 PMID:26968103 PMID:27276713 PMID:27915094 PMID:27959697 PMID:28328801 PMID:28333917 PMID:28492532 PMID:28575650 PMID:29682453 PMID:30640974 PMID:31526516 More...
RGD:14402039 RGD:14402040 RGD:14402052 RGD:150429592
NCBI chr13:25,163,550...25,208,314
Ensembl chr13:25,164,277...25,208,311
G
CTSB
cathepsin B
ISO
RGD
PMID:15641152
RGD:2315605
NCBI chr14:15,014,139...15,035,081
Ensembl chr14:15,011,711...15,033,877
G
CTSD
cathepsin D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 2:1,188,548...1,197,642
Ensembl chr 2:1,188,549...1,197,643
G
CTSL
cathepsin L
ISO
RGD
PMID:15641152
RGD:2315605
NCBI chr10:27,668,523...27,674,705
Ensembl chr10:27,668,264...27,674,618
G
CUnH14orf180
chromosome Un C14orf180 homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
G
CUX1
cut like homeobox 1
ISO
mRNA:increased expression:liver (human)
RGD
PMID:30561038
RGD:152985541
NCBI chr 3:9,317,145...9,669,999
Ensembl chr 3:9,317,140...9,669,998
G
CXCL10
C-X-C motif chemokine ligand 10
disease_progression treatment
ISO
RGD
PMID:27245433 PMID:28592115 PMID:28638480
RGD:27095889 RGD:27095898 RGD:27095899
NCBI chr 8:71,693,641...71,695,948
Ensembl chr 8:71,693,339...71,695,948
G
CXCL11
C-X-C motif chemokine ligand 11
ISO
mRNA:increased expression:liver (mouse)
RGD
PMID:26569409
RGD:11344640
NCBI chr 8:71,713,790...71,725,669
Ensembl chr 8:71,713,803...71,725,674
G
CXCL12
C-X-C motif chemokine ligand 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144 PMID:28284560
NCBI chr14:91,516,383...91,543,857
Ensembl chr14:91,516,431...91,552,752
G
CXCL14
C-X-C motif chemokine ligand 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:137,803,988...137,813,118
Ensembl chr 2:137,803,992...137,813,118
G
CXCL8
C-X-C motif chemokine ligand 8
disease_progression susceptibility
ISO
protein:increased expression:liver (human) CTD Direct Evidence: marker/mechanism|therapeutic mRNA:increased expression:liver (human) DNA:SNPs, haplotype:multiple
RGD CTD
PMID:12432545 PMID:24381110 PMID:26078356 PMID:30523154 PMID:35776891
RGD:11526468 RGD:26884364 RGD:26884366
NCBI chr 8:69,932,646...69,935,861
Ensembl chr 8:69,932,643...69,935,861
G
CXCR4
C-X-C motif chemokine receptor 4
severity treatment
ISO
protein:increased expression:liver (human) human cells in mouse model
RGD
PMID:30034941 PMID:33574707
RGD:151665327 RGD:151665331
NCBI chr15:15,663,652...15,666,706
Ensembl chr15:15,663,494...15,667,232
G
CYLD
CYLD lysine 63 deubiquitinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21109933
NCBI chr 6:34,058,091...34,121,939
Ensembl chr 6:34,059,081...34,121,264
G
CYP17A1
cytochrome P450 family 17 subfamily A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15341023
NCBI chr14:113,805,616...113,820,445
Ensembl chr14:113,805,611...113,812,041
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15341023
NCBI chr 7:58,802,887...58,809,155
Ensembl chr 7:58,802,887...58,809,775
G
CYP1A2
cytochrome P450 family 1 subfamily A member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:58,779,529...58,786,155
Ensembl chr 7:58,779,475...58,786,100
G
CYP26B1
cytochrome P450 family 26 subfamily B member 1
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr 3:70,573,551...70,593,416
Ensembl chr 3:70,572,197...70,593,408
G
CYP2B6B
cytochrome P450 family 2 subfamily B member 6B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:49,158,175...49,173,872
Ensembl chr 6:49,110,812...49,178,334
G
CYP2C49
cytochrome P450 2C49
susceptibility
ISO
associated with hepatitis C; DNA:polymorphisms: :
RGD
PMID:11021356
RGD:124713413
NCBI chr14:106,571,803...106,612,082
Ensembl chr14:106,285,173...106,612,455
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
ISO
associated with alcohol dependence DNA, mRNA:SNP, Decreased expression:liver: rs2031920 (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:15162526 PMID:20364586 PMID:29765251
RGD:14700882 RGD:14700899
NCBI chr14:141,690,737...141,703,078
Ensembl chr14:141,690,426...141,736,817
G
CYP39A1
cytochrome P450 family 39 subfamily A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:41,345,011...41,425,854
Ensembl chr 7:41,344,804...41,425,997
G
DAB2IP
DAB2 interacting protein
severity
ISO
mRNA:decreased expression:liver (human) protein:decreased expression:liver (human)
RGD
PMID:22168621 PMID:31176165
RGD:151665110 RGD:151665148
NCBI chr 1:261,732,280...261,859,833
Ensembl chr 1:261,659,660...261,859,022
G
DBH
dopamine beta-hydroxylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:273,204,407...273,225,562
Ensembl chr 1:273,204,175...273,225,552
G
DCN
decorin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 5:91,678,601...91,713,925
Ensembl chr 5:91,682,658...91,714,235
G
DDR1
discoidin domain receptor tyrosine kinase 1
severity
ISO
mRNA:increased expression:liver (human)
RGD
PMID:33173221
RGD:151347691
NCBI chr 7:23,371,358...23,391,585
Ensembl chr 7:23,373,845...23,391,584
G
DDR2
discoidin domain receptor tyrosine kinase 2
disease_progression treatment
ISO
RGD
PMID:26362312 PMID:33969575
RGD:11086753 RGD:150429748
NCBI chr 4:87,749,738...87,911,818
Ensembl chr 4:87,756,168...87,911,296
G
DDX3X
DEAD-box helicase 3 X-linked
exacerbates sexual_dimorphism
ISO
associated with hepatitis B; mRNA,protein:decreased expression:liver (human)
RGD
PMID:16301996 PMID:30297359
RGD:151356499 RGD:151356660
NCBI chr X:36,988,031...37,005,496
Ensembl chr X:36,988,031...37,018,202
G
DEPDC1
DEP domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:144,157,569...144,183,977
Ensembl chr 6:144,157,588...144,185,963
G
DEPDC1B
DEP domain containing 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr16:39,466,496...39,558,750
Ensembl chr16:39,466,497...39,557,840
G
DEPDC5
DEP domain containing 5, GATOR1 subcomplex subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21725309
NCBI chr14:48,421,788...48,523,530
Ensembl chr14:48,421,880...48,523,593
G
DHFR
dihydrofolate reductase
ISO
ClinVar Annotator: match by term: Hepatocellular cancer
ClinVar
PMID:28492532
NCBI chr 2:89,230,660...89,255,830
G
DICER1
dicer 1, ribonuclease III
susceptibility
ISO
associated with hepatitis B; DNA:SNP: :rs1057035 T>C (human)
RGD
PMID:23868705
RGD:149735346
NCBI chr 7:116,361,630...116,436,471
Ensembl chr 7:116,365,802...116,411,224
G
DIPK2B
divergent protein kinase domain 2B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr X:40,179,289...40,223,011
Ensembl chr X:40,178,969...40,222,542
G
DIRAS3
DIRAS family GTPase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:144,576,342...144,578,820
Ensembl chr 6:144,576,342...144,578,818
G
DLGAP5
DLG associated protein 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:184,500,791...184,550,028
Ensembl chr 1:184,501,182...184,549,993
G
DLK1
delta like non-canonical Notch ligand 1
ISO
mRNA:increased expression:liver (mouse)
RGD
PMID:26569409
RGD:11344640
NCBI chr 7:121,565,844...121,577,493
Ensembl chr 7:121,565,854...121,576,654
G
DMGDH
dimethylglycine dehydrogenase
disease_progression
ISO
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human)
RGD
PMID:30901224
RGD:152995286
NCBI chr 2:87,791,827...87,867,189
Ensembl chr 2:87,791,943...87,866,679
G
DNAJC6
DnaJ heat shock protein family (Hsp40) member C6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:146,990,115...147,161,010
Ensembl chr 6:146,989,351...147,155,131
G
DNASE1L3
deoxyribonuclease 1L3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr13:39,958,384...39,976,114
Ensembl chr13:39,958,387...39,975,946
G
DNMT1
DNA methyltransferase 1
ISO
mRNA, protein:increased expression:liver
RGD
PMID:11844796
RGD:2289670
NCBI chr 2:68,981,564...69,040,364
Ensembl chr 2:68,981,566...69,029,844
G
DNMT3A
DNA methyltransferase 3 alpha
ISO
mRNA, protein:increased expression:liver protein:increased expression:liver:
RGD
PMID:11844796 PMID:15885882
RGD:2289670 RGD:9588598
NCBI chr 3:113,501,972...113,609,148
Ensembl chr 3:113,528,926...113,603,087
G
DNMT3B
DNA methyltransferase 3 beta
ISO
mRNA:increased expression:liver: mRNA, protein:increased expression:liver
RGD
PMID:11844796 PMID:15885882
RGD:2289670 RGD:9588598
NCBI chr17:36,345,715...36,386,076
Ensembl chr17:36,345,816...36,386,072
G
DPYD
dihydropyrimidine dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18019677
NCBI chr 4:119,931,471...120,712,461
Ensembl chr 4:119,931,414...120,712,459
G
DSN1
DSN1 component of MIS12 kinetochore complex
disease_progression
ISO
RGD
PMID:30136646
RGD:27372884
NCBI chr17:39,992,769...40,017,388
Ensembl chr17:39,990,624...40,017,365
G
DTL
denticleless E3 ubiquitin protein ligase homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:131,225,840...131,275,426
Ensembl chr 9:131,227,705...131,275,451
G
DYNLRB1
dynein light chain roadblock-type 1
ISO
RGD
PMID:11750132
RGD:13208527
NCBI chr17:37,923,451...37,941,851
Ensembl chr17:37,923,475...37,945,880
G
DYNLRB2
dynein light chain roadblock-type 2
ISO
RGD
PMID:11750132
RGD:13208527
NCBI chr 6:7,650,444...7,661,380
Ensembl chr 6:7,649,699...7,661,308
G
E2F1
E2F transcription factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12029619 PMID:15565109 PMID:28284560
NCBI chr17:37,178,587...37,190,118
Ensembl chr17:37,178,599...37,189,883
G
E2F8
E2F transcription factor 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:40,178,182...40,194,932
Ensembl chr 2:40,178,177...40,194,935
G
EAF2
ELL associated factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20564326
NCBI chr13:138,632,541...138,681,607
Ensembl chr13:138,648,270...138,681,613
G
ECM1
extracellular matrix protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 4:98,615,776...98,633,081
Ensembl chr 4:98,615,778...98,621,836
G
ECT2
epithelial cell transforming 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr13:111,248,215...111,310,746
Ensembl chr13:111,248,131...111,314,828
G
EEF2
eukaryotic translation elongation factor 2
exacerbates
ISO
protein:increased expression, increased phosphorylation:liver (human)
RGD
PMID:28060762
RGD:153298915
NCBI chr 2:74,746,541...74,756,687
Ensembl chr 2:74,747,080...74,756,680
G
EFEMP1
EGF containing fibulin extracellular matrix protein 1
disease_progression
ISO
protein:decreased expression:liver:
RGD
PMID:23936443
RGD:10401793
NCBI chr 3:85,407,677...85,473,251
Ensembl chr 3:85,407,677...85,473,252
G
EFTUD2
elongation factor Tu GTP binding domain containing 2
severity ameliorates
ISO
RGD
PMID:34282556
RGD:155791664
NCBI chr12:18,474,367...18,514,993
Ensembl chr12:18,474,097...18,517,479
G
EGF
epidermal growth factor
susceptibility
ISO
associated with hepatitis B;DNA:SNP:exon: (rs11569017) (human) associated with liver cirrhosis;DNA:SNP:5'UTR: (rs4444903) (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:9029167 PMID:18167406 PMID:23790025
RGD:14695013 RGD:14695014
NCBI chr 8:112,235,607...112,330,062
Ensembl chr 8:112,234,386...112,330,046
G
EGFR
epidermal growth factor receptor
disease_progression
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:9029167 PMID:11355950
RGD:126781769
NCBI chr 9:139,302,410...139,474,632
Ensembl chr 9:139,300,022...139,475,589
G
EGR1
early growth response 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:140,440,829...140,445,302
Ensembl chr 2:140,441,421...140,445,296
G
EGR2
early growth response 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr14:66,280,665...66,291,308
Ensembl chr14:66,284,581...66,291,299
G
EHD3
EH domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 3:108,103,631...108,135,161
Ensembl chr 3:108,100,401...108,134,906
G
EIF3H
eukaryotic translation initiation factor 3 subunit H
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14578863
NCBI chr 4:21,955,026...22,053,683
Ensembl chr 4:21,954,874...22,058,699
G
ENAH
ENAH actin regulator
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:35030977
RGD:155791678
NCBI chr10:13,439,772...13,609,347
Ensembl chr10:13,446,426...13,609,303
G
ENG
endoglin
ISO
protein:increased expression:liver (rat)
RGD
PMID:20368095
RGD:7257538
NCBI chr 1:268,309,379...268,343,861
Ensembl chr 1:268,309,400...268,343,783
G
ENO1
enolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 6:69,385,879...69,401,664
Ensembl chr 6:69,385,879...69,401,151
G
EP300
E1A binding protein p300
ISO
protein:increased expression:liver (rat)
RGD
PMID:17083329
RGD:2312274
NCBI chr 5:7,311,165...7,394,515
Ensembl chr 5:7,311,171...7,393,760
G
EPAS1
endothelial PAS domain protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26735578
NCBI chr 3:94,167,759...94,253,662
Ensembl chr 3:94,165,816...94,254,079
G
EPCAM
epithelial cell adhesion molecule
severity
ISO
protein:increased expression:liver
RGD
PMID:24616575
RGD:14695007
NCBI chr 3:93,169,800...93,185,221
Ensembl chr 3:93,168,852...93,185,653
G
EPHB1
EPH receptor B1
ISO
protein:increased phosphorylation:liver (mouse)
RGD
PMID:28100771
RGD:127285675
NCBI chr13:75,904,678...76,351,540
Ensembl chr13:75,905,676...76,345,534
G
EPHX1
epoxide hydrolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7892276
NCBI chr10:13,757,489...13,773,071
Ensembl chr10:13,751,881...13,773,072
G
EPO
erythropoietin
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr 3:8,620,508...8,622,936
Ensembl chr 3:8,620,508...8,622,936
G
EPS8L3
EPS8 signaling adaptor L3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 4:110,311,533...110,326,999
Ensembl chr 4:110,311,519...110,326,994
G
ERBB3
erb-b2 receptor tyrosine kinase 3
disease_progression
ISO
RGD
PMID:11355950
RGD:126781769
NCBI chr 5:21,474,218...21,495,040
Ensembl chr 5:21,474,475...21,495,038
G
ERBB4
erb-b2 receptor tyrosine kinase 4
ISO
DNA:insertion/deletion:3'UTR:rs6147150 (human)
RGD
PMID:22294845
RGD:126781763
NCBI chr15:113,966,573...115,096,984
Ensembl chr15:113,974,437...115,096,565
G
ERCC1
ERCC excision repair 1, endonuclease non-catalytic subunit
ISO
mRNA, protein:increased expression:liver (human)
RGD
PMID:15922480
RGD:155598683
NCBI chr 6:51,783,537...51,808,898
Ensembl chr 6:51,783,478...51,798,984
G
ERCC2
ERCC excision repair 2, TFIIH core complex helicase subunit
susceptibility disease_progression
ISO
DNA:SNPs:exon 23: p.K751Q (human) DNA:SNP:cd: 312A>G (human) DNA:SNPs:exon 23: p.K751Q (rs13181) (human) DNA:SNPs:exon 23: p.K751Q (human)
RGD
PMID:19919686 PMID:25531380 PMID:28598207 PMID:28927037
RGD:150530503 RGD:25671459 RGD:25671460 RGD:25671461
NCBI chr 6:51,734,318...51,757,508
Ensembl chr 6:51,734,320...51,757,553
G
EREG
epiregulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35776891
NCBI chr 8:70,351,316...70,372,530
Ensembl chr 8:70,351,311...70,372,569
G
ERN1
endoplasmic reticulum to nucleus signaling 1
ISO
DNA:hypomethylation: CpG islands:
RGD
PMID:20165882
RGD:14694974
NCBI chr12:14,881,913...14,963,290
Ensembl chr12:14,881,923...14,963,284
G
ERP29
endoplasmic reticulum protein 29
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr14:39,687,028...39,695,748
Ensembl chr14:39,687,000...39,695,752
G
ESM1
endothelial cell specific molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr16:34,184,255...34,193,877
Ensembl chr16:34,184,257...34,193,441
G
ESR1
estrogen receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144 PMID:28284560
NCBI chr 1:14,217,032...14,604,906
Ensembl chr 1:14,217,036...14,493,363
G
ETFA
electron transfer flavoprotein subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 7:56,450,508...56,540,275
Ensembl chr 7:56,450,520...56,540,253
G
EXO1
exonuclease 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr10:15,317,555...15,360,593
Ensembl chr10:15,317,581...15,359,839
G
EZH2
enhancer of zeste 2 polycomb repressive complex 2 subunit
susceptibility
ISO
mRNA:increased expression:liver (human) CTD Direct Evidence: marker/mechanism DNA:SNPs: :multiple
RGD CTD
PMID:24040354 PMID:24211739 PMID:25226601 PMID:26517514 PMID:28284560 PMID:34545456 More...
RGD:10755339 RGD:11537550 RGD:126779595 RGD:126779608
NCBI chr 9:109,384,976...109,450,943
Ensembl chr 9:109,385,015...109,450,941
G
F2
coagulation factor II, thrombin
severity
ISO
CTD Direct Evidence: marker/mechanism associated with liver cirrhosis;protein:altered expression, altered processing:liver (human)
CTD RGD
PMID:2821104 PMID:7620113
RGD:14975114
NCBI chr 2:15,793,257...15,819,151
Ensembl chr 2:15,791,455...15,819,137
G
FABP5
fatty acid binding protein 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 4:55,277,831...55,282,585
Ensembl chr 4:55,275,205...55,282,908
G
FAM111B
FAM111 trypsin like peptidase B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:12,268,692...12,279,386
Ensembl chr 2:12,268,695...12,279,559
G
FAM180A
family with sequence similarity 180 member A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr18:13,574,024...13,589,117
Ensembl chr18:13,575,527...13,592,344
G
FAM83D
family with sequence similarity 83 member D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr17:41,868,982...41,892,222
Ensembl chr17:41,868,976...41,892,220
G
FANCD2
FA complementation group D2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr13:66,241,951...66,308,601
Ensembl chr13:66,241,967...66,310,433
G
FANCI
FA complementation group I
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:54,811,024...54,889,992
Ensembl chr 7:54,811,027...54,889,998
G
FAS
Fas cell surface death receptor
treatment
ISO
protein:increased expression:liver:
RGD
PMID:11274632 PMID:29634416 PMID:30737368
RGD:13792608 RGD:14700677 RGD:14700700
NCBI chr14:100,927,305...100,954,781
Ensembl chr14:100,927,089...100,956,716
G
FASLG
Fas ligand
ISO
protein:increased expression:liver:
RGD
PMID:11274632
RGD:14700677
NCBI chr 9:115,068,314...115,075,147
Ensembl chr 9:115,068,090...115,076,464
G
FASN
fatty acid synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14563831 PMID:15543204 PMID:21147110
NCBI chr12:922,405...937,560
Ensembl chr12:920,509...937,561
G
FAT1
FAT atypical cadherin 1
disease_progression
ISO
mRNA,protein:increased expression:liver (human)
RGD
PMID:24590895
RGD:151347630
NCBI chr17:8,466,099...8,580,715
Ensembl chr17:8,457,187...8,580,715
G
FATE1
fetal and adult testis expressed 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15580283
NCBI chr X:123,106,086...123,113,178
Ensembl chr X:123,099,746...123,113,171
G
FBP1
fructose-bisphosphatase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22039417
NCBI chr10:27,588,609...27,622,225
Ensembl chr10:27,588,570...27,622,674
G
FBXL18
F-box and leucine rich repeat protein 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 3:4,031,784...4,079,605
Ensembl chr 3:4,033,580...4,079,549
G
FBXO11
F-box protein 11
ameliorates exacerbates
ISO
mRNA:increased expression:liver (human) protein:increased expression:liver (human)
RGD
PMID:29518611 PMID:29603830 PMID:32657545
RGD:152025259 RGD:152025263 RGD:152025266
NCBI chr 3:92,696,402...92,792,623
Ensembl chr 3:92,696,441...92,792,616
G
FDFT1
farnesyl-diphosphate farnesyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147110
NCBI chr14:14,976,259...15,010,701
Ensembl chr14:14,967,074...15,016,227
G
FES
FES proto-oncogene, tyrosine kinase
exacerbates
ISO
DNA:hypermethylation:promoter (human)
RGD
PMID:31038805
RGD:153323297
NCBI chr 7:53,472,947...53,485,084
Ensembl chr 7:53,472,947...53,485,082
G
FGF19
fibroblast growth factor 19
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25822088
NCBI chr 2:3,583,027...3,586,985
Ensembl chr 2:3,582,828...3,587,752
G
FGF3
fibroblast growth factor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25822088
NCBI chr 2:3,489,208...3,496,532
Ensembl chr 2:3,489,009...3,497,533
G
FGF4
fibroblast growth factor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25822088
NCBI chr 2:3,527,113...3,529,011
Ensembl chr 2:3,526,914...3,529,874
G
FGFR1
fibroblast growth factor receptor 1
treatment
ISO
ClinVar Annotator: match by term: Hepatocellular carcinoma
RGD ClinVar
PMID:21573021 PMID:25705862 PMID:26619011 PMID:26942290 PMID:33448156
RGD:25440476
NCBI chr15:48,053,895...48,106,634
Ensembl chr15:48,053,340...48,106,724
G
FGFR2
fibroblast growth factor receptor 2
severity
ISO
associated with hepatitis B;DNA:SNPs: promoter, intron:rs308379, rs1219648 (human)
RGD
PMID:30952770
RGD:38501096
NCBI chr14:131,183,095...131,285,001
Ensembl chr14:131,181,713...131,289,425
G
FGFR4
fibroblast growth factor receptor 4
treatment
ISO
RGD
PMID:32677805
RGD:150520166
NCBI chr 2:80,841,536...80,853,791
Ensembl chr 2:80,841,536...80,853,796
G
FH
fumarate hydratase
ISO
ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar
PMID:10896297 PMID:15221078 PMID:16876016 PMID:17182618 PMID:18313410 PMID:19151755 PMID:20301679 PMID:21445611 PMID:25637381 PMID:25741868 PMID:28492532 PMID:28747166 More...
NCBI chr10:12,404,143...12,431,843
Ensembl chr10:12,404,176...12,431,824
G
FHIT
fragile histidine triad diadenosine triphosphatase
ISO
RGD
PMID:12112319
RGD:632723
NCBI chr13:41,443,963...42,884,799
Ensembl chr13:41,443,965...42,392,817
G
FLT3
fms related receptor tyrosine kinase 3
ameliorates
ISO
human cells in mouse model
RGD
PMID:27511526
RGD:149735514
NCBI chr11:5,370,475...5,455,439
Ensembl chr11:5,370,496...5,455,358
G
FLVCR1
FLVCR choline and heme transporter 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:130,543,911...130,570,486
Ensembl chr 9:130,541,660...130,570,702
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9029167 PMID:28284560
NCBI chr 7:98,449,508...98,451,971
Ensembl chr 7:98,449,349...98,455,554
G
FOSB
FosB proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:51,836,780...51,844,531
Ensembl chr 6:51,837,719...51,844,529
G
FOSL2
FOS like 2, AP-1 transcription factor subunit
ISO
mRNA:increased expression:liver (human)
RGD
PMID:30086463 PMID:32048611
RGD:153344517 RGD:153344521
NCBI chr 3:110,820,403...110,842,903
Ensembl chr 3:110,823,666...110,843,068
G
FOXA1
forkhead box A1
disease_progression sexual_dimorphism susceptibility
ISO
protein:decreased expression:liver DNA:VNTR, SNPs, haplotypes:multiple:
RGD
PMID:25965836 PMID:29208003 PMID:31400761
RGD:11054501 RGD:151665752 RGD:151665820
NCBI chr 7:62,471,233...62,479,638
Ensembl chr 7:62,471,249...62,479,220
G
FOXM1
forkhead box M1
ISO
CTD Direct Evidence: marker/mechanism OMIM:114550
CTD MouseDO
PMID:15082532 PMID:17173139 PMID:28284560
NCBI chr 5:67,246,219...67,263,215
Ensembl chr 5:67,245,694...67,263,211 Ensembl chr 5:67,245,694...67,263,211
G
FOXO1
forkhead box O1
ISO
mRNA:decreased expression:liver
RGD
PMID:28972178
RGD:14401599
NCBI chr11:15,317,222...15,410,059
Ensembl chr11:15,317,124...15,410,473
G
FOXP1
forkhead box P1
treatment
ISO
RGD
PMID:25156538
RGD:9587823
NCBI chr13:52,346,844...52,974,358
Ensembl chr13:52,348,234...52,876,892
G
FOXP3
forkhead box P3
ISO
protein:increased expression:liver
RGD
PMID:21086571
RGD:38548919
NCBI chr X:43,303,777...43,328,164
Ensembl chr X:43,303,785...43,322,968
G
FST
follistatin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12203361 PMID:19363144
NCBI chr16:32,806,341...32,811,382
Ensembl chr16:32,805,932...32,811,421
G
FTH1
ferritin heavy chain 1
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:9054589
RGD:632698
NCBI chr 2:9,535,051...9,537,979
G
FUBP1
far upstream element binding protein 1
ameliorates exacerbates
ISO
human cell line in a mouse model associated with Chronic Hepatitis C;mRNA:increased expression:liver (human)
RGD
PMID:19637194 PMID:25995247 PMID:31587040
RGD:151361188 RGD:151361194 RGD:151361196
NCBI chr 6:135,281,474...135,319,055
Ensembl chr 6:135,281,521...135,318,714
G
G6PC1
glucose-6-phosphatase catalytic subunit 1
treatment
ISO
associated with Glycogen Storage Disease IA, human gene in a mouse model
RGD
PMID:28096054
RGD:14695537
NCBI chr12:19,965,885...19,975,783
Ensembl chr12:19,965,330...19,975,857
G
G6PD
glucose-6-phosphate dehydrogenase
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:25473368 PMID:35693827
RGD:10449118 RGD:153344586
NCBI chr X:125,029,147...125,041,040
Ensembl chr X:125,029,150...125,041,040
G
GABRD
gamma-aminobutyric acid type A receptor subunit delta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:64,049,665...64,059,644
Ensembl chr 6:64,049,675...64,059,640
G
GAPDH
glyceraldehyde-3-phosphate dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16767786 PMID:21472284
NCBI chr 5:64,129,678...64,135,194
Ensembl chr 5:64,129,679...64,133,991
G
GBA3
glucosylceramidase beta 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:16,897,275...17,012,886
Ensembl chr 8:16,897,288...17,044,570
G
GC
GC vitamin D binding protein
susceptibility
ISO
protein:increased expression:liver associated with Hepatitis B, Chronic;DNA:SNP: :rs7041(human)
RGD
PMID:21683810 PMID:25541958
RGD:14402025 RGD:5509919
NCBI chr 8:68,326,293...68,360,262
Ensembl chr 8:68,326,299...68,360,262
G
GDF15
growth differentiation factor 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20512989
NCBI chr 2:59,409,035...59,411,356
Ensembl chr 2:59,408,904...59,411,358
G
GDF2
growth differentiation factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23936038 PMID:28284560
NCBI chr14:88,506,083...88,513,416
Ensembl chr14:88,507,399...88,513,375
G
GHR
growth hormone receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr16:27,126,300...27,422,618
Ensembl chr16:27,126,734...27,421,449
G
GINS1
GINS complex subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr17:31,060,540...31,076,807
Ensembl chr17:31,060,650...31,080,314
G
GJB1
gap junction protein beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17978847
NCBI chr X:57,241,990...57,249,496
Ensembl chr X:57,242,045...57,249,885
G
GJB2
gap junction protein beta 2
ISO
DNA, mRNA:promoter hypermethylation, decreased expression:liver
RGD
PMID:17295234
RGD:2289638
NCBI chr11:774,090...781,252
Ensembl chr11:775,166...775,846
G
GLI1
GLI family zinc finger 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26189965
NCBI chr 5:22,736,325...22,747,421
Ensembl chr 5:22,739,900...22,747,421
G
GLUL
glutamate-ammonia ligase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144
NCBI chr 9:123,751,551...123,762,575
Ensembl chr 9:123,751,548...123,762,547
G
GMNN
geminin DNA replication inhibitor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:19,585,968...19,595,346
Ensembl chr 7:19,586,002...19,595,344
G
GMPS
guanine monophosphate synthase
ISO
protein:increased activity:hepatoma (rat)
RGD
PMID:6861338
RGD:5135537
NCBI chr13:95,742,342...95,820,903
Ensembl chr13:95,738,659...95,819,759
G
GNAO1
G protein subunit alpha o1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:29,416,574...29,592,874
Ensembl chr 6:29,416,708...29,592,516
G
GNAS
GNAS complex locus
ISO
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar
PMID:1517386 PMID:1594625 PMID:1944469 PMID:2549426 PMID:3720010 PMID:7739708 PMID:8766942 PMID:9626141 PMID:11093740 PMID:12727968 PMID:12970318 PMID:15126527 PMID:15952988 PMID:16507630 PMID:16543670 PMID:17873334 PMID:20197676 PMID:21835143 PMID:23403822 PMID:23536913 PMID:23843956 PMID:24855271 PMID:25157968 PMID:25719192 PMID:25741868 PMID:26619011 PMID:27398169 PMID:27506760 PMID:28492532 PMID:30702195 More...
NCBI chr17:58,985,580...59,053,022
Ensembl chr17:58,998,981...59,053,021
G
GNAZ
G protein subunit alpha z
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr14:49,132,012...49,174,114
Ensembl chr14:49,132,013...49,174,108
G
GNMT
glycine N-methyltransferase
ISO
CTD Direct Evidence: marker/mechanism OMIM:114550
CTD MouseDO
PMID:19146867 PMID:31086990
NCBI chr 7:38,038,359...38,041,218
Ensembl chr 7:38,038,358...38,041,217
G
GOLM1
golgi membrane protein 1
severity
ISO
mRNA, protein:increased expression:liver protein:increased expression:serum
RGD
PMID:21140449 PMID:21443671
RGD:401827118 RGD:401827119
NCBI chr10:29,117,578...29,219,024
Ensembl chr10:29,118,314...29,219,018
G
GPC1
glypican 1
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr15:139,457,866...139,483,704
Ensembl chr15:139,457,669...139,484,670
G
GPC3
glypican 3
disease_progression exacerbates severity treatment
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:blood serum (human) protein:increased expression:liver (human) mRNA,protein:increased expression:peripheral blood mononuclear cell,blood serum, liver (human) mRNA:increased expression:Peripheral Blood (human) protein:increased expression:serum
CTD RGD
PMID:16698587 PMID:19496787 PMID:21438004 PMID:22883669 PMID:23558072 PMID:25449037 PMID:27286460 PMID:28284560 PMID:28801286 More...
RGD:14695019 RGD:14695020 RGD:243065125 RGD:243065131 RGD:243065134 RGD:243065135 RGD:243065139
NCBI chr X:109,536,495...109,973,605
Ensembl chr X:109,536,504...109,973,607
G
GPM6A
glycoprotein M6A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr15:38,258,496...38,555,129
Ensembl chr15:38,259,244...38,305,603
G
GPR158
G protein-coupled receptor 158
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr10:49,862,312...50,202,748
Ensembl chr10:49,862,312...50,202,453
G
GPR182
G protein-coupled receptor 182
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 5:22,303,466...22,309,652
Ensembl chr 5:22,304,588...22,311,028
G
GPX1
glutathione peroxidase 1
severity no_association susceptibility
ISO
associated with hepatitis C;DNA:missense mutation:CDS:p.P198L (rs1050450) (human) DNA:missense mutation:CDS:p.P198L (human) associated with alcoholic liver cirrhosis;DNA:missense mutation:CDS:p.P198L (human)
RGD
PMID:16510607 PMID:19929244 PMID:25894370 PMID:26990426
RGD:11533013 RGD:151708729 RGD:152995483 RGD:152998906
NCBI chr13:31,916,269...31,917,337
Ensembl chr13:31,916,246...31,917,433
G
GPX3
glutathione peroxidase 3
severity disease_progression
ISO
mRNA,protein:decreased expression:liver, blood plasma (human) DNA:hypermethylation
RGD
PMID:25333265 PMID:25445749 PMID:27570561
RGD:151665355 RGD:151665509 RGD:401827855
NCBI chr16:71,980,467...71,989,011
Ensembl chr16:71,980,475...71,989,026
G
GRB7
growth factor receptor bound protein 7
exacerbates
ISO
protein:increased expression:liver (human)
RGD
PMID:17634422
RGD:151347655
NCBI chr12:22,574,579...22,583,386
Ensembl chr12:22,574,584...22,582,345
G
GTSE1
G2 and S-phase expressed 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 5:3,227,813...3,246,679
Ensembl chr 5:3,227,816...3,242,789
G
GYS2
glycogen synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 5:51,862,952...51,915,153
Ensembl chr 5:51,862,863...51,917,757
G
HAMP
hepcidin antimicrobial peptide
ISO
DNA:hypermethylation,hypomethylation:promoter CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:28284560 PMID:29235098
RGD:15042879
NCBI chr 6:44,785,863...44,787,303
Ensembl chr 6:44,784,160...44,787,305
G
HAO2
hydroxyacid oxidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 4:101,588,510...101,787,818
Ensembl chr 4:101,588,861...101,732,304
G
HAVCR1
hepatitis A virus cellular receptor 1
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr16:66,162,318...66,208,868
G
HAVCR2
hepatitis A virus cellular receptor 2
disease_progression
ISO
associated with hepatitis B;DNA:SNP: : ���1516 G>T (human)
RGD
PMID:27034168
RGD:40818257
NCBI chr16:66,138,157...66,160,568
Ensembl chr16:66,139,535...66,160,538
G
HDAC2
histone deacetylase 2
disease_progression
ISO
mRNA:increased expression:liver:
RGD
PMID:24448241
RGD:9590206
NCBI chr 1:79,867,713...79,901,597
Ensembl chr 1:79,863,094...79,901,585
G
HDAC4
histone deacetylase 4
ISO
mRNA:increased expression:liver:
RGD
PMID:21837748
RGD:9681451
NCBI chr15:138,378,237...138,657,266
Ensembl chr15:138,381,635...138,614,301
G
HERC5
HECT and RLD domain containing E3 ubiquitin protein ligase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28919514
NCBI chr 8:130,532,256...130,591,158
Ensembl chr 8:130,533,877...130,590,841
G
HFE
homeostatic iron regulator
disease_progression
ISO
associated with Liver Cirrhosis;DNA:missense mutation:cds:p.C282Y (human)
RGD
PMID:20019189 PMID:29642405
RGD:14746967 RGD:2317357
NCBI chr 7:20,758,604...20,767,004
Ensembl chr 7:20,758,741...20,767,000
G
HGF
hepatocyte growth factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9932610 PMID:11896611
NCBI chr 9:98,437,771...98,513,573
Ensembl chr 9:98,438,143...98,513,564
G
HGFAC
HGF activator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144
NCBI chr 8:2,077,164...2,084,506
Ensembl chr 8:2,077,176...2,084,507
G
HHIP
hedgehog interacting protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18559595
NCBI chr 8:83,583,735...83,678,368
Ensembl chr 8:83,583,739...83,679,136
G
HIF1A
hypoxia inducible factor 1 subunit alpha
disease_progression treatment
ISO
protein:increased expression:liver (human)
RGD
PMID:19335982 PMID:26078356 PMID:31321740
RGD:11526468 RGD:155882550 RGD:9068886
NCBI chr 1:190,625,436...190,673,926
Ensembl chr 1:190,625,244...190,674,845
G
HILPDA
hypoxia inducible lipid droplet associated
disease_progression
ISO
mRNA, protein:increased expression:liver (human) mRNA:increased expression:liver (human) human cells in mouse model
RGD
PMID:30205391 PMID:31142329 PMID:35693827
RGD:153344574 RGD:153344577 RGD:153344586
NCBI chr18:19,944,929...19,947,080
Ensembl chr18:19,944,930...19,947,080
G
HJURP
Holliday junction recognition protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr15:134,106,561...134,123,163
Ensembl chr15:134,106,578...134,123,140
G
HMGB2
high mobility group box 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20851854
NCBI chr14:16,709,966...16,712,288
Ensembl chr14:16,710,047...16,717,101
G
HMGCR
3-hydroxy-3-methylglutaryl-CoA reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9207284 PMID:21147110
NCBI chr 2:84,380,245...84,401,117
Ensembl chr 2:84,380,224...84,402,957
G
HMGCS2
3-hydroxy-3-methylglutaryl-CoA synthase 2
disease_progression
ISO
RGD
PMID:28867541
RGD:14975299
NCBI chr 4:101,420,941...101,440,302
Ensembl chr 4:101,420,872...101,438,126
G
HMMR
hyaluronan mediated motility receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr16:60,290,684...60,332,411
Ensembl chr16:60,290,001...60,331,936
G
HNF1A
HNF1 homeobox A
treatment
ISO
human cell line in mouse model
RGD
PMID:29466992
RGD:14700664
NCBI chr14:40,868,819...40,888,322
Ensembl chr14:40,868,676...40,888,328
G
HNF4A
hepatocyte nuclear factor 4 alpha
ISO
protein:decreased expression:liver:
RGD
PMID:20876809
RGD:12904747
NCBI chr17:46,783,772...46,847,505
Ensembl chr17:46,783,777...46,847,500
G
HNRNPA1
heterogeneous nuclear ribonucleoprotein A1
ISO
protein:increased expression:liver (human)
RGD
PMID:23633480
RGD:9685423
NCBI chr 5:19,485,033...19,491,418
Ensembl chr 5:19,485,096...19,491,417
G
HNRNPA2B1
heterogeneous nuclear ribonucleoprotein A2/B1
ISO
mRNA:increased expression:liver (rat) protein:increased expression:liver (human)
RGD
PMID:20604928 PMID:23633480
RGD:9685422 RGD:9685423
NCBI chr18:46,205,164...46,215,861
Ensembl chr18:46,205,418...46,215,856
G
HNRNPAB
heterogeneous nuclear ribonucleoprotein A/B
severity
ISO
human gene in a mouse model
RGD
PMID:24638979
RGD:10059322
NCBI chr 2:80,186,998...80,194,155
G
HNRNPD
heterogeneous nuclear ribonucleoprotein D
ISO
protein:increased expression:liver (human) protein:increased expression:liver (rat)
RGD
PMID:20102719 PMID:22318685
RGD:10042969 RGD:10042977
NCBI chr 8:135,844,492...135,862,633
Ensembl chr 8:135,844,487...135,862,626
G
HNRNPH1
heterogeneous nuclear ribonucleoprotein H1
ISO
protein:increased expression:liver (human)
RGD
PMID:23633480
RGD:9685423
NCBI chr 2:78,961,456...78,971,799
Ensembl chr 2:78,963,309...78,969,949
G
HNRNPL
heterogeneous nuclear ribonucleoprotein L
ISO
associated with Hepatitis B
RGD
PMID:24125732
RGD:9999429
NCBI chr 6:47,643,561...47,655,856
Ensembl chr 6:47,643,566...47,657,833
G
HOXA10
homeobox A10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr18:45,393,525...45,403,259
Ensembl chr18:45,393,885...45,403,257
G
HOXA13
homeobox A13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr18:45,373,340...45,379,046
Ensembl chr18:45,373,440...45,376,325
G
HOXD9
homeobox D9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr15:81,910,415...81,926,276
Ensembl chr15:81,924,142...81,926,274
G
HP
haptoglobin
ISO
protein:increased expression:saliva protein:decreased expression:liver (human)
RGD
PMID:24259486 PMID:31041878
RGD:152995276 RGD:27095881
NCBI chr 6:14,980,382...14,985,245
G
HPRT1
hypoxanthine phosphoribosyltransferase 1
ISO
protein:increased activity:hepatoma (rat)
RGD
PMID:6327016
RGD:5135035
NCBI chr X:110,321,144...110,357,902
Ensembl chr X:110,321,204...110,357,894
G
HRAS
HRas proto-oncogene, GTPase
treatment
ISO
human cells in a mouse model ClinVar Annotator: match by term: Hepatocellular cancer
RGD ClinVar
PMID:10791191 PMID:11150980 PMID:12835555 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17211612 PMID:17384584 PMID:17412879 PMID:17601930 PMID:17979197 PMID:18039947 PMID:18042262 PMID:18247425 PMID:18978862 PMID:19206176 PMID:19213030 PMID:19255327 PMID:19371735 PMID:19382114 PMID:19669404 PMID:19773371 PMID:20660566 PMID:20859122 PMID:20937837 PMID:20979192 PMID:21438134 PMID:21495179 PMID:21686750 PMID:21834037 PMID:21850009 PMID:22087699 PMID:22256804 PMID:22317973 PMID:22420426 PMID:22495892 PMID:22499344 PMID:22683711 PMID:22726224 PMID:22926243 PMID:23093928 PMID:23096712 PMID:23406027 PMID:23429430 PMID:23751039 PMID:23884457 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24390138 PMID:24803665 PMID:25157968 PMID:25326635 PMID:25741868 PMID:25815234 PMID:25914166 PMID:26467025 PMID:26619011 PMID:26778095 PMID:27195699 PMID:27283355 PMID:27444071 PMID:27589201 PMID:28027064 PMID:28139825 PMID:28492532 PMID:29493581 PMID:30055033 PMID:30138938 PMID:30191474 PMID:31394527 PMID:31560489 PMID:31564432 PMID:31775759 PMID:32371413 PMID:32732226 PMID:33027564 PMID:33372952 PMID:34008892 PMID:34958143 PMID:168335863 More...
RGD:14688055
NCBI chr 2:299,662...302,539
Ensembl chr 2:299,660...302,501
G
HSPA5
heat shock protein family A (Hsp70) member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284 PMID:29698666
NCBI chr 1:265,930,044...265,934,959
Ensembl chr 1:265,930,045...265,934,894
G
HSPA9
heat shock protein family A (Hsp70) member 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 2:140,515,239...140,532,164
Ensembl chr 2:140,515,253...140,531,857
G
HSPB1
heat shock protein family B (small) member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 3:10,038,074...10,039,441
Ensembl chr 3:10,037,949...10,039,704
G
HTATIP2
HIV-1 Tat interactive protein 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16799960
NCBI chr 2:39,035,337...39,052,178
Ensembl chr 2:39,034,013...39,055,315
G
HTRA1
HtrA serine peptidase 1
exacerbates disease_progression
ISO
protein:decreased expression:liver (human) mRNA:decreased expression:liver (human)
RGD
PMID:20943460 PMID:26403966
RGD:152985524 RGD:152985529
NCBI chr14:132,043,044...132,103,590
Ensembl chr14:132,041,934...132,103,595
G
ICAM1
intercellular adhesion molecule 1
severity
ISO
protein:increased expression:serum
RGD
PMID:26109813
RGD:11056752
NCBI chr 2:69,097,136...69,107,722
Ensembl chr 2:69,097,122...69,108,205
G
IDH1
isocitrate dehydrogenase (NADP(+)) 1
ISO
ClinVar Annotator: match by term: Hepatocellular cancer
ClinVar
PMID:18772396 PMID:19657110 PMID:19798509 PMID:19818334 PMID:20946881 PMID:21352804 PMID:21446021 PMID:22160010 PMID:22397365 PMID:22417203 PMID:22898539 PMID:23558169 PMID:24606448 PMID:25043048 PMID:25157968 PMID:25741868 PMID:26619011 PMID:27993330 PMID:30231226 PMID:36201590 More...
NCBI chr15:111,341,153...111,362,330
Ensembl chr15:111,341,153...111,362,296
G
IDH2
isocitrate dehydrogenase (NADP(+)) 2
disease_progression
ISO
ClinVar Annotator: match by term: Hepatocellular cancer
RGD ClinVar
PMID:20946881 PMID:21250968 PMID:21596855 PMID:21997850 PMID:22160010 PMID:22397365 PMID:22417203 PMID:22616558 PMID:22898539 PMID:23949315 PMID:24606448 PMID:24716838 PMID:25157968 PMID:26619011 More...
RGD:14985249
NCBI chr 7:55,654,298...55,675,571
Ensembl chr 7:55,651,609...55,675,554
G
IER2
immediate early response 2
ISO
mRNA, protein:decreased expression:liver (human)
RGD
PMID:32009420
RGD:153323326
NCBI chr 2:65,909,638...65,912,491
Ensembl chr 2:65,909,651...65,912,445
G
IFNA1
interferon, alpha 1
susceptibility
ISO
CTD Direct Evidence: therapeutic associated with hepatitis B; DNA:SNP:: ( rs1831583) (human)
CTD RGD
PMID:17088986 PMID:17971768 PMID:18665156 PMID:29080269
RGD:21406429
NCBI chr 1:201,515,835...201,516,477
Ensembl chr 1:201,515,809...201,516,488
G
IFNG
interferon gamma
ISO
mRNA:increased expression:liver (mouse)
RGD
PMID:26569409
RGD:11344640
NCBI chr 5:32,477,906...32,482,670
Ensembl chr 5:32,477,906...32,482,670
G
IGBP1
immunoglobulin binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21339737
NCBI chr X:56,173,773...56,206,121
G
IGF1
insulin like growth factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 5:81,762,027...81,909,253
Ensembl chr 5:81,775,970...81,848,033
G
IGF1R
insulin like growth factor 1 receptor
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:SNPs, haplotype: :
CTD RGD
PMID:17441810 PMID:23958494 PMID:24758241
RGD:14985227
NCBI chr 1:137,383,623...137,691,038
Ensembl chr 1:137,387,825...137,691,058
G
IGF2
insulin like growth factor 2
susceptibility
ISO
associated with hepatitis B;DNA:SNPs:intron, 3'utr:+2482A>C, +820A>G (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12532445 PMID:16092956 PMID:16750516 PMID:17554210
RGD:14401723 RGD:2311523
NCBI chr 2:1,469,183...1,496,417
G
IGF2BP1
insulin like growth factor 2 mRNA binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr12:25,196,955...25,244,660
Ensembl chr12:25,197,058...25,243,272
G
IGF2BP3
insulin like growth factor 2 mRNA binding protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:92,104,786...92,272,264
Ensembl chr 9:92,104,848...92,272,211
G
IGF2R
insulin like growth factor 2 receptor
disease_progression no_association treatment
ISO
ClinVar Annotator: match by term: Hepatocellular carcinoma DNA:loss of heterozygosity:liver DNA:loss of heterozygosity,mutations:liver:
OMIM ClinVar RGD
PMID:9722161 PMID:10347113 PMID:18322954 PMID:25741868 PMID:30720132
RGD:14985219 RGD:14985220 RGD:14985221
NCBI chr 1:7,369,485...7,472,480
Ensembl chr 1:7,368,103...7,472,548
G
IGFALS
insulin like growth factor binding protein acid labile subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 3:40,173,595...40,177,789
Ensembl chr 3:40,174,764...40,177,784
G
IKBKG
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
treatment
ISO
protein:decreased expression:liver (human)
RGD
PMID:17292824 PMID:22176836 PMID:22922425 PMID:24971483 PMID:25173965 PMID:29551768 More...
RGD:11079569 RGD:153297807 RGD:153297813 RGD:153305943 RGD:153305945 RGD:153305947
NCBI chr X:125,035,575...125,056,445
Ensembl chr X:125,036,508...125,056,453
G
IKZF1
IKAROS family zinc finger 1
ameliorates
ISO
protein:increased expression:liver (human)
RGD
PMID:25301737
RGD:150540326
NCBI chr 9:136,372,202...136,464,942
Ensembl chr 9:136,372,725...136,464,940
G
IL10
interleukin 10
treatment
ISO
RGD
PMID:23822114 PMID:26890368
RGD:14975171 RGD:7365006
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
G
IL12A
interleukin 12A
susceptibility
ISO
associated with hepatitis B; DNA:SNP, haplotype:3′UTR :rs568408(human) DNA:SNP:3'UTR: rs568408( G>A)(human) associated with hepatitis C;DNA:SNP:3'UTR: rs568408( G>A)(human)
RGD
PMID:20521253 PMID:26631030 PMID:27819525
RGD:25440490 RGD:25440491 RGD:25440501
NCBI chr13:99,733,394...99,741,078
Ensembl chr13:99,733,394...99,741,078
G
IL15RA
interleukin 15 receptor subunit alpha
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr10:65,022,227...65,054,385
G
IL18
interleukin 18
disease_progression susceptibility severity
ISO
associated with hepatitis B, chronic;DNA:SNP:promoter:-607C>A(human) DNA:SNP:promoter:-137G>C(rs187238)(human) associated with hepatitis C;DNA:SNPs, haplotype:promoter:-607C>A, -137G>C(human)
RGD
PMID:26893476 PMID:27429592 PMID:27470888 PMID:29341496
RGD:11538094 RGD:14695526 RGD:14695540 RGD:14696663
NCBI chr 9:39,839,959...39,861,258
Ensembl chr 9:39,834,973...39,861,219
G
IL18R1
interleukin 18 receptor 1
ISO
mRNA:decreased expression:liver
RGD
PMID:26893476
RGD:11538094
NCBI chr 3:51,803,383...51,844,758
Ensembl chr 3:51,803,175...51,844,684
G
IL1RAP
interleukin 1 receptor accessory protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr13:127,933,239...128,071,984
Ensembl chr13:127,933,693...128,043,480
G
IL1RN
interleukin 1 receptor antagonist
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
G
IL2
interleukin 2
treatment
ISO
RGD
PMID:9449371 PMID:10933975
RGD:14747035 RGD:8693323
NCBI chr 8:101,640,938...101,645,683
Ensembl chr 8:101,640,944...101,645,609
G
IL21
interleukin 21
ISO
associated with hepatitis B;DNA:SNPS, haplotype:(rs13143866, rs2221903, rs907715) (human)
RGD
PMID:25892873
RGD:127285359
NCBI chr 8:101,532,742...101,540,712
Ensembl chr 8:101,532,531...101,541,713
G
IL29
interleukin 29 (interferon, lambda 1)
ameliorates
ISO
human protein and cells in mouse model
RGD
PMID:24769671
RGD:126848750
NCBI chr17:51,484,658...51,485,233
Ensembl chr17:51,484,658...51,485,233
G
IL6
interleukin 6
treatment disease_progression
ISO
DNA:SNP: :rs2069852 (human) mRNA,protein:increased expression:liver, blood serum (mouse) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17615358 PMID:20818158 PMID:26297436 PMID:26569409 PMID:27022031 PMID:27368337 More...
RGD:11344640 RGD:14975289
NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263
G
IL6ST
interleukin 6 cytokine family signal transducer
ISO
RGD
PMID:15780071
RGD:1626706
NCBI chr16:35,101,304...35,151,832
Ensembl chr16:35,101,306...35,192,220
G
ING3
inhibitor of growth family member 3
treatment
ISO
RGD
PMID:25156538
RGD:9587823
NCBI chr18:25,946,529...25,976,528
Ensembl chr18:25,948,097...25,976,499
G
INMT
indolethylamine N-methyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr18:42,213,335...42,218,175
Ensembl chr18:42,209,352...42,218,174
G
INPP4B
inositol polyphosphate-4-phosphatase type II B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29415082
NCBI chr 8:84,812,041...85,555,200
Ensembl chr 8:85,084,133...85,514,516
G
INS
insulin
ISO
associated with Chronic Hepatitis C;mRNA:decreased expression:liver (human)
RGD
PMID:33132693
RGD:150340613
NCBI chr 2:1,496,842...1,498,052
Ensembl chr 2:1,496,842...1,497,841
G
INSR
insulin receptor
ISO
human cells in a mouse model mRNA, protein:increased expression:liver (human, rat)
RGD
PMID:23633480 PMID:29610518
RGD:14700930 RGD:9685423
NCBI chr 2:71,797,209...71,939,923
Ensembl chr 2:71,797,204...71,936,104
G
IQGAP2
IQ motif containing GTPase activating protein 2
ISO
CTD Direct Evidence: marker/mechanism OMIM:114550
CTD MouseDO
PMID:20977743
NCBI chr 2:85,294,423...85,633,645
Ensembl chr 2:85,294,530...85,633,642
G
IQGAP3
IQ motif containing GTPase activating protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 4:93,495,999...93,556,915
Ensembl chr 4:93,513,187...93,559,001
G
IRF2
interferon regulatory factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561517
NCBI chr15:45,546,779...45,693,241
Ensembl chr15:45,546,783...45,634,704
G
IRS1
insulin receptor substrate 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:1311924 PMID:23958494
NCBI chr15:128,245,846...128,307,321
Ensembl chr15:128,245,846...128,307,284
G
IRS2
insulin receptor substrate 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16127164
NCBI chr11:76,626,158...76,654,639
Ensembl chr11:76,626,179...76,653,881
G
ISG15
ISG15 ubiquitin like modifier
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28919514
NCBI chr 6:63,363,201...63,364,211
Ensembl chr 6:63,363,173...63,364,208
G
ITIH3
inter-alpha-trypsin inhibitor heavy chain 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144
NCBI chr13:34,911,104...34,924,881
Ensembl chr13:34,906,538...34,933,706
G
ITIH4
inter-alpha-trypsin inhibitor heavy chain 4
disease_progression
ISO
associated with hepatitis B;protein:decreased expression:serum
RGD
PMID:24836184
RGD:40903002
NCBI chr13:34,928,455...34,948,250
Ensembl chr13:34,928,439...34,948,229
G
JAG1
jagged canonical Notch ligand 1
ISO
protein:increased expression:liver
RGD
PMID:30660174
RGD:14694832
NCBI chr17:19,591,248...19,629,659
Ensembl chr17:19,591,259...19,629,641
G
JAK1
Janus kinase 1
ISO
RGD
PMID:23788652
RGD:150524353
NCBI chr 6:147,320,288...147,567,188
Ensembl chr 6:147,429,056...147,567,182
G
JAK2
Janus kinase 2
severity treatment ameliorates exacerbates
ISO
mRNA:decreased expression:liver (human) L-JAK2 KO associated with Diseases of the Aged and non-alcoholic fatty liver disease protein:increased phosphorylation:liver (mouse) protein:increased phosphorylation:liver (human)
RGD
PMID:22392353 PMID:22821478 PMID:25420511 PMID:28100771 PMID:29486150 PMID:31393852 More...
RGD:125097525 RGD:127285621 RGD:127285655 RGD:127285672 RGD:127285675 RGD:18182928
NCBI chr 1:216,849,744...217,002,310
Ensembl chr 1:216,848,689...217,002,148
G
JDP2
Jun dimerization protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20214788
NCBI chr 7:98,574,386...98,616,480
Ensembl chr 7:98,575,667...98,616,474
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20214788
NCBI chr 6:153,686,425...153,687,635
Ensembl chr 6:153,685,682...153,687,636
G
JUND
JunD proto-oncogene, AP-1 transcription factor subunit
ISO
associated with HBV;protein:increased expression:liver (human)
RGD
PMID:15927205
RGD:153297768
NCBI chr 2:59,530,991...59,532,846
G
KAT2B
lysine acetyltransferase 2B
severity
ISO
protein:decreased expression:liver (human)
RGD
PMID:23643089
RGD:9590314
NCBI chr13:6,985,151...7,099,771
Ensembl chr13:6,985,235...7,100,345
G
KBTBD11
kelch repeat and BTB domain containing 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr15:33,487,439...33,501,274
Ensembl chr15:33,494,430...33,497,201
G
KCNH1
potassium voltage-gated channel subfamily H member 1
ISO
protein:increased expression:liver (human)
RGD
PMID:17022810
RGD:9693723
NCBI chr 9:131,960,566...132,336,029
Ensembl chr 9:131,960,480...132,334,953
G
KCNN2
potassium calcium-activated channel subfamily N member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:118,439,328...118,882,299
Ensembl chr 2:118,439,403...118,882,295
G
KDM1A
lysine demethylase 1A
severity
ISO
mRNA, protein:increased expression:liver (human)
RGD
PMID:23236241
RGD:9681002
NCBI chr 6:80,903,407...80,971,875
Ensembl chr 6:80,903,424...80,971,873
G
KDM3A
lysine demethylase 3A
ISO
mRNA:increased expression:liver (human)
RGD
PMID:21607773
RGD:9590222
NCBI chr 3:58,300,109...58,355,000
Ensembl chr 3:58,302,949...58,354,945
G
KDM5C
lysine demethylase 5C
exacerbates
ISO
protein:increased expression:liver (human)
RGD
PMID:26503415
RGD:11530160
NCBI chr X:45,968,812...46,003,215
Ensembl chr X:45,968,814...46,003,215
G
KDM6A
lysine demethylase 6A
ameliorates
ISO
human cells in a mouse model
RGD
PMID:32765772
RGD:150429729
NCBI chr X:39,953,764...40,154,197
Ensembl chr X:39,953,814...40,154,029
G
KDM8
lysine demethylase 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 3:19,653,396...19,676,207
Ensembl chr 3:19,653,402...19,676,148
G
KDR
kinase insert domain receptor
disease_progression treatment
ISO
protein:decreased expression:liver associated with alcoholic liver cirrhosis;DNA:SNP: :1416A>T (human) protein:increased expression:liver DNA:SNPs: :rs1870377, rs2071559, rs2305948 (human)
RGD
PMID:19177438 PMID:23660204 PMID:24445728 PMID:25182707 PMID:25333267
RGD:126848806 RGD:126848810 RGD:126848812 RGD:126848813 RGD:126848814
NCBI chr 8:41,809,116...41,856,379
Ensembl chr 8:41,809,122...41,856,336
G
KIF11
kinesin family member 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr14:104,125,839...104,177,381
Ensembl chr14:104,125,898...104,177,379
G
KIF14
kinesin family member 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr10:23,123,379...23,177,919
Ensembl chr10:23,123,480...23,174,273
G
KIF15
kinesin family member 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr13:27,966,586...28,041,121
Ensembl chr13:27,966,586...28,041,451
G
KIF18A
kinesin family member 18A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:32,244,073...32,331,392
Ensembl chr 2:32,244,137...32,335,736
G
KIF18B
kinesin family member 18B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr12:18,426,828...18,448,214
Ensembl chr12:18,426,835...18,448,208
G
KIF1B
kinesin family member 1B
severity susceptibility
ISO
mRNA, protein:decreased expression:liver (human) DNA:snp:intron:c.2537+518A>G (rs17401966) (human)
RGD
PMID:26217094 PMID:27122668
RGD:11052488 RGD:12738461
NCBI chr 6:70,495,143...70,663,464
Ensembl chr 6:70,495,144...70,661,798
G
KIF20A
kinesin family member 20A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:140,202,316...140,213,144
Ensembl chr 2:140,202,015...140,211,155
G
KIF23
kinesin family member 23
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:167,239,973...167,281,250
Ensembl chr 1:167,239,997...167,281,245
G
KIF2C
kinesin family member 2C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:166,556,765...166,577,904
Ensembl chr 6:166,556,776...166,577,904
G
KIF4A
kinesin family member 4A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr X:56,319,453...56,447,560
Ensembl chr X:56,319,529...56,447,553
G
KIFC1
kinesin family member C1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:29,692,775...29,713,716
Ensembl chr 7:29,694,778...29,713,712
G
KLF4
KLF transcription factor 4
treatment disease_progression
ISO
RGD
PMID:22677193
RGD:14402023
NCBI chr 1:248,604,817...248,609,574
Ensembl chr 1:248,604,820...248,609,035
G
KLRF1
killer cell lectin like receptor F1
disease_progression
ISO
mRNA:decreased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr 5:62,032,559...62,044,856
Ensembl chr 5:62,032,574...62,043,988
G
KMT2A
lysine methyltransferase 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22634756
NCBI chr 9:45,743,566...45,828,559
Ensembl chr 9:45,743,397...45,824,884
G
KMT2B
lysine methyltransferase 2B
ISO
DNA:insertions, translocations:intron:IVS3, multiple (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:18320596 PMID:22634754
RGD:9588597
NCBI chr 6:45,146,863...45,166,854
Ensembl chr 6:45,147,566...45,166,852
G
KMT2C
lysine methyltransferase 2C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22634756
NCBI chr18:4,993,213...5,279,668
Ensembl chr18:4,993,227...5,278,723
G
KRAS
KRAS proto-oncogene, GTPase
induced
ISO
aflatoxin B1 induced:DNA:transversion,transition mutations:cds: ClinVar Annotator: match by term: Hepatocellular cancer
RGD ClinVar
PMID:2278970 PMID:3122217 PMID:8446626 PMID:12460918 PMID:15696205 PMID:16361624 PMID:16434492 PMID:16618717 PMID:18316791 PMID:18794081 PMID:19075190 PMID:19114683 PMID:19679400 PMID:20921462 PMID:20921465 PMID:21228335 PMID:22407852 PMID:22722830 PMID:23325582 PMID:25157968 PMID:26619011 PMID:30891959 More...
RGD:11568697
NCBI chr 5:48,508,774...48,546,260
Ensembl chr 5:48,508,811...48,549,358
G
KRT18
keratin 18
ISO
OMIM:114550
MouseDO
NCBI chr 5:18,217,686...18,221,432
Ensembl chr 5:18,217,691...18,221,429
G
LCAT
lecithin-cholesterol acyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:28,550,356...28,553,561
Ensembl chr 6:28,550,358...28,553,566
G
LECT2
leukocyte cell derived chemotaxin 2
ameliorates
ISO
human cells in mouse model protein:increased expression:blood serum (human) protein:increased expression:blood serum (mouse)
RGD
PMID:21394108 PMID:24892551
RGD:153323333 RGD:153323335
NCBI chr 2:138,109,537...138,120,285
Ensembl chr 2:138,109,351...138,124,464
G
LEP
leptin
severity susceptibility
ISO
protein:increased expression:liver (human) DNA:SNP:enhancer:-2548G>A (rs7799039) (human)
RGD
PMID:18573568 PMID:28452232
RGD:15039399 RGD:25330348
NCBI chr18:20,106,867...20,124,071
Ensembl chr18:20,106,868...20,123,323
G
LEPR
leptin receptor
susceptibility
ISO
associated with Hepatitis B, Chronic;DNA:missense mutations:cds:p.Q223R, p.K109R (human)
RGD
PMID:23090836
RGD:21079466
NCBI chr 6:146,802,297...146,896,152
Ensembl chr 6:146,801,954...146,895,995
G
LETM1
leucine zipper and EF-hand containing transmembrane protein 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23392203
NCBI chr 8:898,178...926,500
Ensembl chr 8:898,181...926,593
G
LOC100153163
MHC class I polypeptide-related sequence B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21499248
NCBI chr 7:23,596,900...23,610,431
G
LOC100157117
kallistatin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:19709125
NCBI chr 7:115,781,772...115,792,469
Ensembl chr 7:115,783,931...115,792,466
G
LOC100511937
phosphatidylinositol 3-kinase regulatory subunit gamma
treatment
ISO
RGD
PMID:25999787
RGD:152177911
NCBI chr 6:165,268,260...165,402,668
Ensembl chr 6:165,268,568...165,402,649
G
LOC100515114
serine/threonine-protein phosphatase 4 regulatory subunit 3B-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr X:23,301,323...23,303,743
G
LOC100517408
cytochrome c oxidase subunit 7B2, mitochondrial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:36,736,233...36,856,176
Ensembl chr 8:36,736,352...36,736,597
G
LOC100737875
solute carrier family 22 member 10-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560 PMID:30705370
NCBI chr 2:8,734,036...8,750,828
G
LOC100739508
glutathione S-transferase P-like
ISO
DNA:increased methylation:promoter CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:9029167 PMID:22536438
RGD:14401712
NCBI chr 2:5,005,498...5,009,247
G
LOC102167255
leukemia inhibitory factor receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr16:23,627,700...23,672,724
Ensembl chr16:23,634,298...23,804,854
G
LOC110255234
liver carboxylesterase-like
disease_progression
ISO
associated with tumor vascularization; protein:decreased expression:liver tumor (human) protein:decreased expression:liver (human) mRNA, protein:decreased expression:liver tumor (human)
RGD
PMID:19658107 PMID:24259486 PMID:30901224
RGD:152995276 RGD:152995279 RGD:152995286
G
LOC110256483
carbonyl reductase [NADPH] 1-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21056497
NCBI chr13:199,713,741...199,719,535
G
LOC110258578
interleukin-1 beta-like
susceptibility
ISO
DNA:polymorphism:promoter:-31T>C (human)
RGD
PMID:21653279
RGD:7401222
G
LOXL3
lysyl oxidase like 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35841383
NCBI chr 3:68,498,114...68,516,829
Ensembl chr 3:68,498,189...68,517,445
G
LPAR1
lysophosphatidic acid receptor 1
ISO
RGD
PMID:19000703
RGD:2317680
NCBI chr 1:251,811,583...251,979,828
Ensembl chr 1:251,811,584...251,979,159
G
LRAT
lecithin retinol acyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:74,412,226...74,428,713
Ensembl chr 8:74,409,461...74,419,681
G
LRP1B
LDL receptor related protein 1B
exacerbates
ISO
protein:increased expression:liver (human) DNA:mutations:multiple: (human)
RGD
PMID:33324588 PMID:33391418
RGD:150429776 RGD:150429785
NCBI chr15:9,612,805...11,499,969
Ensembl chr15:9,613,238...11,499,530
G
LRRC1
leucine rich repeat containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:26,860,138...26,989,664
Ensembl chr 7:26,860,140...26,989,698
G
LRRC56
leucine rich repeat containing 56
ISO
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar
PMID:11150980 PMID:12835555 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17211612 PMID:17384584 PMID:17412879 PMID:17601930 PMID:17979197 PMID:18039947 PMID:18042262 PMID:18247425 PMID:18978862 PMID:19206176 PMID:19213030 PMID:19255327 PMID:19371735 PMID:19382114 PMID:19669404 PMID:19773371 PMID:20660566 PMID:20859122 PMID:20937837 PMID:20979192 PMID:21438134 PMID:21495179 PMID:21686750 PMID:21834037 PMID:21850009 PMID:22087699 PMID:22256804 PMID:22317973 PMID:22420426 PMID:22495892 PMID:22499344 PMID:22683711 PMID:22726224 PMID:22926243 PMID:23093928 PMID:23096712 PMID:23406027 PMID:23429430 PMID:23751039 PMID:23884457 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24390138 PMID:24803665 PMID:25157968 PMID:25326635 PMID:25741868 PMID:25815234 PMID:25914166 PMID:26467025 PMID:26619011 PMID:26778095 PMID:27195699 PMID:27283355 PMID:27444071 PMID:27589201 PMID:28027064 PMID:28139825 PMID:28492532 PMID:29493581 PMID:30055033 PMID:30138938 PMID:30191474 PMID:31394527 PMID:31560489 PMID:31564432 PMID:31775759 PMID:32371413 PMID:32732226 PMID:33027564 PMID:33372952 PMID:34008892 PMID:34958143 PMID:168335863 More...
NCBI chr 2:303,836...323,701
Ensembl chr 2:304,430...323,699
G
LRRC59
leucine rich repeat containing 59
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30705370
NCBI chr12:26,678,207...26,694,277
Ensembl chr12:26,677,226...26,694,279
G
LYVE1
lymphatic vessel endothelial hyaluronan receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:48,937,357...48,954,206
Ensembl chr 2:48,937,419...48,954,196
G
LZTR1
leucine zipper like post translational regulator 1
ISO
DNA:missense mutation:cds, liver (human)
RGD
PMID:28622513
RGD:151893487
NCBI chr14:50,576,413...50,590,397
Ensembl chr14:50,576,624...50,590,397
G
MAD2L1
mitotic arrest deficient 2 like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:103,927,358...103,936,669
Ensembl chr 8:103,927,353...103,936,664
G
MAP2K2
mitogen-activated protein kinase kinase 2
exacerbates
ISO
protein:increased expression:liver, cytosol (rat) mRNA:increased expression:liver (human)
RGD
PMID:9397988 PMID:33553243
RGD:150530475 RGD:150530477
NCBI chr 2:74,626,739...74,651,352
Ensembl chr 2:74,626,783...74,651,348
G
MAP2K4
mitogen-activated protein kinase kinase 4
ISO
protein:decreased expression:liver (human)
RGD
PMID:32850377
RGD:150429765
NCBI chr12:56,402,029...56,516,217
Ensembl chr12:56,402,075...56,516,238
G
MAP3K1
mitogen-activated protein kinase kinase kinase 1
exacerbates
ISO
mRNA:decreased expression:liver (human)
RGD
PMID:31310010
RGD:150573714
NCBI chr16:35,872,301...35,947,097
Ensembl chr16:35,872,131...35,946,987
G
MAP3K8
mitogen-activated protein kinase kinase kinase 8
ameliorates
ISO
RGD
PMID:26560698
RGD:11342977
NCBI chr10:40,714,004...40,746,390
Ensembl chr10:40,713,847...40,742,462
G
MAP4K4
mitogen-activated protein kinase kinase kinase kinase 4
ameliorates treatment severity
ISO
human cell line in a mouse model human recombinant gene and cell line in a mouse model
RGD
PMID:21196414 PMID:27010469 PMID:31922225
RGD:151347673 RGD:151347674 RGD:151347839
NCBI chr 3:52,483,028...52,649,480
Ensembl chr 3:52,484,274...52,649,410
G
MAPK1
mitogen-activated protein kinase 1
ISO
protein:increased expression:liver
RGD
PMID:27468214
RGD:401976278
NCBI chr14:50,083,079...50,165,528
Ensembl chr14:50,082,896...50,165,513
G
MAPK14
mitogen-activated protein kinase 14
exacerbates treatment
ISO
RGD
PMID:23271722 PMID:25216638
RGD:151665347 RGD:151665348
NCBI chr 7:31,791,398...31,861,544
Ensembl chr 7:31,790,877...31,862,031
G
MAPK8
mitogen-activated protein kinase 8
ameliorates
ISO
protein:decreased phosphorylation:liver (human)
RGD
PMID:33875785
RGD:150340688
NCBI chr14:88,988,914...89,108,875
Ensembl chr14:88,988,949...89,108,874
G
MAPT
microtubule associated protein tau
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr12:17,098,259...17,211,483
Ensembl chr12:17,095,587...17,211,373
G
MARCO
macrophage receptor with collagenous structure
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr15:24,502,935...24,541,286
Ensembl chr15:24,503,108...24,541,283
G
MAT1A
methionine adenosyltransferase 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12060674
NCBI chr14:82,109,405...82,126,487
Ensembl chr14:82,107,390...82,127,049
G
MBL2
mannose binding lectin 2
susceptibility no_association severity
ISO
DNA:SNPs:promoter:rs7096206(human) associated with hepatitis B;DNA:SNP:exon: associated with hepatitis B-related cirrhosis;DNA:SNP: :rs11003123(G>A)(human) associated with viral hepatitis;DNA:polymorphisms:exon: associated with hepatitis C;DNA:SNP: :221C>G(rs709620)(human) protein:decreased expression:plasma
RGD
PMID:18221301 PMID:21733090 PMID:25787238 PMID:26857650 PMID:27298104 PMID:27557564 More...
RGD:14696813 RGD:14696814 RGD:14696829 RGD:14696833 RGD:14696835 RGD:14696836
NCBI chr14:97,103,926...97,107,635
Ensembl chr14:97,102,823...97,108,083
G
MBTPS1
membrane bound transcription factor peptidase, site 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14563831
NCBI chr 6:4,503,530...4,558,601
Ensembl chr 6:4,503,565...4,558,609
G
MBTPS2
membrane bound transcription factor peptidase, site 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14563831
NCBI chr X:18,013,360...18,054,250
G
MCM10
minichromosome maintenance 10 replication initiation factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr10:48,481,292...48,523,921
Ensembl chr10:48,480,705...48,538,952
G
MCM2
minichromosome maintenance complex component 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr13:72,630,378...72,651,270
Ensembl chr13:72,630,380...72,657,786
G
MCM7
minichromosome maintenance complex component 7
susceptibility
ISO
associated with hepatitis B;DNA:SNP:promoter: (rs999885) (human) associated with hepatitis B;miRNA:increased expression:liver (human)
RGD
PMID:24416400 PMID:27298561
RGD:15042853 RGD:15042885
NCBI chr 3:8,005,890...8,014,047
Ensembl chr 3:8,005,900...8,014,053
G
MCM9
minichromosome maintenance 9 homologous recombination repair factor
ISO
OMIM:114550
MouseDO
NCBI chr 1:43,171,906...43,268,533
G
MDM2
MDM2 proto-oncogene
susceptibility
ISO
DNA:transversion:promoter:g.-309T>G (human)
RGD
PMID:20019189
RGD:2317357
NCBI chr 5:33,105,717...33,137,602
Ensembl chr 5:33,105,759...33,137,739
G
ME1
malic enzyme 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147110
NCBI chr 1:82,799,878...82,989,895
Ensembl chr 1:82,799,684...82,991,085
G
MECP2
methyl-CpG binding protein 2
ISO
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:liver
CTD RGD
PMID:11844796 PMID:26189965
RGD:2289670
NCBI chr X:124,735,523...124,789,063
Ensembl chr X:124,735,656...124,738,659
G
MED1
mediator complex subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20007298
NCBI chr12:22,830,405...22,872,420
Ensembl chr12:22,841,205...22,872,409
G
MELK
maternal embryonic leucine zipper kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:237,317,161...237,431,522
Ensembl chr 1:237,317,191...237,431,589
G
MET
MET proto-oncogene, receptor tyrosine kinase
severity
ISO
protein:increased expression:liver (human) ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma
RGD OMIM ClinVar
PMID:21774103 PMID:21970370 PMID:22703879 PMID:24728327 PMID:25741868 PMID:28259294 PMID:28492532 PMID:29303510 PMID:29641532 More...
RGD:152995524
NCBI chr18:29,426,044...29,541,526
Ensembl chr18:29,426,048...29,541,512
G
MFSD2A
MFSD2 lysolipid transporter A, lysophospholipid
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:95,738,961...95,753,245
Ensembl chr 6:95,738,969...95,753,245
G
MIR107
microRNA mir-107
onset treatment
ISO
RNA:increased expression:liver: RNA:decreased expression:liver:
RGD
PMID:26191213 PMID:27773820 PMID:28079796 PMID:30738047
RGD:11066920 RGD:14975277 RGD:14975278 RGD:14975300
NCBI chr14:101,420,743...101,420,829
Ensembl chr14:101,420,743...101,420,829
G
MIR122
microRNA mir-122
severity
ISO
CTD Direct Evidence: marker/mechanism mRNA:decreased expression:blood (human) protein:decreased expression:liver (human) associated with hepatitis B; miRNA:decreased expression:liver
CTD RGD
PMID:16924677 PMID:19584283 PMID:25269820 PMID:25422324 PMID:27528885
RGD:14394424 RGD:14401603 RGD:151356981 RGD:151361113
NCBI chr 1:162,329,776...162,329,860
Ensembl chr 1:162,329,767...162,329,860
G
MIR125A
microRNA mir-125a
treatment severity
ISO
RNA:increased expression:liver:
RGD
PMID:29951066 PMID:30257386
RGD:21403677 RGD:21403679
NCBI chr 6:58,331,566...58,331,645
Ensembl chr 6:58,331,566...58,331,645
G
MIR127
microRNA mir-127
ISO
miRNA:decreased expression:liver (human)
RGD
PMID:24854842
RGD:152995355
NCBI chr 7:121,709,636...121,709,715
Ensembl chr 7:121,709,640...121,709,720
G
MIR133A-2
microRNA mir-133a-2
disease_progression
ISO
mRNA:decreased expression:liver (human) human cells in mouse model
RGD
PMID:30086463
RGD:153344517
NCBI chr 6:106,998,899...106,998,971
Ensembl chr 6:106,998,896...106,998,982
G
MIR133B
microRNA mir-133b
severity
ISO
mRNA:decreased expression:liver(human)
RGD
PMID:30391496
RGD:155804298
NCBI chr 7:45,980,138...45,980,217
Ensembl chr 7:45,980,138...45,980,217
G
MIR136
microRNA mir-136
exacerbates
ISO
RNA:decreased expression:liver (human)
RGD
PMID:28849100
RGD:153345547
NCBI chr 7:121,711,328...121,711,409
Ensembl chr 7:121,711,325...121,711,414
G
MIR139
microRNA mir-139
ISO
RNA:decreased expression:liver (human)
RGD
PMID:30710422
RGD:153344549
NCBI chr 9:7,175,314...7,175,381
Ensembl chr 9:7,175,308...7,175,385
G
MIR145
microRNA mir-145
severity
ISO
miRNA:decreased expression:liver (human)
RGD
PMID:30572504
RGD:15039395
NCBI chr 2:150,580,126...150,580,211
Ensembl chr 2:150,580,126...150,580,211
G
MIR150-1
microRNA mir-150-1
ISO
mRNA:decreased expression:liver (human)
RGD
PMID:30205391
RGD:153344577
NCBI chr 6:54,580,912...54,580,988
Ensembl chr 6:54,580,912...54,580,988
G
MIR152
microRNA mir-152
disease_progression
ISO
miRNA:decreased expression:liver
RGD
PMID:26531720 PMID:30967300
RGD:19165146 RGD:21066331
NCBI chr12:24,292,249...24,292,328
Ensembl chr12:24,292,251...24,292,336
G
MIR155
microRNA mir-155
disease_progression
ISO
miRNA:increased expression:serum miRNA:decreased expression:peripheral blood mononuclear cell associated with hepatitis C;DNA:SNP: :rs767649 (human)
RGD
PMID:27035278 PMID:27531892 PMID:28074870 PMID:29528577 PMID:30710754
RGD:21079433 RGD:21079477 RGD:21081523 RGD:24922222 RGD:25671465
NCBI chr13:189,138,822...189,138,902
Ensembl chr13:189,138,822...189,138,902
G
MIR181C
microRNA mir-181c
ISO
miRNA:decreased expression:liver (human)
RGD
PMID:31114379
RGD:15042894
NCBI chr 2:65,279,950...65,280,036
Ensembl chr 2:65,279,944...65,280,040
G
MIR18A
microRNA mir-18a
severity
ISO
associated with Hepatitis C, Chronic;miRNA:increased expression:serum (human) associated with hepatitis B;miRNA:increased expression:liver (human)
RGD
PMID:19027010 PMID:24975878 PMID:29455432 PMID:30191950 PMID:30519035
RGD:15039389 RGD:15039398 RGD:15039400 RGD:15039401 RGD:15039404
NCBI chr11:60,734,791...60,734,882
Ensembl chr11:60,734,791...60,734,882
G
MIR193A
microRNA mir-193a
disease_progression exacerbates
ISO
RNA:decreased expression:liver (human) miRNA:decreased expression:liver (human) RNA:increased expression:blood serum (human) DNA:hypomethylation
RGD
PMID:26263159 PMID:28036298 PMID:30710422 PMID:32960907
RGD:11070076 RGD:153344549 RGD:153344563 RGD:153344564
NCBI chr12:43,336,969...43,337,048
Ensembl chr12:43,336,969...43,337,048
G
MIR195
microRNA mir-195
severity
ISO
miRNA:decreased expression:liver (mouse) miRNA:decreased expression:liver (human)
RGD
PMID:25607636
RGD:15042896
NCBI chr12:52,422,039...52,422,118
Ensembl chr12:52,422,039...52,422,118
G
MIR196A-2
microRNA mir-196a-2
susceptibility
ISO
associated with hepatitis B, chronic; DNA:SNP: : (rs12304647) DNA:SNP: : (rs11614913)
RGD
PMID:21692953 PMID:24248733
RGD:14401594 RGD:14401595
NCBI chr 5:19,204,442...19,204,548
Ensembl chr 5:19,204,442...19,204,548
G
MIR199B
microRNA mir-199b
disease_progression
ISO
miRNA:decreased expression:liver
RGD
PMID:30536310
RGD:14694833
NCBI chr 1:268,691,520...268,691,593
Ensembl chr 1:268,691,502...268,691,610
G
MIR20A
microRNA mir-20a
ISO
associated with Human Viral Hepatitis
RGD
PMID:30623908
RGD:25823145
NCBI chr11:60,735,109...60,735,179
Ensembl chr11:60,735,099...60,735,196
G
MIR21
microRNA mir-21
treatment severity
ISO
miRNA:increased expression:liver
RGD
PMID:20447717 PMID:21749846 PMID:24963487
RGD:14695022 RGD:40925952 RGD:41404642
NCBI chr12:36,065,267...36,065,358
Ensembl chr12:36,065,267...36,065,358
G
MIR212
microRNA mir-212
disease_progression ameliorates
ISO
RGD
PMID:25965836
RGD:11054501
NCBI chr12:48,163,054...48,163,135
Ensembl chr12:48,163,046...48,163,145
G
MIR221
microRNA mir-221
treatment disease_progression
ISO
RGD
PMID:22009537 PMID:25817558 PMID:28096271 PMID:29713162 PMID:31801250
RGD:11086123 RGD:151893509 RGD:18337267 RGD:18337273 RGD:18337275
NCBI chr X:40,571,068...40,571,137
Ensembl chr X:40,571,068...40,571,137
G
MIR222
microRNA mir-222
disease_progression severity
ISO
RGD
PMID:20103675 PMID:24124720
RGD:151709003 RGD:151709004
NCBI chr X:40,571,808...40,571,887
Ensembl chr X:40,571,808...40,571,887
G
MIR224
microRNA mir-224
severity
ISO
associated with hepatitis B;miRNA:increased expression:liver (human) miRNA:increased expression:plasma (human)
RGD
PMID:22459148 PMID:23913306 PMID:23922662 PMID:24923856 PMID:27462777
RGD:18182921 RGD:18182922 RGD:18182923 RGD:18182924 RGD:18182926
NCBI chr X:123,283,427...123,283,507
Ensembl chr X:123,283,427...123,283,507
G
MIR23A
microRNA mir-23a
ISO
miRNA:increased expression:liver
RGD
PMID:22318941
RGD:14694846
NCBI chr 2:65,308,117...65,308,186
Ensembl chr 2:65,308,117...65,308,186
G
MIR23B
microRNA mir-23b
ISO
DNA:hypermethylation
RGD
PMID:28036298
RGD:153344564
NCBI chr10:27,080,197...27,080,276
Ensembl chr10:27,080,197...27,080,276
G
MIR27A
microRNA mir-27a
severity treatment
ISO
human cell line in a mouse model human miRNA and cell line in a mouse model
RGD
PMID:29143999 PMID:30083261
RGD:14696659 RGD:14696660
NCBI chr 2:65,308,294...65,308,375
Ensembl chr 2:65,308,294...65,308,375
G
MIR29A
microRNA mir-29a
severity
ISO
associated with hepatitis B;miRNA:increased expression:liver (human)
RGD
PMID:23285022
RGD:15042850
NCBI chr18:18,040,032...18,040,117
Ensembl chr18:18,040,032...18,040,118
G
MIR31
microRNA mir-31
severity
ISO
RNA:decreased expression:liver (human) miRNA:decreased expression:liver (human) miRNA:decreased expression:liver (rat)
RGD
PMID:25797269 PMID:28623129
RGD:11085965 RGD:152998991
NCBI chr 1:201,198,732...201,198,809
Ensembl chr 1:201,198,732...201,198,809
G
MIR432
microRNA mir-432
disease_progression
ISO
mRNA:decreased expression:liver (human) human cells in mouse model
RGD
PMID:25797263 PMID:30086881 PMID:33675609
RGD:11087457 RGD:152999436 RGD:152999437
NCBI chr 7:121,711,137...121,711,216
Ensembl chr 7:121,711,137...121,711,216
G
MIR455
microRNA mir-455
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35286011
NCBI chr 1:254,824,200...254,824,279
Ensembl chr 1:254,824,196...254,824,291
G
MIR885
microRNA mir-885
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:27738331
NCBI chr13:66,597,531...66,597,610
Ensembl chr13:66,597,531...66,597,610
G
MIR96
microRNA mir-96
severity
ISO
miRNA:increased expression:liver (human)
RGD
PMID:25813403 PMID:28892647
RGD:15042901 RGD:15042902
NCBI chr18:18,982,506...18,982,590
Ensembl chr18:18,982,506...18,982,590
G
MIRLET7C
microRNA let-7c
ISO
miRNA:decreased expression:liver
RGD
PMID:22289550
RGD:14695021
NCBI chr13:181,303,209...181,303,302
Ensembl chr13:181,303,209...181,303,302
G
MKI67
marker of proliferation Ki-67
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr14:137,266,622...137,296,312
G
MLXIPL
MLX interacting protein like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147110
NCBI chr 3:10,898,675...10,934,257
Ensembl chr 3:10,898,670...10,934,048
G
MME
membrane metalloendopeptidase
ISO
RGD
PMID:8302012
RGD:13801035
NCBI chr13:95,018,395...95,122,977
Ensembl chr13:95,019,081...95,126,045
G
MMP14
matrix metallopeptidase 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33010264
NCBI chr 7:76,174,502...76,185,931
Ensembl chr 7:76,172,971...76,185,928
G
MMP2
matrix metallopeptidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20084675
NCBI chr 6:30,059,247...30,087,031
Ensembl chr 6:30,058,595...30,086,982
G
MMP9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20084675 PMID:21681821
RGD:8547864
NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,179,671...48,186,788
G
MOGAT2
monoacylglycerol O-acyltransferase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:9,937,654...9,951,679
Ensembl chr 9:9,937,700...10,008,913
G
MPL
MPL proto-oncogene, thrombopoietin receptor
ISO
human cells in mouse model
RGD
PMID:23157389
RGD:126925755
NCBI chr 6:167,896,191...167,908,988
Ensembl chr 6:167,896,287...167,908,625
G
MPO
myeloperoxidase
susceptibility disease_progression
ISO
CTD Direct Evidence: marker/mechanism associated with liver cirrhosis; DNA:SNP:promoter:-463G>A( rs2333227)(human) associated with liver cirrhosis with Hepatitis C;DNA:SNP:promoter:-463G>A(human)
CTD RGD
PMID:19731237 PMID:21907168
RGD:26923907 RGD:27095879
NCBI chr12:34,557,031...34,570,091
Ensembl chr12:34,556,408...34,567,904
G
MRO
maestro
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:100,342,040...100,368,355
Ensembl chr 1:100,343,462...100,368,354
G
MSH3
mutS homolog 3
ISO
ClinVar Annotator: match by term: Hepatocellular cancer
ClinVar
PMID:28492532
NCBI chr 2:89,255,647...89,456,102
Ensembl chr 2:89,250,003...89,453,936
G
MSH5
mutS homolog 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:23,852,864...23,872,760
Ensembl chr 7:23,852,918...23,872,755
G
MT-2B
metallothionein-2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17363595 PMID:28284560
NCBI chr 6:18,645,125...18,646,034
Ensembl chr 6:18,645,153...18,646,033
G
MT-CO1
mitochondrially encoded cytochrome c oxidase I
ISO
RGD
PMID:2548155
RGD:2302301
NCBI chr MT:6,511...8,055
Ensembl chr MT:6,511...8,055
G
MT-ND5
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5
ISO
mRNA:increased expression:liver
RGD
PMID:2507335
RGD:2302316
NCBI chr MT:12,935...14,755
Ensembl chr MT:12,935...14,755
G
MT1A
metallothionein 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17363595 PMID:19363144
NCBI chr 6:18,672,016...18,673,673
Ensembl chr 6:18,672,001...18,673,672
G
MTBP
MDM2 binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29765550
NCBI chr 4:18,533,201...18,608,702
Ensembl chr 4:18,532,041...18,608,602
G
MTDH
metadherin
treatment
ISO
human cells in a mouse model
RGD
PMID:26351209
RGD:11096879
NCBI chr 4:39,052,895...39,113,380
Ensembl chr 4:39,051,537...39,113,385
G
MTHFD2
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
ISO
mRNA:increased expression:liver
RGD
PMID:3878730
RGD:2302305
NCBI chr 3:68,819,171...68,833,641
Ensembl chr 3:68,818,119...68,833,600
G
MTHFR
methylenetetrahydrofolate reductase
susceptibility disease_progression onset
ISO
DNA:SNP,haplotype: :677C>T, 1298A>C(human) DNA:SNP: :677C>T(human) DNA:SNPs: :677C>T, 1298A>C(human) DNA:SNP: :1298A>C(human)
RGD
PMID:17503006 PMID:17659576 PMID:19035314 PMID:23996892
RGD:14696703 RGD:14696704 RGD:14696707 RGD:14696708
NCBI chr 6:71,863,637...71,882,118
Ensembl chr 6:71,863,637...71,881,820
G
MTOR
mechanistic target of rapamycin kinase
severity
ISO
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:liver (human)
CTD RGD
PMID:21147110 PMID:25371154
RGD:152995471
NCBI chr 6:71,286,989...71,412,913
Ensembl chr 6:71,286,989...71,412,888
G
MTRR
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
susceptibility
ISO
DNA:SNP: :66A>G(human)
RGD
PMID:19035314
RGD:14696707
NCBI chr16:74,245,214...74,270,828
Ensembl chr16:74,245,228...74,270,783
G
MVK
mevalonate kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147110
NCBI chr14:41,320,790...41,357,437
Ensembl chr14:41,281,673...41,357,368
G
MYBL2
MYB proto-oncogene like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr17:46,256,245...46,287,929
Ensembl chr17:46,256,257...46,287,927
G
MYC
MYC proto-oncogene, bHLH transcription factor
treatment severity
ISO
mRNA:increased expression:liver (rat) mRNA:increased expression:liver (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:9029167 PMID:12029619 PMID:15565109 PMID:21644509 PMID:22076107 PMID:22129741 PMID:22434528 PMID:29698666 More...
RGD:6903288 RGD:7240567 RGD:7240695 RGD:7241004
NCBI chr 4:12,455,141...12,460,360
Ensembl chr 4:12,455,122...12,461,078
G
MYD88
MYD88 innate immune signal transduction adaptor
exacerbates treatment ameliorates
ISO
mRNA:increased expression:liver (human) human gene and cell in a mouse model mouse cell line in a mouse model human cell line in a mouse model protein:increased expression:liver (human) protein, mRNA:decreased expression:liver (human)
RGD
PMID:17615358 PMID:24603331 PMID:26985932 PMID:28370778 PMID:29022910 PMID:31068809 PMID:31074165 PMID:32144747 PMID:33575076 More...
RGD:150520022 RGD:150520169 RGD:150521532 RGD:150521534 RGD:150524327 RGD:150524329 RGD:150524330 RGD:150524334 RGD:150530285
NCBI chr13:22,976,951...22,979,568
Ensembl chr13:22,966,137...22,983,109
G
NBN
nibrin
ISO
ClinVar Annotator: match by term: Hepatocellular cancer
ClinVar
PMID:9590180 PMID:9590181 PMID:9620777 PMID:10398434 PMID:10799436 PMID:10848790 PMID:10852373 PMID:11093281 PMID:11279524 PMID:11953735 PMID:12123493 PMID:12505263 PMID:12833396 PMID:12845677 PMID:14973119 PMID:15185344 PMID:15279809 PMID:16033915 PMID:16544999 PMID:17103455 PMID:18606567 PMID:18940477 PMID:19635536 PMID:19908051 PMID:20444919 PMID:22131123 PMID:22293976 PMID:22373003 PMID:22491912 PMID:22941933 PMID:23317186 PMID:24033266 PMID:24113799 PMID:25485873 PMID:25741868 PMID:25980754 PMID:26083025 PMID:26467025 PMID:26822949 PMID:26845104 PMID:27150568 PMID:27616075 PMID:28492532 PMID:28873162 PMID:29368341 PMID:29419426 PMID:30426508 PMID:31173646 PMID:32295079 PMID:33050356 PMID:33471974 PMID:33471991 PMID:33840814 PMID:34072463 PMID:34072659 PMID:34544220 PMID:35309086 More...
NCBI chr 4:46,787,664...46,854,331
Ensembl chr 4:46,787,691...46,874,603
G
NCAPG
non-SMC condensin I complex subunit G
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:12,759,225...12,807,164
Ensembl chr 8:12,759,641...12,807,163
G
NCAPH
non-SMC condensin I complex subunit H
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 3:46,852,388...46,893,008
Ensembl chr 3:46,852,392...46,893,013
G
NCOA2
nuclear receptor coactivator 2
exacerbates
ISO
RGD
PMID:22556267 PMID:28273073
RGD:153002573 RGD:153002576
NCBI chr 4:64,888,029...65,245,757
Ensembl chr 4:64,954,238...65,246,572
G
NDC80
NDC80 kinetochore complex component
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:104,000,794...104,055,785
Ensembl chr 6:103,999,034...104,055,760
G
NEIL3
nei like DNA glycosylase 3
disease_progression
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver (human)
CTD RGD
PMID:28284560 PMID:35693827
RGD:153344586
NCBI chr15:39,416,073...39,632,313
Ensembl chr15:39,581,856...39,632,308
G
NEK2
NIMA related kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:131,547,044...131,560,527
Ensembl chr 9:131,547,069...131,561,095
G
NF2
NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor
disease_progression
ISO
DNA, protein:SNP, increased expression:intron, liver protein:decreased expression:liver
RGD
PMID:26443326 PMID:27289045 PMID:29130106
RGD:11076529 RGD:150530489 RGD:150530504
NCBI chr14:46,653,869...46,726,421
Ensembl chr14:46,653,900...46,731,999
G
NFE2L1
NFE2 like bZIP transcription factor 1
ISO
OMIM:114550
MouseDO
NCBI chr12:24,303,381...24,316,765
Ensembl chr12:24,303,399...24,316,763
G
NFE2L2
NFE2 like bZIP transcription factor 2
ISO
ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar
PMID:26619011 PMID:29018201
NCBI chr15:82,967,485...83,146,185
Ensembl chr15:82,973,656...83,146,183
G
NFKB1
nuclear factor kappa B subunit 1
disease_progression treatment
ISO
associated with Chronic Hepatitis B;DNA:insertion/deletion:3'utr: -94ins/delATTG (rs28720239) (human)
RGD
PMID:19797428 PMID:25999787
RGD:152177911 RGD:40400751
NCBI chr 8:118,391,010...118,478,927
Ensembl chr 8:118,390,638...118,506,691
G
NFKBIA
NFKB inhibitor alpha
susceptibility disease_progression
ISO
CTD Direct Evidence: therapeutic associated with hepatitis B;DNA:SNP:promoter:-826C>T (rs2233406) (human) associated with Chronic Hepatitis B;DNA:SNPs,haplotype:3'utr,promoter: 826C>T,881A>G (rs2233406,rs3138053) (human)
CTD RGD
PMID:19797428 PMID:22022477 PMID:25223483
RGD:40400751 RGD:40902986
NCBI chr 7:64,508,119...64,510,754
Ensembl chr 7:64,507,822...64,511,277
G
NKX3-1
NK3 homeobox 1
treatment
ISO
mRNA:decreased expression:liver human gene in a mouse model
RGD
PMID:28972178
RGD:14401599
NCBI chr14:7,783,296...7,787,036
Ensembl chr14:7,783,323...7,787,033
G
NLRC3
NLR family CARD domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30081150
NCBI chr 3:38,673,590...38,719,188
Ensembl chr 3:38,687,967...38,710,938
G
NLRC5
NLR family CARD domain containing 5
ISO
protein:increased expression:liver
RGD
PMID:27338800
RGD:15003194
NCBI chr 6:18,933,179...19,036,288
Ensembl chr 6:18,937,677...19,036,820
G
NME1
NME/NM23 nucleoside diphosphate kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr12:27,416,308...27,435,044
Ensembl chr12:27,416,346...27,436,140
G
NNMT
nicotinamide N-methyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:41,871,072...41,882,415
Ensembl chr 9:41,870,980...41,882,756
G
NOS2
nitric oxide synthase 2
treatment
ISO
RGD
PMID:25999787
RGD:152177911
NCBI chr12:44,174,944...44,219,875
Ensembl chr12:44,174,948...44,218,146
G
NOTCH3
notch receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:62,364,507...62,402,348
Ensembl chr 2:62,364,501...62,402,344
G
NR0B2
nuclear receptor subfamily 0 group B member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23811326
NCBI chr 6:84,225,670...84,228,156
Ensembl chr 6:84,225,694...84,228,481
G
NR1H2
nuclear receptor subfamily 1 group H member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147110
NCBI chr 6:55,238,536...55,245,457
Ensembl chr 6:55,239,500...55,245,456
G
NR1H4
nuclear receptor subfamily 1 group H member 4
ISO
OMIM:114550 CTD Direct Evidence: marker/mechanism intestinally expressed human gene in mouse model mRNA:splice variant(s):liver (human)
RGD MouseDO CTD
PMID:23213087 PMID:23811326 PMID:24954587 PMID:25496033
RGD:14696796 RGD:14928330 RGD:14928334
NCBI chr 5:83,607,222...83,732,668
Ensembl chr 5:83,604,294...83,684,604
G
NRAS
NRAS proto-oncogene, GTPase
severity disease_progression
ISO
mRNA, protein:increased expression:liver (mouse, human) ClinVar Annotator: match by term: Hepatocellular cancer human gene in mouse model
RGD ClinVar
PMID:1654209 PMID:2278970 PMID:2674680 PMID:3122217 PMID:6587382 PMID:8120410 PMID:10821536 PMID:12460918 PMID:12727991 PMID:14508525 PMID:15899789 PMID:16273091 PMID:16291983 PMID:16434492 PMID:17699718 PMID:18390968 PMID:18633438 PMID:18668139 PMID:18948947 PMID:19075190 PMID:19657110 PMID:19880792 PMID:19966803 PMID:20130576 PMID:20149136 PMID:20179705 PMID:20406486 PMID:20619739 PMID:20736745 PMID:21107323 PMID:21305640 PMID:21576590 PMID:21729679 PMID:21829508 PMID:21993994 PMID:22407852 PMID:22499344 PMID:22718121 PMID:22761467 PMID:22773810 PMID:23076151 PMID:23392294 PMID:23400451 PMID:23414587 PMID:23515407 PMID:23538902 PMID:23569304 PMID:23614898 PMID:24006476 PMID:24033266 PMID:24148783 PMID:24370118 PMID:24671188 PMID:25157968 PMID:25348872 PMID:25695684 PMID:25741868 PMID:26619011 PMID:26821351 PMID:27050078 PMID:28492532 PMID:28780248 PMID:30685691 More...
RGD:14696775 RGD:14696793
NCBI chr 4:105,845,913...105,853,769
Ensembl chr 4:105,845,872...105,858,227
G
NRG1
neuregulin 1
disease_progression
ISO
mRNA:increased expression:liver (human) associated with hepatitis C;mRNA:altered expression:liver (human
RGD
PMID:17393520 PMID:27514687
RGD:39456104 RGD:39456110
NCBI chr15:52,625,550...53,688,003
Ensembl chr15:52,630,679...52,839,505
G
NRP1
neuropilin 1
disease_progression
ISO
protein:decreased expression:liver
RGD
PMID:25333267
RGD:126848812
NCBI chr10:56,280,673...56,430,832
Ensembl chr10:56,280,665...56,430,777
G
NUF2
NUF2 component of NDC80 kinetochore complex
treatment disease_progression
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:28284560 PMID:30653265 PMID:31933938
RGD:28867240 RGD:28912742
NCBI chr 4:87,162,873...87,194,193
Ensembl chr 4:87,162,818...87,194,170
G
NUSAP1
nucleolar and spindle associated protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:129,992,797...130,065,641
Ensembl chr 1:129,992,804...130,065,605
G
OIT3
oncoprotein induced transcript 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr14:75,726,353...75,753,461
Ensembl chr14:75,726,364...75,754,331
G
OLFML2A
olfactomedin like 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:265,577,250...265,604,365
Ensembl chr 1:265,577,704...265,604,502
G
OLFML2B
olfactomedin like 2B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 4:88,522,171...88,560,305
Ensembl chr 4:88,522,240...88,560,306
G
ORC1
origin recognition complex subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:159,819,302...159,852,306
Ensembl chr 6:159,819,339...159,852,305
G
OTC
ornithine transcarbamylase
severity
ISO
mRNA:altered expression:liver tumor (human)
RGD
PMID:30901224
RGD:152995286
NCBI chr X:34,322,398...34,391,711
Ensembl chr X:34,322,298...34,391,821
G
PAFAH1B1
platelet activating factor acetylhydrolase 1b regulatory subunit 1
disease_progression
ISO
mRNA,protein:decreased expression:liver:
RGD
PMID:21569763
RGD:12790589
NCBI chr12:48,567,329...48,735,836
Ensembl chr12:48,628,816...48,735,834
G
PAMR1
peptidase domain containing associated with muscle regeneration 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:25,422,390...25,591,615
Ensembl chr 2:25,514,193...25,591,617
G
PARK7
Parkinsonism associated deglycase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 6:68,629,327...68,645,147
Ensembl chr 6:68,629,214...68,645,516
G
PARP1
poly(ADP-ribose) polymerase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18695907
NCBI chr10:14,203,157...14,241,164
Ensembl chr10:14,203,160...14,241,196
G
PBK
PDZ binding kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr14:11,543,657...11,577,286
Ensembl chr14:11,543,603...11,566,702
G
PCK1
phosphoenolpyruvate carboxykinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144 PMID:28284560
NCBI chr17:57,930,507...57,936,523
Ensembl chr17:57,930,432...57,936,522
G
PCLAF
PCNA clamp associated factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:107,659,509...107,669,477
Ensembl chr 1:107,659,509...107,670,954
G
PCNA
proliferating cell nuclear antigen
treatment
ISO
protein:increased expression:liver:
RGD
PMID:23219601 PMID:25999787
RGD:10448993 RGD:152177911
NCBI chr17:14,137,746...14,142,584
Ensembl chr17:14,136,886...14,142,744
G
PDCD1
programmed cell death 1
disease_progression
ISO
associated with hepatitis B;DNA:SNP: : +8669 A>G (human)
RGD
PMID:21912640 PMID:27034168
RGD:40818257 RGD:41410800
NCBI chr15:140,337,353...140,347,493
Ensembl chr15:140,336,258...140,347,478
G
PDGFB
platelet derived growth factor subunit B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20506153
Ensembl chr 5:8,986,462...9,007,435
G
PDGFRL
platelet derived growth factor receptor like
ISO
ClinVar Annotator: match by term: Hepatocellular carcinoma
OMIM ClinVar
PMID:7898930
NCBI chr17:5,278,872...5,328,859
Ensembl chr17:5,279,004...5,329,511
G
PDIA3
protein disulfide isomerase family A member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 1:127,786,174...127,814,096
Ensembl chr 1:127,785,772...127,814,196
G
PDK4
pyruvate dehydrogenase kinase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28003426
NCBI chr 9:75,246,956...75,260,134
Ensembl chr 9:75,246,002...75,260,134
G
PFAS
phosphoribosylformylglycinamidine synthase
ISO
protein:increased activity:hepatoma (rat) protein:increased expression:liver
RGD
PMID:6722784
RGD:5135276
NCBI chr12:53,458,401...53,477,254
G
PFN2
profilin 2
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr13:90,177,534...90,185,978
Ensembl chr13:90,177,540...90,183,742
G
PGD
phosphogluconate dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144
NCBI chr 6:70,675,751...70,692,697
Ensembl chr 6:70,675,815...70,692,679
G
PGK1
phosphoglycerate kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr X:62,187,472...62,210,321
Ensembl chr X:62,187,434...62,210,705
G
PHB1
prohibitin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr12:25,596,520...25,609,693
Ensembl chr12:25,596,523...25,609,706
G
PHF6
PHD finger protein 6
exacerbates
ISO
mRNA:increased expression:liver (human)
RGD
PMID:30888215 PMID:31329335
RGD:155260288 RGD:155260308
NCBI chr X:110,249,010...110,311,503
Ensembl chr X:110,249,010...110,303,017
G
PHLDA1
pleckstrin homology like domain family A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 5:39,309,701...39,319,313
Ensembl chr 5:39,291,560...39,315,615
G
PIGE-108A11.3
leukocyte immunoglobulin-like receptor-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:59,042,881...59,046,646
G
PIK3CA
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
treatment severity no_association susceptibility
ISO
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma DNA:mutations:exons: DNA:mutation:exon: DNA:SNPs: :rs17849071,rs17849079(human)
OMIM ClinVar RGD
PMID:15016963 PMID:15254419 PMID:15520168 PMID:15608678 PMID:15647370 PMID:15805248 PMID:15930273 PMID:16331247 PMID:16906227 PMID:16930767 PMID:17376864 PMID:17673550 PMID:18676830 PMID:18725974 PMID:19029981 PMID:19223544 PMID:19366826 PMID:19513541 PMID:19903786 PMID:20453058 PMID:20593314 PMID:20619739 PMID:21078999 PMID:21430269 PMID:21558396 PMID:21824802 PMID:22162582 PMID:22162589 PMID:22209294 PMID:22271473 PMID:22357840 PMID:22370636 PMID:22658544 PMID:22729222 PMID:22729223 PMID:22729224 PMID:23066039 PMID:23100325 PMID:23408298 PMID:23888070 PMID:23946963 PMID:24033266 PMID:24265155 PMID:24559322 PMID:24673525 PMID:24782230 PMID:25157968 PMID:25599672 PMID:25741868 PMID:25880439 PMID:25999787 PMID:26266975 PMID:26266985 PMID:26619011 PMID:26627007 PMID:26637981 PMID:26822237 PMID:26823876 PMID:26851524 PMID:27126994 PMID:27626068 PMID:27631024 PMID:28151489 PMID:28425981 PMID:28492532 PMID:29446767 PMID:29661094 PMID:29758562 PMID:29988677 PMID:30063105 PMID:30376034 PMID:30543347 PMID:31536475 PMID:31775759 PMID:32778138 PMID:34008892 PMID:34496175 PMID:37712948 More...
RGD:11556371 RGD:14402404 RGD:14402405 RGD:152177911
NCBI chr13:117,193,935...117,282,151
Ensembl chr13:117,180,544...117,274,587
G
PIK3CB
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
treatment
ISO
RGD
PMID:25999787
RGD:152177911
NCBI chr13:79,427,033...79,610,840
Ensembl chr13:79,425,835...79,610,840
G
PIK3R1
phosphoinositide-3-kinase regulatory subunit 1
treatment
ISO
RGD
PMID:25999787 PMID:31801250
RGD:151893509 RGD:152177911
NCBI chr16:46,434,757...46,523,626
Ensembl chr16:46,511,521...46,523,609
G
PIK3R2
phosphoinositide-3-kinase regulatory subunit 2
treatment
ISO
RGD
PMID:25999787
RGD:152177911
NCBI chr 2:59,637,363...59,652,075
Ensembl chr 2:59,637,371...59,652,073
G
PINX1
PIN2 (TERF1) interacting telomerase inhibitor 1
disease_progression
ISO
associated with Chronic Hepatitis B; DNA:SNP::rs1469557(human)
RGD
PMID:27221889
RGD:152977752
NCBI chr14:13,965,733...14,041,841
Ensembl chr14:13,967,070...14,041,788
G
PITPNM3
PITPNM family member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr12:50,806,302...50,898,316
Ensembl chr12:50,742,773...50,898,331
G
PITX1
paired like homeodomain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:137,200,424...137,212,500
Ensembl chr 2:137,200,423...137,206,979
G
PKM
pyruvate kinase M1/2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144
NCBI chr 7:60,971,807...61,032,780
Ensembl chr 7:60,975,667...61,004,316 Ensembl chr 7:60,975,667...61,004,316
G
PKMYT1
protein kinase, membrane associated tyrosine/threonine 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 3:39,201,819...39,209,261
Ensembl chr 3:39,201,878...39,210,125
G
PKP1
plakophilin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr10:23,689,394...23,735,457
Ensembl chr10:23,689,380...23,735,453
G
PLAC8
placenta associated 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:135,250,761...135,279,091
G
PLCG1
phospholipase C gamma 1
ameliorates
ISO
human cell line in a mouse model
RGD
PMID:30623526
RGD:151356937
NCBI chr17:43,810,003...43,844,553
Ensembl chr17:43,810,048...43,844,554
G
PLK1
polo like kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 3:22,537,814...22,550,901
Ensembl chr 3:22,537,831...22,552,380
G
PLK4
polo like kinase 4
sexual_dimorphism
ISO
DNA:hypermethylation:promoter
RGD
PMID:21324136
RGD:27226690
NCBI chr 8:96,989,011...97,013,324
Ensembl chr 8:96,991,847...97,013,461
G
PLOD3
procollagen-lysine,2-oxoglutarate 5-dioxygenase 3
treatment
ISO
mRNA, protein:increased expression:liver (human)
RGD
PMID:29059470
RGD:155791679
NCBI chr 3:8,911,787...8,919,525
Ensembl chr 3:8,911,791...8,919,516
G
PLVAP
plasmalemma vesicle associated protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:60,324,565...60,344,450
Ensembl chr 2:60,324,560...60,344,443
G
PLXDC1
plexin domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr12:23,073,292...23,142,529
Ensembl chr12:23,073,302...23,142,547
G
PML
PML nuclear body scaffold
disease_progression ameliorates exacerbates
ISO
protein:increased expression:liver (human) mRNA:increased expression:liver (mouse) associated with hepatitis C
RGD
PMID:11511788 PMID:26118777 PMID:31144474
RGD:41404685 RGD:41404687 RGD:41404690
NCBI chr 7:59,405,044...59,450,155
Ensembl chr 7:59,405,053...59,450,105
G
PMS2
PMS1 homolog 2, mismatch repair system component
ISO
ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar
NCBI chr 3:5,118,002...5,145,634
Ensembl chr 3:5,118,018...5,145,628
G
PNPLA3
patatin like phospholipase domain containing 3
ISO
associated with Hepatitis C, Chronic;DNA:SNP: :rs738409 (p.I148M) (human)
RGD
PMID:21319195
RGD:14981585
NCBI chr 5:5,075,608...5,092,599
Ensembl chr 5:5,075,622...5,092,515
G
PNPT1
polyribonucleotide nucleotidyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 3:85,595,356...85,639,665
Ensembl chr 3:85,595,392...85,639,690
G
POLG
DNA polymerase gamma, catalytic subunit
susceptibility
ISO
DNA:SNPs:introns: (rs1061316, rs758130) (human)
RGD
PMID:28457473
RGD:15039387
NCBI chr 7:54,889,150...54,907,167
Ensembl chr 7:54,889,157...54,906,844
G
PON1
paraoxonase 1
disease_progression
ISO
mRNA:decreased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr 9:74,943,646...74,974,720
Ensembl chr 9:74,926,048...74,974,723
G
POT1
protection of telomeres 1
disease_progression
ISO
associated with hepatitis B;DNA:SNP: :rs7784168(human)
RGD
PMID:23907815
RGD:152975963
NCBI chr18:22,885,704...22,981,893
Ensembl chr18:22,885,749...22,981,890
G
PPARA
peroxisome proliferator activated receptor alpha
susceptibility
ISO
associated with hepatitis B;DNA:missense mutation:cds:p.L162V (human)
RGD
PMID:19119483
RGD:15042881
NCBI chr 5:3,302,755...3,321,091
Ensembl chr 5:3,300,741...3,364,239
G
PPARG
peroxisome proliferator activated receptor gamma
severity
ISO
protein:decreased expression:liver CTD Direct Evidence: therapeutic
RGD CTD
PMID:16374840 PMID:27451128
RGD:14694822
NCBI chr13:68,301,566...68,433,951
Ensembl chr13:68,302,322...68,433,944
G
PPAT
phosphoribosyl pyrophosphate amidotransferase
ISO
protein:increased activity:hepatoma (rat)
RGD
PMID:6327016
RGD:5135035
NCBI chr 8:55,652,194...55,701,077
Ensembl chr 8:55,654,377...55,701,077
G
PPP1R1A
protein phosphatase 1 regulatory inhibitor subunit 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15010824
NCBI chr 5:19,753,850...19,763,281
Ensembl chr 5:19,753,847...19,763,269
G
PPP1R9A
protein phosphatase 1 regulatory subunit 9A
onset
ISO
protein:increased expression:liver (rat)
RGD
PMID:20935162
RGD:10002734
NCBI chr 9:74,635,285...74,944,050
Ensembl chr 9:74,635,403...74,940,362
G
PPP1R9B
protein phosphatase 1 regulatory subunit 9B
severity
ISO
mRNA, protein:decreased expression:liver (human)
RGD
PMID:23591196
RGD:10043803
NCBI chr12:26,319,123...26,337,089
Ensembl chr12:26,319,124...26,336,562
G
PRC1
protein regulator of cytokinesis 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:55,869,749...55,900,640
Ensembl chr 7:55,869,821...55,900,978
G
PRDM1
PR/SET domain 1
disease_progression
ISO
associated with hepatitis B; associated with hepatitis B;DNA:SNP: :rs1010273(human)
RGD
PMID:31100710 PMID:31376415
RGD:150530465 RGD:150530466
NCBI chr 1:72,309,096...72,335,474
Ensembl chr 1:72,311,880...72,335,466
G
PRDX1
peroxiredoxin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27517622
NCBI chr 6:165,847,390...165,859,918
Ensembl chr 6:165,824,395...165,861,442
G
PRDX2
peroxiredoxin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 2:66,207,829...66,211,474
Ensembl chr 2:66,207,828...66,212,009
G
PRDX6
peroxiredoxin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 9:115,857,629...115,868,898
Ensembl chr 9:115,857,644...115,868,892
G
PREX2
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2
exacerbates
ISO
mRNA:decreased expression:liver (human) mRNA:increased expression:liver (human) protein:increased expression:liver (human)
RGD
PMID:25151370 PMID:28000796 PMID:28205209 PMID:31776854
RGD:151665185 RGD:151665186 RGD:151665188 RGD:151665343
NCBI chr 4:66,712,412...66,996,258
Ensembl chr 4:66,715,237...66,996,044
G
PRKN
parkin RBR E3 ubiquitin protein ligase
severity
ISO
protein:decreased expression:liver (human)
RGD
PMID:28862485
RGD:13432206
NCBI chr 1:5,698,508...6,731,132
Ensembl chr 1:5,465,312...6,730,872
G
PRL
prolactin
onset
ISO
protein:increased expression:serum (human)
RGD
PMID:22392353
RGD:125097525
NCBI chr 7:17,451,367...17,463,771
Ensembl chr 7:17,451,367...17,463,710
G
PROM1
prominin 1
ISO
mRNA:increased expression:liver (mouse)
RGD
PMID:26569409
RGD:11344640
NCBI chr 8:11,215,659...11,331,442
Ensembl chr 8:11,215,663...11,317,312
G
PTCH1
patched 1
severity disease_progression
ISO
RGD
PMID:18538319 PMID:22911366
RGD:150523837 RGD:150523842
NCBI chr10:26,627,165...26,703,225
Ensembl chr10:26,627,425...26,703,223
G
PTEN
phosphatase and tensin homolog
severity treatment exacerbates
ISO
CTD Direct Evidence: marker/mechanism OMIM:114550 protein:decreased expression:liver (human) associated with hepatitis B;protein:decreased expression:liver (human) associated with hepatitis C, liver cirrhosis;protein:decreased expression:liver (human)
CTD MouseDO RGD
PMID:12115563 PMID:12673720 PMID:27022031 PMID:29303510 PMID:30690477 PMID:31801250 More...
RGD:127285591 RGD:127285603 RGD:127285610 RGD:151893509 RGD:152995524
NCBI chr14:99,929,590...100,021,619
G
PTGS2
prostaglandin-endoperoxide synthase 2
treatment severity susceptibility
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:liver, cytosol DNA:SNP:promoter:-1195A>G (rs689466) (human) mRNA,protein:decreased expression:liver
RGD CTD
PMID:11872629 PMID:12024111 PMID:14563831 PMID:15800977 PMID:16374840 PMID:17510421 PMID:18373278 PMID:24720952 PMID:24759835 PMID:25999787 More...
RGD:14695010 RGD:14695011 RGD:14695012 RGD:152177911 RGD:2300283
NCBI chr 9:127,850,164...127,858,866
Ensembl chr 9:127,850,015...127,858,884
G
PTH1R
parathyroid hormone 1 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr13:29,749,940...29,775,361
Ensembl chr13:29,753,326...29,775,348
G
PTK2
protein tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:14578863 PMID:17203219
RGD:2292584
NCBI chr 4:2,656,606...2,896,060
Ensembl chr 4:2,656,614...2,896,054
G
PTPN13
protein tyrosine phosphatase non-receptor type 13
susceptibility disease_progression
ISO
DNA:SNP: :p.Y2081D(human)
RGD
PMID:16489062 PMID:26801674
RGD:152176666 RGD:152599190
NCBI chr 8:132,035,170...132,200,425
Ensembl chr 8:132,035,151...132,249,411
G
PTPRB
protein tyrosine phosphatase receptor type B
disease_progression
ISO
mRNA:decreased expression:liver (human)
RGD
PMID:30237408
RGD:151361293
NCBI chr 5:34,656,460...34,794,838
Ensembl chr 5:34,659,964...34,794,289
G
PYCARD
PYD and CARD domain containing
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17471463
NCBI chr 3:17,305,921...17,307,521
Ensembl chr 3:17,306,099...17,307,786
G
PYGL
glycogen phosphorylase L
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2885971
NCBI chr 1:180,645,849...180,704,124
Ensembl chr 1:180,620,314...180,719,979
G
RAC1
Rac family small GTPase 1
exacerbates
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (human) mRNA:increased expression:liver (human)
CTD RGD
PMID:18506888 PMID:20522449 PMID:33482578
RGD:153298967 RGD:153350129
NCBI chr 3:4,781,776...4,803,510
Ensembl chr 3:4,781,780...4,803,543
G
RACGAP1
Rac GTPase activating protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 5:15,894,314...15,943,619
Ensembl chr 5:15,904,712...15,943,609
G
RAD21
RAD21 cohesin complex component
treatment exacerbates susceptibility
ISO
human cells in a mouse model protein:increased expression:liver (human) associated with hepatitis c, liver cirrhosis;mRNA:increased expression:liver (human)
RGD
PMID:28434945 PMID:30698808 PMID:32596342 PMID:33251678
RGD:150520026 RGD:150520029 RGD:150520030 RGD:150520035
NCBI chr 4:21,772,821...21,802,453
Ensembl chr 4:21,772,855...21,802,715
G
RAD50
RAD50 double strand break repair protein
ISO
ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar
PMID:16385572 PMID:18281469 PMID:19409520 PMID:24894818 PMID:25452441 PMID:25741868 PMID:26467025 PMID:28492532 PMID:29961768 PMID:31159747 PMID:31589614 PMID:32295079 More...
NCBI chr 2:134,844,460...134,939,188
Ensembl chr 2:134,700,817...134,939,189
G
RAD52
RAD52 homolog, DNA repair protein
onset susceptibility
ISO
mRNA,protein:increased expression:liver (human) associated with hepatitis B;DNA:SNP:3'utr: (rs7963551) (human)
RGD
PMID:24729511 PMID:31719794
RGD:151361199 RGD:151361207
NCBI chr 5:68,140,846...68,223,587
Ensembl chr 5:68,143,646...68,169,670
G
RAD54L
RAD54 like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:165,156,833...165,184,641
Ensembl chr 6:165,152,978...165,184,776
G
RARA
retinoic acid receptor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18026104
NCBI chr12:22,047,449...22,085,759
Ensembl chr12:22,047,443...22,085,673
G
RB1
RB transcriptional corepressor 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12029619 PMID:14961299 PMID:33841550
RGD:152998960
NCBI chr11:19,186,754...19,317,642
Ensembl chr11:19,186,761...19,317,690
G
RBM10
RNA binding motif protein 10
disease_progression
ISO
mRNA:decreased expression:liver
RGD
PMID:32572914
RGD:151356975
NCBI chr X:41,773,232...41,803,656
Ensembl chr X:41,773,232...41,803,653
G
RCAN1
regulator of calcineurin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr13:198,106,256...198,205,727
Ensembl chr13:198,102,098...198,205,629
G
RECQL
RecQ like helicase
disease_progression
ISO
protein:increased expression:liver
RGD
PMID:18422747
RGD:2317370
NCBI chr 5:51,953,460...51,995,619
Ensembl chr 5:51,953,451...52,003,740
G
RET
ret proto-oncogene
severity
ISO
protein:increased expression:liver (human) ClinVar Annotator: match by term: Hepatocellular carcinoma
RGD ClinVar
PMID:7784092 PMID:7845675 PMID:7911697 PMID:9111992 PMID:9242375 PMID:9263528 PMID:11230481 PMID:12116277 PMID:14715928 PMID:15184865 PMID:15855933 PMID:16736292 PMID:17047083 PMID:17097365 PMID:18062802 PMID:25157968 PMID:25810047 PMID:26046350 PMID:28350084 PMID:28492532 PMID:29656518 More...
RGD:150340602
NCBI chr14:61,305,818...61,361,416
Ensembl chr14:61,305,841...61,361,412
G
RGN
regucalcin
ISO
protein:decreased expression:liver
RGD
PMID:21683810
RGD:5509919
NCBI chr X:41,725,660...41,749,736
Ensembl chr X:41,726,526...41,749,381
G
RICTOR
RPTOR independent companion of MTOR complex 2
severity
ISO
mRNA, protein:increased expression:liver (human)
RGD
PMID:25371154 PMID:29303510
RGD:152995471 RGD:152995524
NCBI chr16:24,109,934...24,250,019
Ensembl chr16:24,109,939...24,311,132
G
RIT1
Ras like without CAAX 1
ameliorates
ISO
human cells in mouse model
RGD
PMID:31247273
RGD:152999016
NCBI chr 4:94,117,721...94,127,882
Ensembl chr 4:94,117,882...94,127,384
G
RND3
Rho family GTPase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr15:1,715,589...1,732,605
Ensembl chr15:1,715,207...1,734,414
G
RNF157
ring finger protein 157
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr12:5,225,978...5,306,197
Ensembl chr12:5,225,849...5,304,458
G
RNF43
ring finger protein 43
exacerbates
ISO
human cells in a mouse model
RGD
PMID:23136185
RGD:151361219
NCBI chr12:34,631,574...34,695,021
Ensembl chr12:34,635,228...34,694,378
G
RNF6
ring finger protein 6
disease_progression
ISO
RGD
PMID:30496760
RGD:151665757
NCBI chr11:4,020,752...4,033,040
Ensembl chr11:4,020,852...4,031,787
G
ROBO1
roundabout guidance receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr13:175,348,223...176,479,482
Ensembl chr13:175,348,410...176,479,481
G
RPS6
ribosomal protein S6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147110
NCBI chr 1:203,444,360...203,447,643
Ensembl chr 1:203,444,450...203,451,468
G
RPS6KA3
ribosomal protein S6 kinase A3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561517
NCBI chr X:16,452,401...16,576,854
Ensembl chr X:16,452,405...16,576,859
G
RRM1
ribonucleotide reductase catalytic subunit M1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18230555
NCBI chr 9:6,026,151...6,065,211
Ensembl chr 9:6,025,073...6,065,143
G
RRM2
ribonucleotide reductase regulatory subunit M2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18230555 PMID:28284560
NCBI chr 3:126,357,198...126,367,145
Ensembl chr 3:126,347,819...126,365,644
G
RSPO3
R-spondin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:35,985,985...36,066,432
Ensembl chr 1:35,984,950...36,067,077
G
RTKN
rhotekin
ISO
mRNA:increased expression:liver
RGD
PMID:27922690
RGD:19165144
NCBI chr 3:68,598,560...68,613,633
Ensembl chr 3:68,598,249...68,613,631
G
RTP3
receptor transporter protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17693185
NCBI chr13:29,471,568...29,476,277
G
RUNX1
RUNX family transcription factor 1
ISO
mRNA:decreased expression:liver
RGD
PMID:17094378
RGD:126775147
NCBI chr13:198,371,835...198,635,648
Ensembl chr13:198,371,837...198,638,189
G
RUNX3
RUNX family transcription factor 3
ISO
CTD Direct Evidence: marker/mechanism mRNA:decreased expression:liver
CTD RGD
PMID:17094378 PMID:28458013
RGD:126775147
NCBI chr 6:82,531,203...82,595,044
Ensembl chr 6:82,531,559...82,595,026
G
RXRA
retinoid X receptor alpha
ISO
ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar
PMID:26619011
NCBI chr 1:273,698,842...273,797,622
Ensembl chr 1:273,705,505...273,797,620
G
RYR3
ryanodine receptor 3
disease_progression
ISO
DNA:SNP:3'UTR:rs1044129(human)
RGD
PMID:26309413
RGD:155882454
NCBI chr 7:80,640,030...81,208,576
Ensembl chr 7:80,640,123...81,208,491
G
S100A9
S100 calcium binding protein A9
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr 4:96,236,114...96,238,989
G
SARDH
sarcosine dehydrogenase
severity
ISO
mRNA:altered expression:liver tumor (human)
RGD
PMID:30901224
RGD:152995286
NCBI chr 1:273,230,357...273,295,170
Ensembl chr 1:273,230,375...273,294,621
G
SAV1
salvador family WW domain containing protein 1
ISO
OMIM:114550
MouseDO
NCBI chr 1:180,404,871...180,434,458
Ensembl chr 1:180,406,162...180,434,196
G
SCAP
SREBF chaperone
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14563831
NCBI chr13:30,253,262...30,320,625
Ensembl chr13:30,253,268...30,320,526
G
SCD
stearoyl-CoA desaturase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147110
NCBI chr14:111,461,560...111,478,033
Ensembl chr14:111,461,569...111,478,020
G
SERPINA1
serpin family A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:6258829 PMID:21472284
NCBI chr 7:115,604,282...115,616,915
Ensembl chr 7:115,583,043...115,614,645
G
SERPINB5
serpin family B member 5
disease_progression
ISO
associated with hepatitis B;
RGD
PMID:26296971
RGD:11520929
NCBI chr 1:158,167,756...158,195,896
Ensembl chr 1:158,167,646...158,195,796
G
SERPINF1
serpin family F member 1
ISO
associated with Human Viral Hepatitis, liver cirrhosis;protein:increased expression:serum (human)
RGD
PMID:27748324
RGD:27226704
NCBI chr12:47,949,004...47,959,471
Ensembl chr12:47,948,510...47,959,470
G
SET
SET nuclear proto-oncogene
ISO
ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar
PMID:26822237
NCBI chr 1:269,050,447...269,064,462
G
SF3B1
splicing factor 3b subunit 1
treatment disease_progression
ISO
ClinVar Annotator: match by term: Hepatocellular carcinoma mRNA, protein:increased expression:liver
RGD ClinVar
PMID:23634996 PMID:26619011 PMID:33038489
RGD:126790494
NCBI chr15:101,274,968...101,338,018
Ensembl chr15:101,276,851...101,299,105
G
SF3B2
splicing factor 3b subunit 2
ISO
ClinVar Annotator: match by term: LIVER CELL CARCINOMA
ClinVar
PMID:26619011
NCBI chr 2:6,279,039...6,295,550
Ensembl chr 2:6,279,049...6,294,639
G
SF3B4
splicing factor 3b subunit 4
treatment severity
ISO
mRNA, protein:increased expression:liver(human) human cells in mouse model mRNA, protein:increased expression:liver (human) mRNA, protein:increased expression:liver (rat)
RGD
PMID:29059470 PMID:30391496
RGD:155791679 RGD:155804298
NCBI chr 4:99,123,564...99,129,218
Ensembl chr 4:99,123,585...99,129,218
G
SFN
stratifin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 6:84,188,521...84,189,824
Ensembl chr 6:84,188,445...84,189,827
G
SFRP1
secreted frizzled related protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr17:10,436,414...10,489,773
Ensembl chr17:10,436,426...10,489,748
G
SH3GL1
SH3 domain containing GRB2 like 1, endophilin A2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33838155
NCBI chr 2:74,414,453...74,445,450
Ensembl chr 2:74,414,466...74,445,447
G
SHC1
SHC adaptor protein 1
ISO
protein:increased expression, increased phosphorylation:hepatocyte
RGD
PMID:15375560
RGD:1643188
NCBI chr 4:94,818,226...94,831,766
Ensembl chr 4:94,810,875...94,831,765
G
SHH
sonic hedgehog signaling molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26189965
NCBI chr18:2,546,202...2,555,484
Ensembl chr18:2,545,994...2,555,484
G
SIK2
salt inducible kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34491613
NCBI chr 9:39,368,555...39,483,519
Ensembl chr 9:39,368,599...39,483,515
G
SIX1
SIX homeobox 1
severity
ISO
protein:increased expression:liver (human)
RGD
PMID:17008870
RGD:11561961
NCBI chr 1:189,620,430...189,624,652
Ensembl chr 1:189,619,855...189,624,651
G
SKA1
spindle and kinetochore associated complex subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:99,976,354...99,993,492
Ensembl chr 1:99,976,485...99,993,462
G
SKA3
spindle and kinetochore associated complex subunit 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr11:1,302,880...1,321,132
Ensembl chr11:1,302,886...1,320,981
G
SKP2
S-phase kinase associated protein 2
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:liver
CTD RGD
PMID:12717389 PMID:19533683
RGD:2315050
NCBI chr16:21,463,270...21,500,925
Ensembl chr16:21,463,012...21,509,310
G
SLC22A1
solute carrier family 22 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:7,340,442...7,365,543
Ensembl chr 1:7,340,126...7,365,520
G
SLC25A47
solute carrier family 25 member 47
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:121,204,213...121,210,376
Ensembl chr 7:121,192,433...121,210,374
G
SLC26A6
solute carrier family 26 member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr13:31,319,287...31,330,649
Ensembl chr13:31,317,877...31,330,580
G
SLC2A1
solute carrier family 2 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8364915
NCBI chr 6:168,535,398...168,561,170
Ensembl chr 6:168,535,440...168,560,867
G
SLC2A2
solute carrier family 2 member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8364915
NCBI chr13:109,592,595...109,614,105
Ensembl chr13:109,587,258...109,638,510
G
SLC38A1
solute carrier family 38 member 1
ameliorates disease_progression
ISO
RGD
PMID:26389641
RGD:151361140
NCBI chr 5:77,009,840...77,076,723
Ensembl chr 5:77,009,862...77,058,427
G
SLC5A5
solute carrier family 5 member 5
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15347726 PMID:15520214
NCBI chr 2:59,869,157...59,885,086
Ensembl chr 2:59,869,155...59,885,266
G
SLC7A5
solute carrier family 7 member 5
ameliorates disease_progression
ISO
mRNA:increased expression:liver
RGD
PMID:7532544 PMID:23696029 PMID:26389641
RGD:151361140 RGD:151361280 RGD:634202
NCBI chr 6:1,545,940...1,574,298
Ensembl chr 6:1,545,944...1,574,285
G
SLCO1B2
solute carrier organic anion transporter family member 1B2
exacerbates disease_progression
ISO
mRNA,protein:decreased expression:liver (human)
RGD
PMID:21626360 PMID:32534581
RGD:152995417 RGD:152995423
NCBI chr 5:52,137,454...52,206,236
G
SLIT2
slit guidance ligand 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19100240
NCBI chr 8:14,758,426...15,149,515
Ensembl chr 8:14,758,335...15,149,510
G
SMAD2
SMAD family member 2
ISO
RGD
PMID:18971187
RGD:12880056
NCBI chr 1:97,415,360...97,511,388
Ensembl chr 1:97,415,716...97,511,357
G
SMAD4
SMAD family member 4
disease_progression
ISO
protein:increased expression:liver: protein:decreased expression:liver
RGD
PMID:18971187 PMID:22799322 PMID:23922662 PMID:29924446
RGD:12880056 RGD:18182921 RGD:21066341 RGD:21066342
NCBI chr 1:100,521,843...100,633,501
Ensembl chr 1:100,589,850...100,628,029
G
SMAD7
SMAD family member 7
ISO
mRNA:increased expression:liver (human)
RGD
PMID:25602745
RGD:14401589
NCBI chr 1:98,512,800...98,543,924
Ensembl chr 1:98,514,267...98,542,382
G
SMARCA4
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
ISO
DNA:SNPs: :rs11879293, rs2072382 (human)
RGD
PMID:24556940
RGD:127285650
NCBI chr 2:69,717,175...69,810,301
Ensembl chr 2:69,662,238...69,810,295
G
SMARCB1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
disease_progression
ISO
mRNA:decreased expression:liver
RGD
PMID:27111394
RGD:127285647
NCBI chr14:49,874,981...49,906,043
Ensembl chr14:49,874,984...49,906,048
G
SMARCC1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1
ameliorates
ISO
mRNA, protein:increased expression:liver (human)
RGD
PMID:32514535
RGD:151347860
NCBI chr13:30,409,979...30,576,270
Ensembl chr13:30,409,983...30,601,441
G
SMC3
structural maintenance of chromosomes 3
exacerbates
ISO
mRNA:increased editing:cds:p.K96R,p.Q103R(human)
RGD
PMID:29996118
RGD:156430111
NCBI chr14:120,969,629...121,008,924
Ensembl chr14:120,969,631...121,021,497
G
SMG9
SMG9 nonsense mediated mRNA decay factor
severity
ISO
RGD
PMID:34456727
RGD:155882446
NCBI chr 6:50,550,743...50,569,753
Ensembl chr 6:50,551,057...50,569,697
G
SMO
smoothened, frizzled class receptor
disease_progression
ISO
DNA:SNP: :rs3824 (human)
RGD
PMID:25944162
RGD:150340548
NCBI chr18:19,450,730...19,478,796
Ensembl chr18:19,450,743...19,478,898
G
SNAI1
snail family transcriptional repressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35841383
NCBI chr17:51,546,446...51,552,498
Ensembl chr17:51,546,477...51,552,499
G
SNRPE
small nuclear ribonucleoprotein polypeptide E
ISO
human gene in a mouse model
RGD
PMID:21688285
RGD:10768833
NCBI chr 9:64,560,544...64,567,007
Ensembl chr 9:64,560,523...64,567,007
G
SNW1
SNW domain containing 1
severity
ISO
protein:increased expression:liver (human)
RGD
PMID:23696020
RGD:11035253
NCBI chr 7:100,718,298...100,749,414
Ensembl chr 7:100,718,036...100,749,356
G
SNX27
sorting nexin 27
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36029209
NCBI chr 4:97,533,643...97,620,816
Ensembl chr 4:97,525,181...97,620,788
G
SOAT1
sterol O-acyltransferase 1
exacerbates
ISO
associated with hepatitis B;protein:increased expression:liver (human)
RGD
PMID:30814741
RGD:126925204
NCBI chr 9:121,045,211...121,112,393
Ensembl chr 9:121,045,234...121,113,692
G
SOAT2
sterol O-acyltransferase 2
ISO
RGD
PMID:16274362
RGD:1581190
NCBI chr 5:18,358,941...18,371,262
Ensembl chr 5:18,358,673...18,371,264
G
SOCS1
suppressor of cytokine signaling 1
treatment
ISO
DNA:hypermethylation:CpG island, 5'untranslated region: associated with liver cirrhosis;DNA:altered methylation:liver:
RGD
PMID:14614012 PMID:15235874 PMID:18843197 PMID:22318090
RGD:150573687 RGD:150573689 RGD:150573700 RGD:150573703
NCBI chr 3:31,879,143...31,883,041
Ensembl chr 3:31,881,225...31,884,967
G
SOCS3
suppressor of cytokine signaling 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16831601
NCBI chr12:3,643,832...3,647,015
Ensembl chr12:3,643,929...3,647,009
G
SOD1
superoxide dismutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33010264
NCBI chr13:195,326,573...195,335,273
Ensembl chr13:195,326,649...195,337,729
G
SOD2
superoxide dismutase 2
disease_progression susceptibility
ISO
protein:increased expression:saliva CTD Direct Evidence: marker/mechanism associated with liver cirrhosis; DNA:SNP:cds:p.Ala16Val(rs1799725)(human)
RGD CTD
PMID:15869407 PMID:16767786 PMID:18760346 PMID:19731237 PMID:21472284 PMID:27221200 PMID:31041878 PMID:33010264 More...
RGD:1581242 RGD:26923907 RGD:26923955 RGD:27095881
NCBI chr 1:7,679,352...7,689,564
Ensembl chr 1:7,679,352...7,689,560
G
SOX30
SRY-box transcription factor 30
disease_progression exacerbates
ISO
RGD
PMID:30312695
RGD:151660341
NCBI chr16:65,642,107...65,677,693
Ensembl chr16:65,642,223...65,678,047
G
SPAG9
sperm associated antigen 9
ISO
associated with Human Viral Hepatitis
RGD
PMID:29344208
RGD:30296654
NCBI chr12:27,225,377...27,370,337
Ensembl chr12:27,202,088...27,370,405
G
SPC25
SPC25 component of NDC80 kinetochore complex
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr15:75,339,171...75,371,275
Ensembl chr15:75,336,514...75,371,277
G
SPOCK1
SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1
ameliorates
ISO
human cells in mouse model
RGD
PMID:30710422
RGD:153344549
NCBI chr 2:139,018,177...139,523,601
Ensembl chr 2:139,018,179...139,522,593
G
SPOP
speckle type BTB/POZ protein
exacerbates
ISO
human cells in mouse model mRNA:decreased expression:liver (human)
RGD
PMID:26156804 PMID:33209975
RGD:11074965 RGD:153298924
NCBI chr12:25,792,621...25,860,630
Ensembl chr12:25,792,630...25,860,595
G
SPP1
secreted phosphoprotein 1
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:16047475 PMID:35693827
RGD:153344586 RGD:1581375
NCBI chr 8:131,077,786...131,085,334
Ensembl chr 8:131,077,786...131,085,340
G
SPRTN
SprT-like N-terminal domain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25261934
NCBI chr14:59,177,801...59,192,221
Ensembl chr14:59,171,192...59,192,269
G
SRC
SRC proto-oncogene, non-receptor tyrosine kinase
disease_progression
ISO
RGD
PMID:9581679
RGD:150521543
NCBI chr17:40,470,970...40,524,862
Ensembl chr17:40,471,009...40,524,860
G
SREBF1
sterol regulatory element binding transcription factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14563831 PMID:21147110
NCBI chr12:60,733,967...60,750,951
Ensembl chr12:60,733,907...60,751,267
G
SREBF2
sterol regulatory element binding transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147110
NCBI chr 5:6,719,484...6,784,724
Ensembl chr 5:6,719,490...6,784,671
G
SRF
serum response factor
ISO
RGD
PMID:9570363
RGD:1581428
NCBI chr 7:38,213,300...38,223,686
Ensembl chr 7:38,213,487...38,222,144
G
SRPX
sushi repeat containing protein X-linked
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr X:34,075,577...34,198,462
Ensembl chr X:34,075,579...34,198,467
G
SRSF1
serine and arginine rich splicing factor 1
ISO
mRNA:increased expression:liver (human)
RGD
PMID:23633480
RGD:9685423
NCBI chr12:34,278,363...34,282,164
Ensembl chr12:34,272,956...34,282,162
G
SRSF2
serine and arginine rich splicing factor 2
treatment disease_progression
ISO
RGD
PMID:28082404 PMID:29278882 PMID:32372053
RGD:150429663 RGD:150429666 RGD:150429692
NCBI chr12:4,800,578...4,803,767
Ensembl chr12:4,800,624...4,801,675
G
ST6GAL1
ST6 beta-galactoside alpha-2,6-sialyltransferase 1
ISO
protein:increased activity:liver:
RGD
PMID:9331085
RGD:10043141
NCBI chr13:124,699,622...124,837,847
Ensembl chr13:124,791,751...124,837,841
G
STAB2
stabilin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 5:80,692,459...80,863,221
G
STAT1
signal transducer and activator of transcription 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22488367
NCBI chr15:95,593,201...95,646,324
Ensembl chr15:95,593,211...95,646,260
G
STAT3
signal transducer and activator of transcription 3
ISO
protein:increased phosphorylation:liver (mouse)
RGD
PMID:28100771
RGD:127285675
NCBI chr12:20,407,316...20,471,091
Ensembl chr12:20,407,233...20,472,992
G
STAT4
signal transducer and activator of transcription 4
susceptibility
ISO
CTD Direct Evidence: marker/mechanism Hepatitis B, Chronic; DNA:SNP: intron 3: (rs7574865) (human)
CTD RGD
PMID:23242368 PMID:26745093
RGD:11553302
NCBI chr15:95,656,206...95,764,099
Ensembl chr15:95,656,077...95,763,472
G
STAT5A
signal transducer and activator of transcription 5A
ameliorates
ISO
RGD
PMID:28100771
RGD:127285675
NCBI chr12:20,474,221...20,498,785
Ensembl chr12:20,474,227...20,499,138
G
STAT5B
signal transducer and activator of transcription 5B
exacerbates ameliorates
ISO
protein:increased expression:liver (human) mRNA:increased expression:liver (human)
RGD
PMID:17047057 PMID:31485610
RGD:153298929 RGD:153298932
NCBI chr12:20,498,103...20,574,365
Ensembl chr12:20,508,404...20,574,266
G
STC2
stanniocalcin 2
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr16:50,989,676...51,001,412
Ensembl chr16:50,989,433...51,004,481
G
STIM1
stromal interaction molecule 1
ISO
mRNA:increased expression:liver (human)
RGD
PMID:23211538
RGD:152995401
NCBI chr 9:6,066,612...6,270,090
Ensembl chr 9:6,066,617...6,270,575
G
STMN1
stathmin 1
disease_progression
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:28284560 PMID:28982915
RGD:21408578
NCBI chr 6:83,356,404...83,362,546
Ensembl chr 6:83,356,412...83,362,500
G
TACC3
transforming acidic coiled-coil containing protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:825,433...835,425
Ensembl chr 8:824,999...837,322
G
TAGLN2
transgelin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 4:90,566,272...90,574,762
G
TALDO1
transaldolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19436114
NCBI chr 2:464,781...472,836
Ensembl chr 2:464,728...472,835
G
TATDN1
TatD DNase domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 4:15,113,318...15,159,501
Ensembl chr 4:15,113,312...15,159,498
G
TBX3
T-box transcription factor 3
disease_progression severity ameliorates
ISO
protein:increased expression:liver (human) human cells in mouse model
RGD
PMID:22811581 PMID:26922018 PMID:29295731 PMID:30578408 PMID:33577921
RGD:151361112 RGD:151361114 RGD:151361122 RGD:151361123 RGD:151361132
NCBI chr14:37,582,704...37,596,767
Ensembl chr14:37,582,822...37,596,766
G
TCF19
transcription factor 19
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:23,558,326...23,562,074
Ensembl chr 7:23,558,384...23,562,069
G
TCIM
transcriptional and immune response regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr17:9,441,488...9,443,053
Ensembl chr17:9,441,766...9,442,086
G
TEDC2
tubulin epsilon and delta complex 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 3:39,580,181...39,584,414
Ensembl chr 3:39,580,199...39,584,380
G
TEK
TEK receptor tyrosine kinase
ISO
protein:increased expression
RGD
PMID:16951510
RGD:1601490
NCBI chr 1:195,938,177...196,052,294
Ensembl chr 1:195,937,432...196,051,980
G
TEP1
telomerase associated protein 1
susceptibility disease_progression
ISO
DNA:SNP:intron:rs1760893(human) associated with hepatitis B;DNA:SNPs: :rs1713449,rs1760898, rs872072 (human)
RGD
PMID:23907815 PMID:27305982
RGD:152975963 RGD:152977750
NCBI chr 7:78,488,248...78,530,185
Ensembl chr 7:78,491,053...78,530,183
G
TERT
telomerase reverse transcriptase
disease_progression susceptibility treatment no_association
ISO
DNA:mutations:promoter: associated with hepatitis B;DNA:SNP: :rs13167280 (human) ClinVar Annotator: match by term: Hepatocellular carcinoma DNA:SNPs::rs2736098(human) DNA:SNP,mutations:promoter:rs2853669 (-245T >C), (-124C > T),(-146C > T)human DNA:mutations, polymorphisms:promoter,intron, exon:rs2736100,rs2736098(human)
RGD ClinVar
PMID:17175353 PMID:19184104 PMID:23000435 PMID:23907815 PMID:25123086 PMID:25339005 PMID:25741868 PMID:26575952 PMID:28416747 PMID:28492532 PMID:28677271 More...
RGD:11564803 RGD:14696767 RGD:14696768 RGD:14696769 RGD:14696770 RGD:150530496 RGD:152975963
NCBI chr16:79,258,591...79,276,421
Ensembl chr16:79,258,591...79,276,421
G
TET1
tet methylcytosine dioxygenase 1
ISO
protein:decreased expression:liver
RGD
PMID:23671639
RGD:9586747
NCBI chr14:71,675,671...71,812,732
Ensembl chr14:71,675,671...71,815,618
G
TET2
tet methylcytosine dioxygenase 2
ameliorates disease_progression severity
ISO
human cells in mouse model mRNA:decreased expression:liver (human) mRNA, protein:increased expression:liver (human) mRNA, protein:decreased expression:liver (human)
RGD
PMID:26366235 PMID:29331390 PMID:30070373 PMID:33097695
RGD:150429595 RGD:150429597 RGD:150429684 RGD:150429689
NCBI chr 8:116,413,253...116,546,976
Ensembl chr 8:116,415,267...116,545,299
G
TFPI2
tissue factor pathway inhibitor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17464989 PMID:28284560
NCBI chr 9:73,684,236...73,694,663
Ensembl chr 9:73,673,535...73,689,095
G
TFRC
transferrin receptor
ISO
mRNA:increased expression:liver
RGD
PMID:16953838
RGD:2292036
NCBI chr13:133,976,765...133,997,554
Ensembl chr13:133,970,985...134,000,276
G
TGFA
transforming growth factor alpha
ISO
associated with Diabetes Mellitus, Experimental CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:9029167 PMID:9060843 PMID:15565109
RGD:2317471
NCBI chr 3:71,948,232...72,054,257
Ensembl chr 3:71,948,137...72,050,474
G
TGFB1
transforming growth factor beta 1
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver (mouse)
CTD RGD
PMID:9029167 PMID:28100771
RGD:127285675
NCBI chr 6:49,332,169...49,348,642
Ensembl chr 6:49,332,173...49,349,046
G
TGFB2
transforming growth factor beta 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33010264
NCBI chr10:8,306,136...8,435,307
Ensembl chr10:8,305,539...8,390,341
G
TGFBR2
transforming growth factor beta receptor 2
ISO
mRNA, protein:decreased expression:liver
RGD
PMID:14585397
RGD:1601598
NCBI chr13:16,784,370...16,875,828
Ensembl chr13:16,784,490...16,878,160
G
TGM3
transglutaminase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr17:33,191,901...33,236,065
Ensembl chr17:33,191,914...33,235,952
G
TH
tyrosine hydroxylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 2:1,499,628...1,506,180
Ensembl chr 2:1,499,620...1,506,170
G
THY1
Thy-1 cell surface antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:46,607,022...46,612,691
Ensembl chr 9:46,607,494...46,612,269
G
TICRR
TOPBP1 interacting checkpoint and replication regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:55,142,957...55,200,259
Ensembl chr 7:55,143,240...55,200,640
G
TIMD4
T cell immunoglobulin and mucin domain containing 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr16:66,253,572...66,292,963
Ensembl chr16:66,253,604...66,292,961
G
TK1
thymidine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr12:3,785,997...3,794,824
Ensembl chr12:3,786,031...3,795,917
G
TLR2
toll like receptor 2
susceptibility
ISO
DNA:deletion:promoter:-196 to -174(human) associated with Hepatitis C, Chronic;DNA:deletion:promoter:-196 to -174(human)
RGD
PMID:21500195 PMID:22859216 PMID:27183918
RGD:15090813 RGD:15090815 RGD:18337266
NCBI chr 8:75,416,257...75,428,370
Ensembl chr 8:75,411,993...75,428,330
G
TLR3
toll like receptor 3
disease_progression
ISO
RGD
PMID:23197495
RGD:21079421
NCBI chr15:46,966,262...46,977,774
Ensembl chr15:46,969,006...46,979,291
G
TLR4
toll like receptor 4
susceptibility
ISO
DNA:SNP: :rs1057317(human) protein:increased expression:liver: CTD Direct Evidence: marker/mechanism DNA:SNPs, haplotype: :multiples
RGD CTD
PMID:21559380 PMID:25179842 PMID:27022031 PMID:28578348
RGD:14700552 RGD:14700557 RGD:14700558
NCBI chr 1:258,044,610...258,054,641
Ensembl chr 1:258,044,610...258,058,970
G
TLR7
toll like receptor 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24990399
NCBI chr X:9,573,178...9,576,987
G
TLR9
toll like receptor 9
treatment
ISO
human cells in a mouse model protein: increased expression:peripheral blood mononuclear cell (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:18215354 PMID:24452201 PMID:24990399
RGD:18337468 RGD:18337472
NCBI chr13:34,353,444...34,370,990
Ensembl chr13:34,349,609...34,357,673
G
TMEM70
transmembrane protein 70
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27914986
NCBI chr 4:61,958,605...61,966,041
Ensembl chr 4:61,958,605...61,966,024
G
TNF
tumor necrosis factor
disease_progression
ISO
mRNA, protein:increased expression:liver, blood serum (mouse) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:26569409 PMID:26890368 PMID:27022031
RGD:11344640 RGD:14975171
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,416
G
TNFAIP3
TNF alpha induced protein 3
sexual_dimorphism ameliorates
ISO
mRNA:decreased expression:liver (human) protein:decreased expression:liver (human) mRNA,protein:increased expression:liver (human)
RGD
PMID:26538215 PMID:27253414 PMID:29190981 PMID:32015333
RGD:151347600 RGD:151347604 RGD:151347618 RGD:151347622
NCBI chr 1:26,474,158...26,489,771
Ensembl chr 1:26,473,938...26,489,822
G
TNFSF10
TNF superfamily member 10
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17326159
NCBI chr13:111,021,952...111,103,060
Ensembl chr13:110,983,298...111,038,324
G
TNFSF9
TNF superfamily member 9
ISO
RGD
PMID:17325342
RGD:2317348
NCBI chr 2:72,578,811...72,582,834
Ensembl chr 2:72,578,821...72,582,745
G
TNIK
TRAF2 and NCK interacting kinase
disease_progression
ISO
protein:increased phosphorylation:liver, nucleus (human)
RGD
PMID:25160513
RGD:151347837
NCBI chr13:109,642,848...110,052,345
Ensembl chr13:109,643,895...110,052,236
G
TONSL
tonsoku like, DNA repair protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 4:349,992...361,749
Ensembl chr 4:350,060...362,167
G
TOP2A
DNA topoisomerase II alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr12:22,001,300...22,028,452
Ensembl chr12:22,001,282...22,028,450
G
TP53
tumor protein p53
treatment
ISO
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma | ClinVar Annotator: match by term: LIVER CELL CARCINOMA
RGD ClinVar OMIM
PMID:253702 PMID:960674 PMID:1349102 PMID:1349175 PMID:1359493 PMID:1565143 PMID:1565144 PMID:1569604 PMID:1591732 PMID:1631137 PMID:1631151 PMID:1672732 PMID:1673792 PMID:1679237 PMID:1683921 PMID:1686725 PMID:1849234 PMID:1915267 PMID:1918170 PMID:1975675 PMID:1978757 PMID:1999338 PMID:2046748 PMID:2259385 PMID:2531845 PMID:2554494 PMID:2654466 PMID:4122735 PMID:6736287 PMID:7565304 PMID:7651740 PMID:7707106 PMID:7732013 PMID:7737263 PMID:7750099 PMID:7783166 PMID:7791795 PMID:7881428 PMID:7885831 PMID:7887414 PMID:7969167 PMID:8023157 PMID:8062826 PMID:8080050 PMID:8099841 PMID:8118819 PMID:8164043 PMID:8242631 PMID:8242752 PMID:8276238 PMID:8336941 PMID:8344492 PMID:8364550 PMID:8401536 PMID:8402598 PMID:8423216 PMID:8425176 PMID:8464896 PMID:8479749 PMID:8527048 PMID:8550239 PMID:8633021 PMID:8718514 PMID:8825920 PMID:8829627 PMID:8829653 PMID:8869100 PMID:9047394 PMID:9049183 PMID:9150393 PMID:9218725 PMID:9242456 PMID:9268986 PMID:9290701 PMID:9364015 PMID:9399658 PMID:9399838 PMID:9405613 PMID:9407971 PMID:9472631 PMID:9525742 PMID:9546439 PMID:9569050 PMID:9572492 PMID:9598730 PMID:9607760 PMID:9627118 PMID:9632751 PMID:9662334 PMID:9667734 PMID:9704930 PMID:9825943 PMID:9839505 PMID:9891044 PMID:10064694 PMID:10089074 PMID:10229196 PMID:10366100 PMID:10411893 PMID:10432928 PMID:10519380 PMID:10557074 PMID:10567903 PMID:10589545 PMID:10616528 PMID:10713666 PMID:10753186 PMID:10754498 PMID:10761705 PMID:10797439 PMID:10802655 PMID:10864200 PMID:10871862 PMID:10914716 PMID:10922393 PMID:11051239 PMID:11051241 PMID:11101847 PMID:11139324 PMID:11152481 PMID:11180592 PMID:11313981 PMID:11315715 PMID:11370630 PMID:11403041 PMID:11429705 PMID:11479205 PMID:11494139 PMID:11590071 PMID:11593407 PMID:11668501 PMID:11782540 PMID:11793474 PMID:11896595 PMID:11900253 PMID:11920788 PMID:11920959 PMID:12007217 PMID:12034820 PMID:12076704 PMID:12124823 PMID:12406399 PMID:12506399 PMID:12509279 PMID:12567188 PMID:12619118 PMID:12672316 PMID:12695689 PMID:12700230 PMID:12726864 PMID:12779080 PMID:12792784 PMID:12826609 PMID:12885464 PMID:12901974 PMID:12909720 PMID:12917626 PMID:14559903 PMID:14584079 PMID:14673037 PMID:14743206 PMID:15004724 PMID:15017592 PMID:15037740 PMID:15060172 PMID:15077194 PMID:15161705 PMID:15308588 PMID:15355915 PMID:15381368 PMID:15390294 PMID:15541116 PMID:15564800 PMID:15580553 PMID:15607980 PMID:15607981 PMID:15611505 PMID:15703170 PMID:15722483 PMID:15781620 PMID:15825182 PMID:15850016 PMID:15925506 PMID:15951970 PMID:15958617 PMID:15977174 PMID:15982667 PMID:16000567 PMID:16199549 PMID:16206219 PMID:16209708 PMID:16247456 PMID:16258005 PMID:16288208 PMID:16322298 PMID:16337994 PMID:16401470 PMID:16474844 PMID:16489069 PMID:16494995 PMID:16508005 PMID:16551709 PMID:16633321 PMID:16682957 PMID:16736287 PMID:16741917 PMID:16754663 PMID:16778209 PMID:16818505 PMID:16827139 PMID:16861262 PMID:16964264 PMID:16969106 PMID:17015838 PMID:17170001 PMID:17308077 PMID:17311302 PMID:17390010 PMID:17401428 PMID:17417627 PMID:17427234 PMID:17530187 PMID:17535973 PMID:17540308 PMID:17541742 PMID:17567834 PMID:17572079 PMID:17599946 PMID:17606709 PMID:17636407 PMID:17638920 PMID:17724467 PMID:17875924 PMID:17881637 PMID:18208484 PMID:18307025 PMID:18391940 PMID:18453682 PMID:18477611 PMID:18511570 PMID:18555592 PMID:18628487 PMID:18685109 PMID:18689542 PMID:18818522 PMID:18937320 PMID:19012332 PMID:19101993 PMID:19127115 PMID:19147582 PMID:19171880 PMID:19336573 PMID:19367569 PMID:19378321 PMID:19405127 PMID:19454241 PMID:19462533 PMID:19468865 PMID:19521721 PMID:19556618 PMID:19681600 PMID:19711436 PMID:19714490 PMID:19834951 PMID:19850740 PMID:19881536 PMID:19913028 PMID:19930417 PMID:20013323 PMID:20028212 PMID:20113312 PMID:20118236 PMID:20127978 PMID:20128691 PMID:20182602 PMID:20234365 PMID:20308654 PMID:20407015 PMID:20436704 PMID:20505364 PMID:20506564 PMID:20516128 PMID:20520810 PMID:20522432 PMID:20538734 PMID:20589832 PMID:20593220 PMID:20689556 PMID:20693561 PMID:20805372 PMID:20878954 PMID:20972454 PMID:21056685 PMID:21059199 PMID:21080251 PMID:21113594 PMID:21115975 PMID:21118481 PMID:21159183 PMID:21187651 PMID:21232794 PMID:21305319 PMID:21343334 PMID:21356188 PMID:21445056 PMID:21483000 PMID:21484931 PMID:21514416 PMID:21519010 PMID:21535297 PMID:21552135 PMID:21561095 PMID:21590121 PMID:21601526 PMID:21619694 PMID:21626334 PMID:21665182 PMID:21672450 PMID:21674059 PMID:21747090 PMID:21761402 PMID:22006311 PMID:22052707 PMID:22090360 PMID:22110706 PMID:22114072 PMID:22186996 PMID:22198284 PMID:22233476 PMID:22265402 PMID:22319594 PMID:22427690 PMID:22484423 PMID:22553421 PMID:22553460 PMID:22672556 PMID:22698404 PMID:22703879 PMID:22710932 PMID:22713868 PMID:22729912 PMID:22744426 PMID:22768918 PMID:22811390 PMID:22822097 PMID:22862161 PMID:22869713 PMID:22887876 PMID:22899716 PMID:22915647 PMID:22919068 PMID:22923379 PMID:22955915 PMID:22983585 PMID:22999923 PMID:23031740 PMID:23161690 PMID:23172776 PMID:23246812 PMID:23259501 PMID:23263379 PMID:23265383 PMID:23315175 PMID:23334668 PMID:23406775 PMID:23484829 PMID:23538418 PMID:23612969 PMID:23624782 PMID:23625637 PMID:23630318 PMID:23667202 PMID:23713777 PMID:23792586 PMID:23887774 PMID:23894400 PMID:23950206 PMID:23967324 PMID:24033266 PMID:24038938 PMID:24065105 PMID:24122735 PMID:24307375 PMID:24381225 PMID:24382691 PMID:24384472 PMID:24395441 PMID:24487413 PMID:24501221 PMID:24573247 PMID:24590827 PMID:24603336 PMID:24641375 PMID:24651012 PMID:24651015 PMID:24677579 PMID:24702488 PMID:24728327 PMID:24744791 PMID:24810334 PMID:24835218 PMID:24857548 PMID:24940547 PMID:25059482 PMID:25119136 PMID:25123297 PMID:25131192 PMID:25157968 PMID:25186627 PMID:25256166 PMID:25293557 PMID:25294809 PMID:25326637 PMID:25339994 PMID:25404506 PMID:25433984 PMID:25503501 PMID:25504633 PMID:25516983 PMID:25525159 PMID:25584008 PMID:25584637 PMID:25612911 PMID:25619955 PMID:25634208 PMID:25691460 PMID:25741868 PMID:25757876 PMID:25787918 PMID:25896519 PMID:25925845 PMID:25927356 PMID:25945745 PMID:25952993 PMID:25980754 PMID:26014290 PMID:26024390 PMID:26066407 PMID:26205489 PMID:26225655 PMID:26230955 PMID:26270727 PMID:26271412 PMID:26332594 PMID:26425688 PMID:26467025 PMID:26497680 PMID:26554828 PMID:26556299 PMID:26580448 PMID:26585234 PMID:26619011 PMID:26628864 PMID:26641009 PMID:26659639 PMID:26681312 PMID:26718964 PMID:26781615 PMID:26786923 PMID:26787237 PMID:26818906 PMID:26822237 PMID:26845104 PMID:26878390 PMID:26911350 PMID:26976419 PMID:27022024 PMID:27077130 PMID:27146902 PMID:27149858 PMID:27153395 PMID:27179933 PMID:27189670 PMID:27276561 PMID:27276934 PMID:27328919 PMID:27374712 PMID:27458004 PMID:27463065 PMID:27489289 PMID:27493922 PMID:27501770 PMID:27516001 PMID:27523101 PMID:27533082 PMID:27616075 PMID:27621308 PMID:27622479 PMID:27680515 PMID:27683180 PMID:27714481 PMID:27724982 PMID:27730344 PMID:27873457 PMID:27895058 PMID:27911860 PMID:27959731 PMID:27993330 PMID:28135145 PMID:28152038 PMID:28160093 PMID:28176830 PMID:28271309 PMID:28279309 PMID:28349240 PMID:28356770 PMID:28369373 PMID:28453743 PMID:28472496 PMID:28477316 PMID:28492532 PMID:28664506 PMID:28724667 PMID:28802053 PMID:28861920 PMID:28873162 PMID:28975465 PMID:29025599 PMID:29058119 PMID:29070607 PMID:29076966 PMID:29126202 PMID:29300620 PMID:29324801 PMID:29470806 PMID:29478780 PMID:29489754 PMID:29581140 PMID:29752822 PMID:29753700 PMID:29785153 PMID:29958926 PMID:29979965 PMID:30076369 PMID:30128536 PMID:30152528 PMID:30216591 PMID:30224644 PMID:30287823 PMID:30299350 PMID:30311369 PMID:30318520 PMID:30322717 PMID:30327374 PMID:30352134 PMID:30374176 PMID:30450585 PMID:30546832 PMID:30583724 PMID:30630526 PMID:30675318 PMID:30709381 PMID:30720243 PMID:30816478 PMID:30840781 PMID:30918304 PMID:31016814 PMID:31050713 PMID:31105275 PMID:31119730 PMID:31121848 PMID:31127191 PMID:31159747 PMID:31168460 PMID:31206626 PMID:31212162 PMID:31296311 PMID:31300551 PMID:31321604 PMID:31494577 PMID:31559875 PMID:31742824 PMID:31748977 PMID:31775759 PMID:31882575 PMID:31983162 PMID:32000721 PMID:32019277 PMID:32126783 PMID:32156018 PMID:32164171 PMID:32179180 PMID:32187361 PMID:32295079 PMID:32318955 PMID:32401780 PMID:32475984 PMID:32658383 PMID:32817165 PMID:32885271 PMID:32888145 PMID:32899294 PMID:32906206 PMID:32959997 PMID:32980694 PMID:33087929 PMID:33138793 PMID:33163847 PMID:33208383 PMID:33245408 PMID:33257846 PMID:33300245 PMID:33332384 PMID:33372952 PMID:33407742 PMID:33471991 PMID:33633026 PMID:33635883 PMID:33674644 PMID:33818021 PMID:33840814 PMID:33841550 PMID:34026625 PMID:34088725 PMID:34240179 PMID:34266904 PMID:34299313 PMID:34308366 PMID:34503094 PMID:34529667 PMID:34675114 PMID:34709361 PMID:34793666 PMID:34805717 PMID:34994652 PMID:35033608 PMID:35043155 PMID:35127508 PMID:35802772 PMID:35820297 PMID:35938033 PMID:35974385 PMID:36008825 PMID:36219266 PMID:36309086 PMID:36329109 PMID:36988593 More...
RGD:152998960
NCBI chr12:52,939,643...52,953,786
Ensembl chr12:52,939,644...52,953,818
G
TP73
tumor protein p73
treatment exacerbates
ISO
human cells in a mouse model protein:decreased phosphorylation:liver (human) mRNA:increased expression:liver (human)
RGD
PMID:14760085 PMID:19664633 PMID:25371988 PMID:27359056 PMID:31429776
RGD:151347579 RGD:151347592 RGD:151347593 RGD:151347594 RGD:151347596
NCBI chr 6:65,169,770...65,228,997
Ensembl chr 6:65,182,456...65,228,990
G
TPX2
TPX2 microtubule nucleation factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr17:35,431,271...35,484,814
Ensembl chr17:35,431,395...35,485,065
G
TRAF7
TNF receptor associated factor 7
treatment
ISO
mRNA:increased expression:liver
RGD
PMID:31730901
RGD:151356961
NCBI chr 3:39,811,803...39,828,450
Ensembl chr 3:39,810,606...39,828,395
G
TRAIP
TRAF interacting protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr13:32,332,336...32,380,988
Ensembl chr13:32,345,599...32,379,766
G
TRIM24
tripartite motif containing 24
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18026104
NCBI chr18:11,055,211...11,151,755
Ensembl chr18:11,055,213...11,151,404
G
TRIP13
thyroid hormone receptor interactor 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr16:79,458,843...79,473,705
Ensembl chr16:79,458,847...79,473,712
G
TROAP
trophinin associated protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 5:15,300,688...15,307,681
Ensembl chr 5:15,300,687...15,307,679
G
TSC1
TSC complex subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21499249
NCBI chr 1:272,636,530...272,685,948
Ensembl chr 1:272,636,532...272,685,951
G
TSC2
TSC complex subunit 2
severity
ISO
protein:decreased expression:liver (human)
RGD
PMID:24119083
RGD:21079731
NCBI chr 3:39,898,924...39,935,579
Ensembl chr 3:39,898,925...39,937,371
G
TSLP
thymic stromal lymphopoietin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:115,832,152...115,837,572
G
TST
thiosulfate sulfurtransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 5:10,749,264...10,759,623
Ensembl chr 5:10,746,890...10,759,622
G
TTC36
tetratricopeptide repeat domain 36
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:45,829,014...45,838,978
Ensembl chr 9:45,829,191...45,838,979
G
TTK
TTK protein kinase
disease_progression
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver (human)
CTD RGD
PMID:28284560 PMID:35693827
RGD:153344586
NCBI chr 1:86,076,576...86,125,334
Ensembl chr 1:86,076,583...86,125,718
G
TTR
transthyretin
disease_progression
ISO
protein:decreased expression:blood serum (human) protein:increased expression:blood serum (human) protein:increased expression:blood serum (rat)
RGD
PMID:16240287 PMID:28876464 PMID:29534342
RGD:151356736 RGD:151664602 RGD:151665161
NCBI chr 6:115,496,338...115,503,974
Ensembl chr 6:115,496,326...115,503,977
G
TXNIP
thioredoxin interacting protein
ISO
OMIM:114550
MouseDO
NCBI chr 4:99,348,589...99,351,760
Ensembl chr 4:99,348,490...99,352,755
G
TYMS
thymidylate synthetase
susceptibility
ISO
DNA:deletion:3'UTR:1494del6(human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17659576 PMID:18019677 PMID:18230555
RGD:14696708
NCBI chr 6:105,642,730...105,660,279
Ensembl chr 6:105,642,381...105,660,578
G
UACA
uveal autoantigen with coiled-coil domains and ankyrin repeats
ISO
OMIM:114550
MouseDO
NCBI chr 1:168,353,655...168,453,175
Ensembl chr 1:168,350,557...168,453,344
G
UBD
ubiquitin D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144
NCBI chr 7:22,501,130...22,502,883
Ensembl chr 7:22,501,130...22,503,094
G
UBE2C
ubiquitin conjugating enzyme E2 C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr17:48,018,403...48,021,542
Ensembl chr17:48,018,400...48,021,534
G
UBE2E2
ubiquitin conjugating enzyme E2 E2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27914986
NCBI chr13:9,998,097...10,380,564
Ensembl chr13:9,998,199...10,380,556
G
UBE2T
ubiquitin conjugating enzyme E2 T
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr10:24,454,492...24,459,085
Ensembl chr10:24,454,495...24,459,057
G
UBR5
ubiquitin protein ligase E3 component n-recognin 5
treatment
ISO
RGD
PMID:32087767
RGD:151665344
NCBI chr 4:34,645,794...34,794,510
Ensembl chr 4:34,645,809...34,793,940
G
UCHL1
ubiquitin C-terminal hydrolase L1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18666234
NCBI chr 8:32,353,766...32,367,288
Ensembl chr 8:32,353,246...32,367,332
G
UHRF1
ubiquitin like with PHD and ring finger domains 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:73,898,061...73,937,727
Ensembl chr 2:73,898,071...73,931,769
G
UMPS
uridine monophosphate synthetase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18230555
NCBI chr13:135,611,857...135,650,656
Ensembl chr13:135,610,058...135,650,603
G
UROC1
urocanate hydratase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:53,592,763...53,634,214
Ensembl chr 7:53,590,776...53,637,713
G
USP2
ubiquitin specific peptidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147110
NCBI chr 9:46,563,469...46,590,392
Ensembl chr 9:46,563,482...46,590,392
G
USP4
ubiquitin specific peptidase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35841383
NCBI chr13:31,844,780...31,904,418
Ensembl chr13:31,848,851...31,904,243
G
VASN
vasorin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25826090
NCBI chr 3:37,961,425...37,972,477
Ensembl chr 3:37,961,432...37,972,114
G
VAV1
vav guanine nucleotide exchange factor 1
ISO
mRNA:decreased expression:liver
RGD
PMID:2064726
RGD:2306008
NCBI chr 2:72,327,433...72,391,649
Ensembl chr 2:72,326,716...72,391,648
G
VCAM1
vascular cell adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22922871
NCBI chr 4:117,496,914...117,511,211
Ensembl chr 4:117,496,920...117,511,222
G
VDR
vitamin D receptor
susceptibility
ISO
associated with alcoholic liver cirrhosis;DNA:haplotype:: ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma associated with Hepatitis B, Chronic;DNA:SNP: :rs2228570(human)
RGD ClinVar
PMID:20572305 PMID:24033266 PMID:25541958 PMID:25741868 PMID:28492532
RGD:14402025 RGD:14402026
NCBI chr 5:78,205,807...78,266,505
Ensembl chr 5:78,205,810...78,266,475
G
VEGFA
vascular endothelial growth factor A
treatment susceptibility disease_progression
ISO
DNA:polymorphism:promoter:-2578C>A (rs699947)(human) DNA:SNP: :2578C>A (human) protein:increased expression:liver protein:increased expression:serum: associated with liver cirrhosis; associated with liver cirrhosis; protein:increased expression:platelet, liver:
RGD
PMID:16835748 PMID:18392108 PMID:18544126 PMID:24445728 PMID:25999787 PMID:26930285 PMID:27338800 PMID:28147320 More...
RGD:11527070 RGD:126848814 RGD:15003194 RGD:15003196 RGD:15003200 RGD:15014783 RGD:15036790 RGD:152177911
NCBI chr 7:38,746,393...38,762,282
Ensembl chr 7:38,746,052...38,761,366
G
VEGFC
vascular endothelial growth factor C
ISO
associated with liver cirrhosis; protein:increased expression:liver:
RGD
PMID:18544126
RGD:15003200
NCBI chr15:39,037,764...39,136,234
Ensembl chr15:39,039,311...39,132,936
G
VHL
von Hippel-Lindau tumor suppressor
disease_progression
ISO
RGD
PMID:31321740
RGD:155882550
NCBI chr13:66,334,535...66,342,401
Ensembl chr13:66,334,591...66,342,654
G
VIPR1
vasoactive intestinal peptide receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr13:26,036,610...26,073,168
Ensembl chr13:26,036,629...26,075,691
G
VSIG4
V-set and immunoglobulin domain containing 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr X:52,175,601...52,198,635
Ensembl chr X:52,175,607...52,198,566
G
WDR62
WD repeat domain 62
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:45,418,966...45,477,619
Ensembl chr 6:45,419,015...45,474,050
G
WDR76
WD repeat domain 76
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:127,651,765...127,741,357
Ensembl chr 1:127,654,178...127,741,354
G
WNT2
Wnt family member 2
susceptibility
ISO
associated with hepatitis B;DNA:SNP: :rs4730775(human)
RGD
PMID:28328801
RGD:14402040
NCBI chr18:28,945,825...28,993,969
Ensembl chr18:28,946,326...28,993,961
G
WRAP53
WD repeat containing antisense to TP53
ISO
RNA:increased expression:liver:
RGD
PMID:26551349
RGD:11096781
NCBI chr12:52,954,674...52,968,371
Ensembl chr12:52,954,669...52,968,364
G
XDH
xanthine dehydrogenase
ISO
protein:decreased activity:tumor (rat)
RGD
PMID:179860
RGD:5135059
NCBI chr 3:107,987,060...108,052,043
Ensembl chr 3:107,987,126...108,053,169
G
XPO1
exportin 1
ameliorates treatment exacerbates
ISO
human cell line in a mouse model mRNA:increased expression:liver (human)
RGD
PMID:25030088 PMID:27013579 PMID:31371628
RGD:151665796 RGD:151667433 RGD:151667441
NCBI chr 3:80,255,016...80,300,260
Ensembl chr 3:80,255,146...80,300,327
G
XPO5
exportin 5
severity
ISO
DNA:snp, haplotype:3' utr:c.*659A>C (rs11077) (human)
RGD
PMID:24676133
RGD:11041737
NCBI chr 7:38,530,704...38,569,558
Ensembl chr 7:38,531,919...38,569,582
G
XRCC1
X-ray repair cross complementing 1
susceptibility severity disease_progression no_association
ISO
DNA:missense mutation:cds:c.1804C>A (p.G506A) (human) associated with Chronic Hepatitis C;DNA:SNP:exon 14: c.1517G>C, p.506G>A (human) DNA:SNPs:exon 9, exon 15: c.910A>G, c.1686C>G (human) DNA:SNP:exon 13: c.1471G>A, p.E491K (human) DNA:SNPs:cds: 194C>T, 280A>G (human) DNA:silent mutation, missense mutation:cds:c.1161G>A, c.1779C>G (p.L387L, p.S593R) (human) DNA:missense mutations:cds:c.482C>T, c.1178G>A (p.P161L, p.R393H) (human) associated with hepatitis B;DNA:missense mutation, haplotype:cds:p.R399Q (human) DNA:missense mutation:cds:p.R399Q (rs25487) (human) DNA:missense mutation:cds:p.R399Q (human) DNA:missense mutations:cds:p.R194W, p.R280H, p.R399Q (human) associated with Hepatitis C, Chronic;DNA:missense mutation:cds:p.R194W (human) DNA:SNPs:exons:c.1254C>T, c.1517G>C (human) associated with Hepatitis C, Chronic;DNA:missense mutation:cds:p.R399Q (human) DNA:missense mutation:cds:p.R399Q (28152G>A) (rs25487) (human)
RGD
PMID:14519756 PMID:19194663 PMID:22502666 PMID:23454624 PMID:23493666 PMID:23534753 PMID:23984316 PMID:24446299 PMID:24526467 PMID:24570146 PMID:24634229 PMID:26918371 PMID:28058700 PMID:28927037 PMID:29682247 PMID:29935355 PMID:32334466 More...
RGD:14696702 RGD:14696772 RGD:14696773 RGD:14985238 RGD:14985240 RGD:14985242 RGD:14985243 RGD:15014789 RGD:15014790 RGD:15014791 RGD:15014792 RGD:15036794 RGD:15036797 RGD:150530503 RGD:150530624 RGD:150540332 RGD:150540333
NCBI chr 6:50,403,691...50,425,730
Ensembl chr 6:50,403,689...50,425,729
G
YAP1
Yes1 associated transcriptional regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29698666
NCBI chr 9:32,811,629...32,924,926
Ensembl chr 9:32,811,416...32,925,603
G
YTHDF2
YTH N6-methyladenosine RNA binding protein F2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28104805
NCBI chr 6:85,717,147...85,756,750
Ensembl chr 6:85,716,983...85,726,473
G
YWHAZ
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta
severity
ISO
RGD
PMID:27811373
RGD:14700875
NCBI chr 4:35,975,513...36,009,909
Ensembl chr 4:35,975,508...36,009,887
G
ZC3H12D
zinc finger CCCH-type containing 12D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34545456
NCBI chr 1:16,463,532...16,498,974
Ensembl chr 1:16,465,252...16,498,971
G
ZFHX3
zinc finger homeobox 3
severity disease_progression
ISO
human cell line in a mouse model associated with Chronic Hepatitis B;protein:decreased expression:blood serum (human)
RGD
PMID:20534899 PMID:32277050
RGD:151361162 RGD:151361169
NCBI chr 6:15,693,987...15,941,301
Ensembl chr 6:15,698,199...15,863,270
G
ZFP36
ZFP36 ring finger protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:48,063,732...48,066,235
Ensembl chr 6:48,063,677...48,066,250
G
ZIC2
Zic family member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr11:68,840,802...68,845,441
Ensembl chr11:68,840,631...68,845,378
G
ZIC4
Zic family member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr13:87,725,642...87,740,724
Ensembl chr13:87,722,146...87,740,921
G
ZIC5
Zic family member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr11:68,821,733...68,830,472
Ensembl chr11:68,821,735...68,830,540
G
ZNF23
zinc finger protein 23
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21965783
NCBI chr 6:14,463,135...14,480,783
Ensembl chr 6:14,463,304...14,480,863
G
ZWINT
ZW10 interacting kinetochore protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr14:94,094,781...94,109,447
Ensembl chr14:94,094,894...94,102,060
G
EPHX1
epoxide hydrolase 1
ISO
associated with estrogen excess;protein:increased activity;liver (rat)
RGD
PMID:6133380
RGD:152998935
NCBI chr10:13,757,489...13,773,071
Ensembl chr10:13,751,881...13,773,072
G
MET
MET proto-oncogene, receptor tyrosine kinase
ISO
ClinVar Annotator: match by term: Pediatric hepatocellular carcinoma
ClinVar
PMID:9927037 PMID:17483355
NCBI chr18:29,426,044...29,541,526
Ensembl chr18:29,426,048...29,541,512
G
CA12
carbonic anhydrase 12
ISO
mRNA:increased expression:liver
RGD
PMID:28304380
RGD:153352326
NCBI chr 1:108,649,277...108,710,658
Ensembl chr 1:108,649,271...108,710,651
G
CTNNB1
catenin beta 1
ISO
protein:increased tyrosine phosphorylation:exon:
RGD
PMID:19101982
RGD:14402052
NCBI chr13:25,163,550...25,208,314
Ensembl chr13:25,164,277...25,208,311
G
FGFR1
fibroblast growth factor receptor 1
ISO
protein:increased expression:liver:
RGD
PMID:24925055
RGD:11055933
NCBI chr15:48,053,895...48,106,634
Ensembl chr15:48,053,340...48,106,724
G
PRKACA
protein kinase cAMP-activated catalytic subunit alpha
ISO
mRNA,protein:increased expression:liver (human)
RGD
PMID:27027723
RGD:151347845
NCBI chr 2:65,074,876...65,095,564
Ensembl chr 2:65,074,870...65,095,551
G
IDH1
isocitrate dehydrogenase (NADP(+)) 1
disease_progression
ISO
DNA:polymorphism: :rs12478635(human) DNA:misssense mutation:cds:p.Arg132Cys(human)
RGD
PMID:25355558 PMID:28403884
RGD:14974227 RGD:14974228
NCBI chr15:111,341,153...111,362,330
Ensembl chr15:111,341,153...111,362,296
G
IDH2
isocitrate dehydrogenase (NADP(+)) 2
disease_progression
ISO
DNA:polymorphism: :rs11632348(human)
RGD
PMID:25355558
RGD:14974228
NCBI chr 7:55,654,298...55,675,571
Ensembl chr 7:55,651,609...55,675,554
G
LEP
leptin
ISO
mRNA:increased expression:liver:
RGD
PMID:20723213
RGD:14696785
NCBI chr18:20,106,867...20,124,071
Ensembl chr18:20,106,868...20,123,323
G
LEPR
leptin receptor
ISO
mRNA:increased expression:liver
RGD
PMID:20723213
RGD:14696785
NCBI chr 6:146,802,297...146,896,152
Ensembl chr 6:146,801,954...146,895,995
G
TERT
telomerase reverse transcriptase
disease_progression
ISO
mRNA:increased expression:liver:
RGD
PMID:20723213 PMID:28460432
RGD:14696783 RGD:14696785
NCBI chr16:79,258,591...79,276,421
Ensembl chr16:79,258,591...79,276,421
G
PRKACA
protein kinase cAMP-activated catalytic subunit alpha
susceptibility
ISO
RGD
PMID:28923495
RGD:151347843
NCBI chr 2:65,074,876...65,095,564
Ensembl chr 2:65,074,870...65,095,551
G
SPRTN
SprT-like N-terminal domain
ISO
ClinVar Annotator: match by term: Progeroid features-hepatocellular carcinoma predisposition syndrome | ClinVar Annotator: match by term: Ruijs-Aalfs syndrome
OMIM ClinVar
PMID:12503110 PMID:25261934 PMID:25741868
NCBI chr14:59,177,801...59,192,221
Ensembl chr14:59,171,192...59,192,269
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all